
<html lang="en"     class="pb-page"  data-request-id="11d12de4-9ed1-4907-8972-66ad3a2d5d2a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2006.49.issue-12;wgroup:string:ACHS website Group;article:article:10.1021/jm060065y;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1H-benzimidazoles" /></meta><meta name="dc.Creator" content="Vassil I.  Ognyanov,*,†" /></meta><meta name="dc.Creator" content="Chenera  Balan,†" /></meta><meta name="dc.Creator" content="Anthony W.  Bannon,‡" /></meta><meta name="dc.Creator" content="Yunxin  Bo,†" /></meta><meta name="dc.Creator" content="Celia  Dominguez,†" /></meta><meta name="dc.Creator" content="Christopher  Fotsch,†" /></meta><meta name="dc.Creator" content="Vijay K.  Gore,†" /></meta><meta name="dc.Creator" content="Lana  Klionsky,‡" /></meta><meta name="dc.Creator" content="Vu V.  Ma,†" /></meta><meta name="dc.Creator" content="Yi-Xin  Qian,†" /></meta><meta name="dc.Creator" content="Rami  Tamir,‡" /></meta><meta name="dc.Creator" content="Xianghong  Wang,†" /></meta><meta name="dc.Creator" content="Ning  Xi,†" /></meta><meta name="dc.Creator" content="Shimin  Xu,†" /></meta><meta name="dc.Creator" content="Dawn  Zhu,‡" /></meta><meta name="dc.Creator" content="Narender R.  Gavva,‡" /></meta><meta name="dc.Creator" content="James J. S.  Treanor,‡ and" /></meta><meta name="dc.Creator" content="Mark H.  Norman†" /></meta><meta name="dc.Description" content="The vanilloid receptor-1 (VR1 or TRPV1) is a membrane-bound, nonselective cation channel that is predominantly expressed by peripheral neurons sensing painful stimuli. TRPV1 antagonists produce ant..." /></meta><meta name="Description" content="The vanilloid receptor-1 (VR1 or TRPV1) is a membrane-bound, nonselective cation channel that is predominantly expressed by peripheral neurons sensing painful stimuli. TRPV1 antagonists produce ant..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="May 19, 2006" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm060065y" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-49-12-3719" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(06)00065-3" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2006 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm060065y" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm060065y" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm060065y" /></link>
        
    
    

<title>Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1H-benzimidazoles | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm060065y" /></meta><meta property="og:title" content="Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1H-benzimidazoles" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yn00001.jpeg" /></meta><meta property="og:description" content=" The vanilloid receptor-1 (VR1 or TRPV1) is a membrane-bound, nonselective cation channel that is predominantly expressed by peripheral neurons sensing painful stimuli. TRPV1 antagonists produce antihyperalgesic effects in animal models of inflammatory and neuropathic pain. Herein, we describe the synthesis and the structure−activity relationships of a series of 2-(4-pyridin-2-ylpiperazin-1-yl)-1H-benzo[d]imidazoles as novel TRPV1 antagonists. Compound 46ad was among the most potent analogues in this series. This compound was orally bioavailable in rats and was efficacious in blocking capsaicin-induced flinch in rats in a dose-dependent manner. Compound 46ad also reversed thermal hyperalgesia in a model of inflammatory pain, which was induced by complete Freund's adjuvant (CFA).  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm060065y"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm060065y">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm060065y&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm060065y&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm060065y&amp;href=/doi/10.1021/jm060065y" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2006</span><span class="cit-fg-volume">, 49</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 3719-3742</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/49/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm060197r" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm051091j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1<i>H</i>-benzimidazoles</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vassil+I.++Ognyanov">Vassil I. Ognyanov</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chenera++Balan">Chenera Balan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+W.++Bannon">Anthony W. Bannon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yunxin++Bo">Yunxin Bo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Celia++Dominguez">Celia Dominguez</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Fotsch">Christopher Fotsch</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vijay+K.++Gore">Vijay K. Gore</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lana++Klionsky">Lana Klionsky</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vu+V.++Ma">Vu V. Ma</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi-Xin++Qian">Yi-Xin Qian</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rami++Tamir">Rami Tamir</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xianghong++Wang">Xianghong Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ning++Xi">Ning Xi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shimin++Xu">Shimin Xu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dawn++Zhu">Dawn Zhu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Narender+R.++Gavva">Narender R. Gavva</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+J.+S.++Treanor">James J. S. Treanor</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+H.++Norman">Mark H. Norman</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm060065y&amp;href=/doi/10.1021%2Fjm060065y" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2006</span></span><span class="cit-volume">, 49</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 3719–3742</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 19, 2006</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 January 2006</li><li><span class="item_label"><b>Published</b> online</span>19 May 2006</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 June 2006</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm060065y" title="DOI URL">https://doi.org/10.1021/jm060065y</a></div><div class="article_header-article-copyright"><strong>Copyright © 2006 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3719%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVassil%2BI.%2BOgnyanov%252C%2BChenera%2BBalan%252C%2BAnthony%2BW.%2BBannon%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D49%26issueNum%3D12%26contentID%3Djm060065y%26title%3DDesign%2Bof%2BPotent%252C%2BOrally%2BAvailable%2BAntagonists%2Bof%2Bthe%2BTransient%2BReceptor%2BPotential%2BVanilloid%2B1.%2BStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2B2-Piperazin-1-yl-1H-benzimidazoles%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3742%26publicationDate%3DJune%2B2006">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm060065y"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4406</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">63</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm060065y" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1H-benzimidazoles&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Vassil&quot;,&quot;last_name&quot;:&quot;I. Ognyanov&quot;},{&quot;first_name&quot;:&quot;Chenera&quot;,&quot;last_name&quot;:&quot;Balan&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;W. Bannon&quot;},{&quot;first_name&quot;:&quot;Yunxin&quot;,&quot;last_name&quot;:&quot;Bo&quot;},{&quot;first_name&quot;:&quot;Celia&quot;,&quot;last_name&quot;:&quot;Dominguez&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Fotsch&quot;},{&quot;first_name&quot;:&quot;Vijay&quot;,&quot;last_name&quot;:&quot;K. Gore&quot;},{&quot;first_name&quot;:&quot;Lana&quot;,&quot;last_name&quot;:&quot;Klionsky&quot;},{&quot;first_name&quot;:&quot;Vu&quot;,&quot;last_name&quot;:&quot;V. Ma&quot;},{&quot;first_name&quot;:&quot;Yi-Xin&quot;,&quot;last_name&quot;:&quot;Qian&quot;},{&quot;first_name&quot;:&quot;Rami&quot;,&quot;last_name&quot;:&quot;Tamir&quot;},{&quot;first_name&quot;:&quot;Xianghong&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Ning&quot;,&quot;last_name&quot;:&quot;Xi&quot;},{&quot;first_name&quot;:&quot;Shimin&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Dawn&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Narender&quot;,&quot;last_name&quot;:&quot;R. Gavva&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;J. S. Treanor&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;H. Norman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2006&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;49&quot;,&quot;pages&quot;:&quot;3719-3742&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm060065y&quot;},&quot;abstract&quot;:&quot;The vanilloid receptor-1 (VR1 or TRPV1) is a membrane-bound, nonselective cation channel that is predominantly expressed by peripheral neurons sensing painful stimuli. TRPV1 antagonists produce antihyperalgesic effects in animal models of inflammatory and neuropathic pain. Herein, we describe the synthesis and the structure−activity relationships of a series of 2-(4-pyridin-2-ylpiperazin-1-yl)-1H-benzo[d]imidazoles as novel TRPV1 antagonists. Compound 46ad was among the most potent analogues in this series. This compound was orally bioavailable in rats and was efficacious in blocking capsaicin-induced flinch in rats in a dose-dependent manner. Compound 46ad also reversed thermal hyperalgesia in a model of inflammatory pain, which was induced by complete Freund's adjuvant (CFA).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm060065y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm060065y" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm060065y&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm060065y" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm060065y&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm060065y" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm060065y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm060065y&amp;href=/doi/10.1021/jm060065y" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm060065y" /></input><a href="/doi/pdf/10.1021/jm060065y" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (488 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm060065y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm060065y%26sid%3Dliteratum%253Aachs%26pmid%3D16759115%26genre%3Darticle%26aulast%3DOgnyanov%26date%3D2006%26atitle%3DDesign%2Bof%2BPotent%252C%2BOrally%2BAvailable%2BAntagonists%2Bof%2Bthe%2BTransient%2BReceptor%2BPotential%2BVanilloid%2B1.%2BStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2B2-Piperazin-1-yl-1H-benzimidazoles%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D49%26issue%3D12%26spage%3D3719%26epage%3D3742%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290703" title="Pyridines">Pyridines</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/49/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The vanilloid receptor-1 (VR1 or TRPV1) is a membrane-bound, nonselective cation channel that is predominantly expressed by peripheral neurons sensing painful stimuli. TRPV1 antagonists produce antihyperalgesic effects in animal models of inflammatory and neuropathic pain. Herein, we describe the synthesis and the structure−activity relationships of a series of 2-(4-pyridin-2-ylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazoles as novel TRPV1 antagonists. Compound <b>46ad</b> was among the most potent analogues in this series. This compound was orally bioavailable in rats and was efficacious in blocking capsaicin-induced flinch in rats in a dose-dependent manner. Compound <b>46ad</b> also reversed thermal hyperalgesia in a model of inflammatory pain, which was induced by complete Freund's adjuvant (CFA). </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm060065yAF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom correspondence should be addressed. Tel:  805-447-1509. Fax:  805-480-1337. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="94e2f5e7e7fdf8fbd4f5f9f3f1fabaf7fbf9ba">[email protected]</a></p></span></div><div class="fnGroupItem" id="jm060065yAF2"><span><h4><span class="NLM_fn-symbol">†</span></h4></span><span><p class="last">  Department of Chemistry Research and Discovery.</p></span></div><div class="fnGroupItem" id="jm060065yAF3"><span><h4><span class="NLM_fn-symbol">‡</span></h4></span><span><p class="last">  Department of Neuroscience.</p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The vanilloid receptor-1 (VR1 or TRPV1)<sup><a onclick="showRef(event, 'jm060065yb00001'); return false;" href="javascript:void(0);" class="ref jm060065yb00001">1</a></sup> is a polymodal nociceptor that belongs to the family of the transient receptor potential (TRP) ion channels. The highly Ca<sup>2+</sup> permeable TRPV1 receptor is predominantly expressed in sensory neurons<sup><a onclick="showRef(event, 'jm060065yb00002 jm060065yb00003 jm060065yb00004'); return false;" href="javascript:void(0);" class="ref jm060065yb00002 jm060065yb00003 jm060065yb00004">2-4</a></sup> and is involved in the detection of painful stimuli. The endogenous activators of TRPV1 are generated as a result of tissue injury and inflammatory conditions in research animals<sup><a onclick="showRef(event, 'jm060065yb00005 jm060065yb00006 jm060065yb00007'); return false;" href="javascript:void(0);" class="ref jm060065yb00005 jm060065yb00006 jm060065yb00007">5-7</a></sup> and in humans<sup><a onclick="showRef(event, 'jm060065yb00008 jm060065yb00009'); return false;" href="javascript:void(0);" class="ref jm060065yb00008 jm060065yb00009">8,9</a></sup> and include heat (>42 °C), protons (pH 5),<sup><a onclick="showRef(event, 'jm060065yb00010'); return false;" href="javascript:void(0);" class="ref jm060065yb00010">10</a></sup> and ligands such as the endocannabinoid anandamide<sup><a onclick="showRef(event, 'jm060065yb00011'); return false;" href="javascript:void(0);" class="ref jm060065yb00011">11</a></sup> and lipoxygenase metabolites.<sup><a onclick="showRef(event, 'jm060065yb00012'); return false;" href="javascript:void(0);" class="ref jm060065yb00012">12</a></sup> TRPV1 is also activated by exogenous ligands such as the vanilloid capsaicin (<b>1</b>)<sup>2</sup> and its ultrapotent analogue resiniferatoxin (RTX, <b>2</b>) (Figure 1<a data-tab="pane-pcw-Figures" href="#jm060065yf00001" id="" class=" internalNav"></a>).<sup><a onclick="showRef(event, 'jm060065yb00013'); return false;" href="javascript:void(0);" class="ref jm060065yb00013">13</a></sup><div id="_i4"><figure id="jm060065yf00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yf00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00001.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 The TRPV1 agonists capsaicin and resiniferatoxin and selected examples of TRPV1 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yf00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">TRPV1 hyperstimulation by capsaicin has an analgesic effect, since it leads to long-term desensitization of the sensory neurons to additional agonist challenges, including noxious stimuli such as heat and acid. Capsaicin is the active component of various topical muscle pain relievers, and both capsaicin and RTX have been used to treat the pain associated with diabetic neuropathy and arthritis.<sup>2,4</sup> The clinical uses of TRPV1 agonists such as capsaicin, however, are limited due to side effects of a burning sensation, irritation and neurotoxicity<sup>3</sup> resulting from the continuous influx of Ca<sup>2+</sup> ions into the cells. On the other hand, blockade of the pain-signaling pathway with a TRPV1 antagonist represents a promising strategy for the development of novel analgesics<sup><a onclick="showRef(event, 'jm060065yb00014'); return false;" href="javascript:void(0);" class="ref jm060065yb00014">14</a></sup> with potentially fewer side effects. This rationale is also supported by the observation that thermal hyperalgesia is reduced in inflammatory pain models in knockout mice lacking the TRPV1 gene.<sup><a onclick="showRef(event, 'jm060065yb00015 jm060065yb00016'); return false;" href="javascript:void(0);" class="ref jm060065yb00015 jm060065yb00016">15,16</a></sup></div><div class="NLM_p">Capsazepine (<b>3</b>)<sup><a onclick="showRef(event, 'jm060065yb00017'); return false;" href="javascript:void(0);" class="ref jm060065yb00017">17</a></sup> (Figure 1), the first reported competitive antagonist of TRPV1, emerged as a result of structure−activity relationship (SAR) studies of capsaicin. It was demonstrated that capsazepine blocks the capsaicin-induced uptake of Ca<sup>2+</sup> in neonatal rat dorsal root ganglia and shows species-dependent efficacies in various in vivo models of inflammatory hyperalgesia and chronic pain.<sup><a onclick="showRef(event, 'jm060065yb00018 jm060065yb00019 jm060065yb00020'); return false;" href="javascript:void(0);" class="ref jm060065yb00018 jm060065yb00019 jm060065yb00020">18-20</a></sup> However, it was also found that capsazepine blocks receptors other than TRPV1, such as voltage-gated Ca<sup>2+</sup> channels<sup><a onclick="showRef(event, 'jm060065yb00021'); return false;" href="javascript:void(0);" class="ref jm060065yb00021">21</a></sup> and nicotinic acetylcholine receptors,<sup><a onclick="showRef(event, 'jm060065yb00022'); return false;" href="javascript:void(0);" class="ref jm060065yb00022">22</a></sup> and does not act as an antagonist when the TRPV1 channel is activated by heat or acid. </div><div class="NLM_p">During the past few years, several classes of TRPV1 antagonists, either structurally related or not to the exogenous agonists capsaicin and RTX, have been described, and their chemistry and pharmacology have been reviewed.<sup><a onclick="showRef(event, 'jm060065yb00023 jm060065yb00024 jm060065yb00025 jm060065yb00026'); return false;" href="javascript:void(0);" class="ref jm060065yb00023 jm060065yb00024 jm060065yb00025 jm060065yb00026">23-26</a></sup> One extensively studied class of TRPV1 antagonists is based on urea templates.<sup>23,24,27-29</sup><a onclick="showRef(event, 'jm060065yb00027'); return false;" href="javascript:void(0);" class="ref jm060065yb00027"></a><a onclick="showRef(event, 'jm060065yb00028'); return false;" href="javascript:void(0);" class="ref jm060065yb00028"></a><a onclick="showRef(event, 'jm060065yb00029'); return false;" href="javascript:void(0);" class="ref jm060065yb00029"></a> For example, the potent TRPV1 antagonist <i>N</i>-(4-<i>tert</i>-butylphenyl)-4-(3-chloropyridin-2-yl)piperazine-1-carboxamide (BCTC) (<b>4</b>)<sup><a onclick="showRef(event, 'jm060065yb00030'); return false;" href="javascript:void(0);" class="ref jm060065yb00030">30</a></sup> (Figure 1) is a member of a well-studied chemical series of urea-based TRPV1 antagonists that contains a piperazine-1-carboxamide template. The BCTC template was disclosed for the first time by Neurogen<sup><a onclick="showRef(event, 'jm060065yb00031'); return false;" href="javascript:void(0);" class="ref jm060065yb00031">31</a></sup> and more recently by Johnson & Johnson,<sup><a onclick="showRef(event, 'jm060065yb00032'); return false;" href="javascript:void(0);" class="ref jm060065yb00032">32</a></sup> Bayer,<sup><a onclick="showRef(event, 'jm060065yb00033'); return false;" href="javascript:void(0);" class="ref jm060065yb00033">33</a></sup> GlaxoSmithKline,<sup><a onclick="showRef(event, 'jm060065yb00034'); return false;" href="javascript:void(0);" class="ref jm060065yb00034">34</a></sup> Abbott,<sup><a onclick="showRef(event, 'jm060065yb00035'); return false;" href="javascript:void(0);" class="ref jm060065yb00035">35</a></sup> and Purdue Pharma.<sup><a onclick="showRef(event, 'jm060065yb00036'); return false;" href="javascript:void(0);" class="ref jm060065yb00036">36</a></sup> While BCTC was found to be efficacious <a name="jm004901203720" id="jm004901203720"></a> in animal models of chronic pain, it has shown poor metabolic stability, a short half-life, poor aqueous solubility, and moderate oral bioavailability.<sup>36</sup></div><div class="NLM_p">As a continuation of our efforts to identify novel TRPV1 antagonists with improved bioavailability, we have investigated conformationally constrained analogues of BCTC. We have found that the rigidified analogue <b>5</b> (Figure 1), designed by the isosteric replacement of the amide bond of BCTC (<b>4</b>) with an imidazole ring,<sup><a onclick="showRef(event, 'jm060065yb00037'); return false;" href="javascript:void(0);" class="ref jm060065yb00037">37</a></sup> behaved as a relatively potent TRPV1 antagonist. Herein, we describe the synthesis and biological activity of a series of 2-(4-pyridin-2-ylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazoles of type <b>5</b> as novel TRPV1 class of antagonists based on constrained analogues of BCTC (Figure 1). Recently, we were the first to disclose this novel 2-piperazin-1-yl-1<i>H</i>-benzimidazole template in a patent application.<sup><a onclick="showRef(event, 'jm060065yb00038 jm060065yb00039'); return false;" href="javascript:void(0);" class="ref jm060065yb00038 jm060065yb00039">38,39</a></sup> In this paper, we include an extensive SAR data set, which provides insights into the binding mode of this novel class of TRPV1 antagonists. </div><div class="NLM_p last">For the purposes of our study, we employed rat TRPV1 channel recombinantly expressed in Chinese hamster ovary (CHO) cells. The ability of compounds to inhibit both the capsaicin- and pH-mediated influx of <sup>45</sup>Ca<sup>2+</sup> was examined. This investigation provided an understanding of the SAR of this class of compounds, resulting in the discovery of a potent new TRPV1 antagonist (e.g., compound <b>46ad</b>) with good oral bioavailability and in vivo activity in animal models of pain. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83186" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83186" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The majority of the compounds required for our SAR study, represented by structure <b>III</b>, were prepared by two general routes (methods A and B, Scheme 1<a data-tab="pane-pcw-Figures" href="#jm060065yh00001" id="" class=" internalNav"></a>). In method A, <i>N</i>-aryl- and <i>N</i>-heteroarylpiperazines of type <b>I </b>were coupled with 2-chloro-1<i>H</i>-benzimidazoles and related heterocycles of type <b>II</b> by heating under conventional or microwave-assisted conditions in the presence of a base. A similar type of <i>N</i>-arylation reaction is utilized in method B, where chloro-heteroaromatic compounds of type <b>IV</b> were coupled with 2-piperazinyl-1<i>H</i>-benzimidazoles of type <b>V</b>. <div id="_i7"><figure id="jm060065yh00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00001.jpeg" id="_i8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> R<sub>1</sub> = H; X, Y, P, and Q = C or N. <i><sup>b</sup></i><sup></sup>Conditions:  (a) <i>N</i>,<i>N</i>-diisopropylethylamine, CH<sub>3</sub>CN, 180 °C, microwave; (b) <i>N</i>,<i>N</i>-diisopropylethylamine, DMSO, 80 °C; (c) Et<sub>3</sub>N, CuI, 3-methyl-1-butanol, 220 °C, microwave; (d) <i>N</i>,<i>N</i>-diisopropylethylamine, dioxane, 190 °C, microwave; (e) NaHCO<sub>3</sub>, 3-methyl-1-butanol, 150 °C, microwave; (f) <i>N</i>,<i>N</i>-diisopropylethylamine, 250 °C, microwave; (g) K<sub>2</sub>CO<sub>3</sub>, Cu powder, DMF, 120 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Schemes 2 and 3 detail the synthesis of the piperazine building blocks of type <b>I</b> that were employed in general method A. For example, the mono- and disubstituted 2-chloropyridines <b>6a</b><b>−</b><b>n </b>were coupled with unprotected and Boc-protected piperazines <b>7a</b><b>−</b><b>f</b> in the presence of a tertiary amine and K<sub>2</sub>CO<sub>3</sub> or NaHCO<sub>3</sub> to give 1-pyridin-2-ylpiperazines <b>8a</b>, <b>8c,d</b>, <b>8f</b><b>−</b><b>i</b>, <b>8o</b>, <b>8q</b><b>−</b><b>u</b>, <b>8ab</b><b>−</b><b>8ae</b>, and <b>8ag</b>, respectively. The 2-chloropyridines <b>6a</b><b>−</b><b>g </b>and<b> 6j</b> were obtained from commercial sources, and <b>6n</b> was prepared according to the method of Koch and Schnatterer,<sup><a onclick="showRef(event, 'jm060065yb00040'); return false;" href="javascript:void(0);" class="ref jm060065yb00040">40</a></sup> while the aldehyde <b>6h</b> and the alcohol <b>6i</b> were prepared from the hydroxymethyl derivative <b>6g</b>. Ester <b>6k </b>and amides <b>6l</b> and <b>6m</b> were prepared from the carboxylic acid <b>6j </b>as illustrated in Scheme 2<a data-tab="pane-pcw-Figures" href="#jm060065yh00002" id="" class=" internalNav"></a>. The Boc protecting group of the 4-pyridin-2-ylpiperazines <b>8a</b>, <b>8d</b>, <b>8k</b>, and <b>8m</b> and was removed with a saturated solution of HCl gas in ethyl acetate, while trifluoroacetic acid was used for the deprotection of <b>8o </b>and <b>8z</b>. Carbodiimide-assisted esterification of the 5-carboxylic acid <b>8g</b> with 2,3,4,5,6-pentafluorophenol gave the ester <b>8j</b>, which upon treatment with methylamine yielded the <i>N</i>-methylamide <b>8k</b>. Ketone <b>8m</b> was prepared by treatment of the Weinreb amide <b>8i</b> with methylmagnesium bromide. The Boc protecting group of <b>8v</b> was introduced by treating the piperazine derivative <b>8u</b> with Boc anhydride in the presence of 1 N NaOH. Treatment of the 4-pyridin-2-ylpiperazines <b>8v</b> and <b>8ae</b> with bromine in dichloromethane afforded the corresponding 5-bromo-substituted derivatives <b>8w</b> and <b>8af</b>, respectively. Heck olefination of the Boc-protected 5-bromo derivative <b>8w </b>with methyl acrylate gave alkene <b>8x</b>. Dihydroxylation of the alkene <b>8x</b> with catalytic osmium tetroxide and stoichiometric <i>N</i>-methylmorpholine <i>N</i>-oxide<sup><a onclick="showRef(event, 'jm060065yb00041'); return false;" href="javascript:void(0);" class="ref jm060065yb00041">41</a></sup> gave a glycol intermediate, which subsequently underwent oxidative C−C cleavage with lead tetraacetate to produce aldehyde <b>8y</b>. Reduction of the aldehyde <b>8y</b> with sodium borohydride afforded the 5-hydroxymethyl derivative <b>8z</b>. <div id="_i9"><figure id="jm060065yh00002" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00002.jpeg" id="_i10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) for <b>8a</b>,<b> 8g</b>,<b> 8h</b>,<b> 8i</b>,<b> 8o</b>, <b>8s</b><b>−</b><b>u</b>, and<b> 8ag</b>, Cu-powder, K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C; for <b>8c</b>, <b>8d</b>, <b>8f</b>, <b>8q</b>, <b>8r, 8ad,</b> and <b>8ae</b>, <i>N</i>,<i>N</i>-diisopropylethylamine, NMP, 240 °C, microwave; for <b>8ab</b> and <b>8ac</b>, NaHCO<sub>3</sub>, 3-methylbutan-1-ol, 170 °C, microwave; (b) MnO<sub>2</sub>, 1:1 CH<sub>2</sub>Cl<sub>2</sub>/hexane, 20 °C; (c) 3 M MeMgBr in Et<sub>2</sub>O, THF, 20 °C; (d) <i>p</i>-TsOH, MeOH, reflux; (e) (1) (COCl)<sub>2</sub>, DMF, 20 °C; (2) 28% NH<sub>4</sub>OH, 20 °C; (f) (1) (COCl)<sub>2</sub>, DMF, 20 °C; (2) CH<sub>3</sub>ONHCH<sub>3</sub>·HCl, 10% K<sub>2</sub>CO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (g) sat. solution of HCl in EtOAc, 20 °C; (h) 2,3,4,5,6-pentafluorophenol, 1,3-dicyclohexylcarbodiimide, EtOAc, 20 °C; (i) 2 M MeNH<sub>2</sub> in THF, 20 °C; (j) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (k) O(COO-<i>t</i>-Bu)<sub>2</sub>, 1 N NaOH, THF, 20 °C; (l) Br<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (m) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>Me, Pd(OAc)<sub>2</sub>, benzyltriethylammonium chloride, DMF, 40 °C; (n) (1) 4% OsO<sub>4</sub> in H<sub>2</sub>O, <i>N</i>-methylmorpholine <i>N</i>-oxide, acetone, 20 °C; (2) Pb(OAc)<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (o) NaBH<sub>4</sub>, MeOH, 0 °C;</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Additional piperazine building blocks of type <b>I</b> were prepared as shown in Scheme 3<a data-tab="pane-pcw-Figures" href="#jm060065yh00003" id="" class=" internalNav"></a>. Under microwave irradiation, (<i>R</i>)-2-methylpiperazine (<b>7b</b>) was coupled with the 2-chloropyridine <b>6b</b> to give the corresponding mixture of products of <i>N</i>-arylation <b>9</b> and <b>8q </b>(Scheme 3). Separation of the mixture by column chromatography gave access to pure <b>9</b>, which was formed by arylation of the more hindered nitrogen atom of the piperazine <b>7b</b>. The 4-chloro-substituted pyridines <b>10a</b> and <b>10b</b> were coupled with <i>N</i>-Boc-protected piperazine (<b>7d</b>) in the presence of base to give the 1-pyridin-4-ylpiperazines <b>11a</b> and <b>11c</b>, respectively. The 6-chloropyrimidine <b>10c</b><sup><a onclick="showRef(event, 'jm060065yb00042'); return false;" href="javascript:void(0);" class="ref jm060065yb00042">42</a></sup> was reacted with <b>7d</b> in an analogous manner to produce 4-piperazin-1-ylpyrimidine <b>11e</b>. The Boc protecting group of 4-pyridin-4-ylpiperazine <b>11a</b> was cleaved with trifluoroacetic acid, while in the case of <b>11c</b> and <b>11e</b> the deprotection was achieved with a saturated solution of HCl gas in ethyl acetate. Finally, condensing the aniline <b>12</b> with bis(2-chloroethyl)amine hydrochloride (<b>13</b>) under microwave irradiation without any solvent<sup><a onclick="showRef(event, 'jm060065yb00043'); return false;" href="javascript:void(0);" class="ref jm060065yb00043">43</a></sup> gave rise to the 1-phenylpiperazine <b>14</b>. <div id="_i11"><figure id="jm060065yh00003" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00003.jpeg" id="_i12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) <i>N</i>,<i>N</i>-diisopropylethylamine, NMP, 240 °C, microwave; (b) Cu-powder, K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (d) sat. solution of HCl in EtOAc, 20 °C; (e) (1) 200 °C, microwave; (2) 1 N NaOH. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The piperazines used in the preparation of the <i>N</i>-aryl- and <i>N</i>-heteroarylpiperazines of type <b>I </b>(Schemes 1−3) and 2-piperazinyl-1<i>H</i>-benzimidazoles of type <b>V</b> (Schemes 1 and 7) were commercially available or were synthesized according to the methods shown in Scheme 4<a data-tab="pane-pcw-Figures" href="#jm060065yh00004" id="" class=" internalNav"></a>. Coupling of the <i>N</i>-Fmoc protected amino acids <b>15a</b> and <b>15b</b> with glycine methyl ester in the presence of PS-carbodiimide furnished amides <b>16a</b> and <b>16b</b>, which underwent intramolecular cyclization after treatment with piperidine to give the corresponding diketopiperazines <b>17a</b> and <b>17b</b>. Subsequent reduction of <b>17a</b> and <b>17b</b> with LiAlH<sub>4</sub> gave the target 2-alkyl-substituted piperazines <b>7e </b>and<b> 7f</b>, respectively. <div id="_i13"><figure id="jm060065yh00004" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00004.jpeg" id="_i14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) MeO<sub>2</sub>CCH<sub>2</sub>NH<sub>2</sub>·HCl, 1-hydroxy-7-azabenzotriazole, <i>N,N</i>-diisopropylethylamine, PS-carbodiimide, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (b) piperidine, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (c) LiAlH<sub>4</sub>, THF, reflux.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Scheme 5<a data-tab="pane-pcw-Figures" href="#jm060065yh00005" id="" class=" internalNav"></a> describes the preparation of 2-chloro-1<i>H</i>-benzimidazoles of type <b>II </b>required for the synthesis of the TRPV1 antagonists by general method A, Scheme 1. The 1,2-diaminoarenes <b>18a</b><b>−</b><b>n</b> were converted into the 2-chloro-1<i>H</i>-benzimidazoles <b>20a</b><b>−</b><b>o</b> via the imidazolones <b>19a</b><b>−</b><b>o</b>. 1,1‘-Carbonyldiimidazole was used as carbonylating reagent for the preparation of imidazolones <b>19a</b><b>−</b><b>d</b>, <b>19f</b><b>−</b><b>h</b>, and <b>19j</b><b>−</b><b>o</b>, while in the case of <b>19e</b><i>N</i>,<i>N</i>-disuccinimidyl carbonate was employed. The 4-aryl-substituted imidazolone <b>19i</b> was prepared by microwave-assisted Suzuki arylation of the 4-bromobenzimidazolone <b>19f</b>. <a name="jm004901203721" id="jm004901203721"></a> Finally, chlorination of the benzimidazolones <b>19a</b><b>−</b><b>o </b>with phosphorus oxychloride provided the necessary 2-chloro-1<i>H</i>-benzimidazole intermediates <b>20a</b><b>−</b><b>o</b>. <div id="_i15"><figure id="jm060065yh00005" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00005.jpeg" id="_i16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a,b</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> X and Y = C or N. <i><sup>b</sup></i><sup></sup>Conditions:  (a) for <b>19a</b><b>−</b><b>d</b>, <b>19f</b><b>−</b><b>h, 19j</b><b>−</b><b>o</b>, 1,1‘-carbonyldiimidazole, THF, 20 °C; for <b>19e</b>, <i>N</i>,<i>N</i>-disuccinimidyl carbonate, MeCN, 75 °C; (b) 3,4,5-trifluorophenylboronic acid, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, MeO(CH<sub>2</sub>)<sub>2</sub>OMe, H<sub>2</sub>O, EtOH, 120 °C, microwave; (c) POCl<sub>3</sub>, 95 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The 1,2-diaminoarenes <b>18b</b><b>−</b><b>e</b> used in the preparation of the 2-chloro-1<i>H</i>-benzimidazoles <b>20b</b><b>−</b><b>e</b> were synthesized according to the reactions illustrated in Scheme 6<a data-tab="pane-pcw-Figures" href="#jm060065yh00006" id="" class=" internalNav"></a>. Acetylation of aniline <a name="jm004901203722" id="jm004901203722"></a><b>21</b> gave the <i>N</i>-acetylaniline <b>22</b>, which was nitrated at the less hindered ortho-position with a mixture of concentrated nitric acid and concentrated sulfuric acid to give nitro derivative <b>23</b>. Subsequent hydrolysis of the <i>N</i>-acetyl group and reduction of the nitro group of <b>23</b> with tin(II) chloride dihydrate afforded the desired 1,2-diaminobenzene <b>18b</b>. Partial palladium-catalyzed hydrogenation of the symmetrical 2,6-dinitroaniline derivative <b>25</b> gave the nitro-substituted 1,2-diaminobenzene <b>18c</b>. Nitration of 2-aminopyridine <b>26</b> ortho to the amino group gave <b>27</b>, which was then reduced with tin(II) chloride dihydrate to form the 2,3-diaminopyridine <b>18d</b>. The amino group at position 2 of the regioisomeric 2,3-diaminopyridine <b>18e</b> was introduced by amination of the 2-chloropyridine <b>28</b> with 4-methoxybenzylamine under microwave irradiation, followed by debenzylation using trifluoroacetic acid. <div id="_i17"><figure id="jm060065yh00006" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00006.jpeg" id="_i18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) Ac<sub>2</sub>O, 20 °C; (b) concd HNO<sub>3</sub>, concd H<sub>2</sub>SO<sub>4</sub>, 0−20 °C; (c) 3 N NaOH, MeOH, 90 °C; (d) SnCl<sub>2</sub>·H<sub>2</sub>O, EtOAc, EtOH, 70 °C; (e) H<sub>2</sub>, 10% Pd/C, EtOH, 20 °C; (f) 4-methoxybenzylamine, NaHCO<sub>3</sub>, 3-methyl-1-butanol, 220 °C, microwave; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Scheme 7<a data-tab="pane-pcw-Figures" href="#jm060065yh00007" id="" class=" internalNav"></a> shows the preparation of 2-piperazinyl-1<i>H</i>-benzimidazoles building blocks of type <b>V</b> used in the synthesis of TRPV1 antagonists via general method B (Scheme 1). Compounds <b>30a</b> and <b>30b</b> were prepared by microwave-assisted coupling of the piperazines <b>7a</b> and <b>7c </b>with the 2-chlorobenzimidazoles <b>20n</b> and <b>20i</b>, respectively. <div id="_i19"><figure id="jm060065yh00007" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00007.jpeg" id="_i20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 7 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) for <b>30a</b>, DMSO, 80 °C; for <b>30b</b>, <i>N</i>,<i>N</i>-diisopropylethylamine, MeCN, 180 °C, microwave.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Schemes 8−11 illustrate the synthesis of the TRPV1 antagonists that were prepared by modification of the substituents of 2-piperazin-1-yl-1<i>H</i>-benzimidazoles of type <b>III</b>. The starting benzimidazoles used in Schemes 8−11 (<b>31a</b>,<b>b</b>, <b>33</b>, <b>35</b>, <b>37a</b>,<b>b</b>, <b>39</b>, <b>42</b>, <b>43a</b>, <b>44a,c</b>, and <b>45</b>) were synthesized by method A or method B described in Scheme 1. Scheme 8<a data-tab="pane-pcw-Figures" href="#jm060065yh00008" id="" class=" internalNav"></a> describes modification of the substituents of 2-piperazin-1-yl-1<i>H</i>-benzimidazoles by reactions involving nitro group transformations. The nitro groups of <b>31a</b> and <b>31b</b> were reduced by palladium-catalyzed hydrogenation to give the corresponding amines <b>32a</b> and <b>32b</b>, while the nitro group of the bromo derivative <b>33</b> was reduced with tin(II) chloride dihydrate to afford amine <b>34</b>. Several additional 2-piperazin-1-yl-1<i>H</i>-benzimidazoles were prepared by reactions involving the amino group of <b>32a </b>and<b> 32b</b>. For example, reductive alkylation of <b>32a </b>and <b>32b</b> with aldehydes was utilized to produce <b>32c</b>, <b>32f</b>, and <b>32g</b>, while acylation of <b>32b</b> with cyclohexanecarboxylic acid and di-<i>tert</i>-butyl dicarbonate afforded <b>32d</b> and <b>32e</b>, respectively. <div id="_i21"><figure id="jm060065yh00008" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00008.jpeg" id="_i22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 8 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) H<sub>2</sub>, 10% Pd/C, EtOH, 20 °C; (b) 3,4,5-trifluorobenzaldehyde, NaBH(OAc)<sub>3</sub>, CHCl<sub>3</sub>, 20 °C; (c) O(COO-<i>t</i>-Bu)<sub>2</sub>, 1 N NaOH, THF, 20 °C; (d) cyclohexanecarboxylic acid, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide·HCl, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (e) PhCH<sub>2</sub>CHO, NaBH(OAc)<sub>3</sub>, CHCl<sub>3</sub>, 20 °C; (f) SnCl<sub>2</sub>·H<sub>2</sub>O, DMF, 80 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00008"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Scheme 9<a data-tab="pane-pcw-Figures" href="#jm060065yh00009" id="" class=" internalNav"></a> lists modifications based on reactions involving a carbonyl group on the 5‘-position of the pyridine ring. The aldehyde <b>36</b> was obtained by oxidation of the hydroxymethyl derivative <b>35</b> with activated manganese(IV) oxide. The carboxylic acid <b>38a</b> was prepared by saponification of the ester <b>37a</b>. Grignard addition of methylmagnesium bromide and phenylmagnesium bromide to the carbonyl group of the aldehyde <b>36 </b>gave the secondary alcohols <b>38c</b> and <b>38d</b>, respectively. Alternatively, reduction of the ketone <b>37b</b> with sodium borohydride in methanol gave the corresponding secondary alcohol <b>38b</b>. <div id="_i23"><figure id="jm060065yh00009" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00009.jpeg" id="_i24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 9 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup>  Conditions:  (a) MnO<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (b) for <b>38a</b>, (1) 1 N NaOH, THF, 50 °C; (2) 1 N HCl, 20 °C; for <b>38b</b>, NaBH<sub>4</sub>, MeOH, 0 °C; for <b>38c</b>, CH<sub>3</sub>MgBr, THF, 0 °C; for <b>38d</b>, C<sub>6</sub>H<sub>5</sub>MgBr, THF, 0 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00009"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p"><a name="jm004901203723" id="jm004901203723"></a><i>N</i>-substituted benzimidazole derivatives were also prepared (Scheme 10<a data-tab="pane-pcw-Figures" href="#jm060065yh00010" id="" class=" internalNav"></a>). For instance, treatment of the sodium salt of the benzimidazole <b>39</b> with benzyl bromide gave the isomeric mixture of <b>40</b> and <b>41</b>, which was separated by column chromatography. The regiochemical assignment for compounds <b>40</b> and <b>41</b> was confirmed on the basis of 2D-NOESY NMR analysis. <div id="_i25"><figure id="jm060065yh00010" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00010.jpeg" id="_i26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 10 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) (1) 50% NaH in mineral oil, DMF, 0−20 °C; (2) C<sub>6</sub>H<sub>5</sub>CH<sub>2</sub>Br, 0 to 20 °C; (3) separation by column chromatography. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00010"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Scheme 11<a data-tab="pane-pcw-Figures" href="#jm060065yh00011" id="" class=" internalNav"></a> describes the preparation of 2-piperazin-1-yl-1<i>H</i>-benzimidazoles by reactions involving bromo-functionalized analogues. For example, Suzuki coupling of the aryl bromides <b>42</b>, <b>34</b>, and <b>43a</b> with various arylboronic acids under conventional heating or microwave irradiation gave the arylated analogues <b>46a</b>, <b>46e</b>, and <b>46m</b>, respectively. Analogously, Suzuki coupling of <b>44a</b> with various arylboronic acids gave the arylated analogues <b>46b</b>, <b>46q</b><b>−</b><b>v</b>, and <b>46x-ab</b>. Amine <b>46e</b> was acylated with acetoxyacetic acid in the presence of benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate and <i>N</i>,<i>N</i>-diisopropylethylamine and subsequently hydrolyzed with potassium carbonate in methanol to give the hydroxyacetylamino derivative <b>46f</b>. Arylation of the bromo-functionalized diastereomeric mixture of secondary alcohols <b>44c</b> with 3,4,5-trifluorophenylboronic acid gave the mixture of the diastereoisomers <b>46k</b> and <b>46l</b>, which were next separated by preparative HPLC. The configuration of each isomer at the chiral center of the 1-hydroxyethyl substituent was assigned at random. To prepare the 4-trifluoromethylcyclohexyl analogue <b>46p</b>, the aryl bromide <b>44a</b> was treated with 4,4,5,5-tetramethyl-2-(4-trifluoromethylcyclohex-1-enyl)[1,3,2]dioxaborolane to give 4-trifluoromethylcyclohex-1-enyl intermediate, which was reduced by palladium-catalyzed hydrogenation. <div id="_i27"><figure id="jm060065yh00011" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00011.jpeg" id="_i28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 11 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) for <b>46a</b>, <b>42</b>, 3,4-difluorophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, LiCl, MeO(CH<sub>2</sub>)<sub>2</sub>OMe, H<sub>2</sub>O, EtOH, 80 °C; for <b>46b</b>, <b>43a</b>, 4-trifluoromethylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, dioxane, 170 °C, microwave; for <b>46c</b>, <b>43b</b>, 4-CF<sub>3</sub>C<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>NH<sub>2</sub>, tris(dibenzylideneacetone)dipalladium(0), 2-(di-<i>tert</i>-butylphosphino)biphenyl, <i>t</i>-BuONa, toluene, 150 °C, microwave; for <b>46e</b>, <b>34</b>, 4-fluorophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for <b>46g</b>, <b>44b</b>, piperidine, tris(dibenzylideneacetone)dipalladium(0), 2-(di-<i>tert</i>-butylphosphino)biphenyl, <i>t</i>-BuONa, toluene, 150 °C, microwave; for <b>46i</b>, <b>44b</b>, morpholine, tris(dibenzylideneacetone)dipalladium(0), 2-(di-<i>tert</i>-butylphosphino)biphenyl, <i>t</i>-BuONa, toluene, 150 °C, microwave; for <b>46k </b>and<b> 46l</b>, <b>44c</b>, (1) 3,4,5-trifluorophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 0.4 M Na<sub>2</sub>CO<sub>3</sub>, MeCN, 90 °C, (2) separation of diastereoisomers by prep. HPLC; for <b>46m</b>, <b>44a</b>, 3,4,5-trifluorophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, dioxane, 170 °C, microwave; for <b>46n</b>, <b>44a</b>, 2-tributylstannylthiazole, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 140 °C, microwave; for <b>46o</b>, <b>44a</b>, 0.5 M 3,4-difluorobenzylzinc bromide, Pd(PPh<sub>3</sub>)<sub>4</sub>, THF, reflux; for<b> 46p</b>, <b>44a</b>, (1) 4,4,5,5-tetramethyl-2-(4-trifluoromethylcyclohex-1-enyl)[1,3,2]dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, MeO(CH<sub>2</sub>)<sub>2</sub>OMe, 200 °C, microwave; (2) H<sub>2</sub>, 10% Pd/C, EtOH, 20 °C; for<b> 46q</b>, <b>44a</b>, 4-trifluoromethylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, LiCl, MeO(CH<sub>2</sub>)<sub>2</sub>OMe, H<sub>2</sub>O, EtOH, 80 °C; for 46r, <b>44a</b>, phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, LiCl, MeO(CH<sub>2</sub>)<sub>2</sub>OMe, H<sub>2</sub>O, EtOH, 80 °C; for<b> 46s</b>, <b>44a</b>, 3-trifluoromethoxyphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46t</b>, <b>44a</b>, 4-<i>tert</i>-butylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46u</b>, <b>44a</b>, thiophen-2-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46v</b>, <b>44a</b>, pyridin-4-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46w</b>, <b>44a</b>, 2-tributylstannylpyrazine, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 140 °C, microwave; for <b>46x</b>, <b>44a</b>, 3-(6-methoxypyridyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46y</b>, <b>44a</b>, benzo[<i>b</i>]thiophen-2-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46z</b>, <b>44a</b>, 4-aminophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46aa</b>, <b>44a</b>, 4-dimethylaminophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46ab</b>, <b>44a</b>, <i>trans</i>-2-phenylvinylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for <b>46ac</b>, <b>45</b>, CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHSnBu<sub>3</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, 3,5-di-<i>tert</i>-butylphenol, LiCl, dioxane, 95 °C; (b) 2-(trimethylsilyl)ethoxymethyl chloride, <i>N</i>,<i>N</i>-diisopropylethylamine, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (d) (1) CH<sub>3</sub>CO<sub>2</sub>CH<sub>2</sub>CO<sub>2</sub>H, benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate, <i>N</i>,<i>N</i>-diisopropylethylamine, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (2) K<sub>2</sub>CO<sub>3</sub>, MeOH, 20 °C; (e) 4-methylmorpholine <i>N</i>-oxide, OsO<sub>4</sub>, acetone, 20 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00011"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">Several other derivatives were prepared by using organotin and organozinc cross-coupling reactions. For example, Stille coupling of the aryl bromides <b>44a</b> and <b>45</b> with 2-tributylstannylthiazole and tributylvinyltin in the presence of tetrakis(triphenylphosphine)palladium(0) as catalyst provided the thiazolyl analogue <b>46n</b> and the vinyl analogue <b>46ac</b>, respectively. Further dihydroxylation of the vinyl analogue <b>46ac</b> with catalytic osmium tetraoxide and stoichiometric <i>N</i>-methylmorpholine <i>N</i>-oxide<sup>41</sup> gave glycol <b>46ad</b> as a mixture of diastereoisomers. Analogously, Stille coupling of <b>44a</b> with 2-tributylstannylpyrazine gave the pyrazine analogue <b>46w</b>. Negishi coupling of <b>44a</b> with 3,4-difluorobenzylzinc bromide furnished the 3,4-difluorobenzyl analogue <b>46o</b>. Selected bromo-substituted 2-piperazin-1-yl-1<i>H</i>-benzimidazoles of type <b>III</b> were also employed in Buchwald amination reactions. For example, <i>N</i>-alkylation of <b>43a</b> with 2-(trimethylsilyl)ethoxymethyl chloride in the presence of base provided the <i>N</i>-protected benzimidazole <b>43b</b>. Subsequent microwave irradiation of <b>43b </b>with 4-(trifluoromethyl)<a name="jm004901203724" id="jm004901203724"></a> benzylamine in the presence of sodium <i>tert</i>-butoxide, tris(dibenzylideneacetone)dipalladium(0) as catalyst and 2-(di-<i>tert</i>-butylphosphino)biphenyl as phosphine ligand gave the benzylamine derivative <b>46c</b>. The target compound <b>46d</b> was obtained after cleavage of the 2-(trimethylsilyl)ethoxymethyl protective groups of <b>46g </b>with trifluoroacetic acid. The analogous Buchwald amination reaction of the <i>N</i>-protected <b>44b</b> with piperidine and morpholine gave the corresponding piperidine derivative <b>46g</b> and the morpholine derivative <b>46i</b>. Next, cleavage of the protective group gave the target compounds <b>46h</b> and <b>46j</b>. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34526" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34526" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a name="jm004901203726" id="jm004901203726"></a>The compounds were tested for their ability to block the capsaicin- or acid-induced (pH 5) uptake of <sup>45</sup>Ca<sup>2+</sup> in CHO cells expressing rat TRPV1. Functional activity is reported as IC<sub>50</sub> (nM) in Tables 1−7. All compounds reported herein behaved as antagonists.<sup><a onclick="showRef(event, 'jm060065yb00044'); return false;" href="javascript:void(0);" class="ref jm060065yb00044">44</a></sup> Results are the average of at least two independent experiments with three replicates at each concentration. </div><div class="NLM_p">Conformationaly constrained analogues of BCTC (<b>4</b>) could be generated by incorporating the carboxanilide function into a five-membered heterocyclic ring fused with the adjacent aromatic ring. For example, our initial results showed that isosteric replacement of the carboxanilide function of BCTC (<b>4</b>) with a benzimidazole ring system gave the constrained analogue <b>5 </b>with an IC<sub>50</sub> value of 87 nM in the capsaicin-mediated assay and 310 nM in the pH-mediated assay (Table 1<a class="ref showTableEvent internalNav" data-ID="jm060065yt00001" href="#jm060065yt00001"></a>). <div class="NLM_table-wrap" id="jm060065yt00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  Inhibition of <sup>45</sup>Ca<sup>2+</sup> Influx:  BCTC (<b>4</b>) and Its Constrained Analogue (<b>5</b>)</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yu00001a.gif" alt="" id="_i30" /></img></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yu00001b.gif" alt="" id="_i31" /></img></td></tr></tbody></table></div></div></div><div class="NLM_p">Since the constrained analogue <b>5</b> displayed reasonable potency as TRPV1 antagonist, we decided to do a detailed structure−activity relationship (SAR) investigation of <b>5</b> in order to provide an understanding of the structural features that influence the functional activity of this novel template. Our initial strategy was to prepare analogues of <b>5</b> by stepwise introduction of various substituents on the benzimidazole (Tables 2 and 3), the piperazine (Table 5), and the pyridine (Table 6) rings of the 2-(4-pyridin-2-ylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole template of <b>5</b>. In addition, several analogues of <b>5</b> having modified benzimidazole and pyridine rings were also prepared (Tables 4 and 7, respectively). The results from this initial SAR were used next in the design of a set of analogues by combining the optimum substituents on all preferred sites of the template of <b>5</b> (Table 8). </div><div class="NLM_p">As exemplified by compound <b>47a</b> in Table 2<a class="ref showTableEvent internalNav" data-ID="jm060065yt00002" href="#jm060065yt00002"></a>, replacement of the chlorine substituent of the pyridine ring of <b>5</b> with a trifluoromethyl group led to 2-fold potency decrease (IC<sub>50</sub> = 183 nM) in the capsaicin-activated uptake assay and almost unchanged potency (IC<sub>50</sub> = 282 nM) in the pH-mediated assay. Due to the relatively similar potencies of the chloro analogue <b>5</b> and the trifluoromethyl analogue <b>47a</b>, the remaining compounds listed in Table 2 retained the trifluoromethyl substituent on the pyridine ring (R<sub>7</sub> = CF<sub>3</sub>) and differed by the nature of the substituents R<sub>1</sub> and R<sub>2</sub> on the benzimidazole ring. The potency in the capsaicin-induced Ca<sup>2+</sup> uptake assay was nearly restored (IC<sub>50</sub> = 110 nM) when the <i>tert</i>-butyl substituent of the benzimidazole ring of <b>47a </b>was replaced with the strongly electron-withdrawing trifluoromethyl group to provide the analogue <b>39</b>. Replacement of the trifluoromethyl group of the benzimidazole ring of <b>39</b> with the electron-donating methyl group resulted in dramatic reduction of potency in both assays (compound <b>47b</b>). A similar decrease of antagonistic activity in both assays was observed for the nitrile <b>47e</b>, while ester <b>47f </b>was 11-fold less active in the caspsaicin-mediated assay but remained inactive in the pH-mediated assay. In contrast, the potency of the 3,4-difluorophenyl substituted <b>46a</b> was similar to that of <b>47f</b> in the capsaicin assay but retained the activity of <b>39</b> in the pH assay. When the substituent R<sub>2</sub> of the benzimidazole ring was halogen, the potency in the capsaicin-mediated assay improved upon increasing of the size of the halogen atom (i.e., F (<b>47c</b>) ≪ Cl (<b>47d</b>) < Br (<b>42</b>)). The activity of the bromo-substituted derivative <b>42</b> was comparable to that of the trifluoromethyl derivative <b>39</b>. <div class="NLM_table-wrap" id="jm060065yt00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  Inhibition of <sup>45</sup>Ca<sup>2+</sup> Influx:  Substituents on the Benzimidazole Ring<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yu00002a.gif" alt="" id="_i32" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">IC<sub>50</sub> (nM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">entry</td><td class="colsep2 rowsep2">R<sub>1</sub></td><td class="colsep2 rowsep2">R<sub>2</sub></td><td class="colsep2 rowsep2">R<sub>7</sub></td><td class="colsep2 rowsep2">capsaicin stimulus</td><td class="colsep2 rowsep2">pH stimulus </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>5</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">t-Bu </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">87 ± 18 </td><td class="colsep2 rowsep2">310 ± 117 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>47a</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">t-Bu </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">183 ± 24 </td><td class="colsep2 rowsep2">282 ± 53 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">110 ± 22 </td><td class="colsep2 rowsep2">301 ± 84 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>47b</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CH<sub>3</sub></td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">3350 ± 330 </td><td class="colsep2 rowsep2">>4000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>47e</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CN </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">3300 ± 160 </td><td class="colsep2 rowsep2">>4000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>47f</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">1230 ± 380 </td><td class="colsep2 rowsep2">>4000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46a</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">3,4-difluoro-Ph </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">1140 ± 260 </td><td class="colsep2 rowsep2">351 ± 34 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>47c</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">>4000 </td><td class="colsep2 rowsep2">>4000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>47d</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">1130 ± 96 </td><td class="colsep2 rowsep2">17250 ± 830 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>42</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">123 ± 13 </td><td class="colsep2 rowsep2">194 ± 58 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>40</b></td><td class="colsep2 rowsep2">CH<sub>2</sub>Ph </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">577 ± 65 </td><td class="colsep2 rowsep2">157 ± 11 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>41</b></td><td class="colsep2 rowsep2">CH<sub>2</sub>Ph </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">6480 ± 1180 </td><td class="colsep2 rowsep2">151 ± 6</td></tr></tbody></table></div></div></div><div class="NLM_p">The effect of substituting the nitrogen atom of the benzimidazole ring was also investigated. <i>N</i>-Alkylation of the analogue <b>39</b> with benzyl bromide gave the corresponding isomeric products <b>40</b> and <b>41</b>. The <i>N</i>-benzyl isomer <b>40</b> was 5-fold less potent (IC<sub>50</sub> = 577 nM) in the capsaicin-mediated assay in comparison with <b>39</b>. In the case of the isomer <b>41</b>, the decrease of the potency in the capsaicin-mediated assay was more pronounced (IC<sub>50</sub> = 6480 nM). In contrast, a 2-fold potency increase was observed for both isomers in the pH-mediated assay. </div><div class="NLM_p">In summary, the influence of the steric effects of the substituents R<sub>2</sub> on the potency of the TRPV1 antagonists in Table 2 was more pronounced than the electronic effects, with trifluoromethyl, bromo, and <i>tert</i>-butyl groups being the optimal substituents. <i>N</i>-Alkylation of the benzimidazole ring was detrimental to activity in the capsaicin-mediated assay, suggesting certain steric limitations and/or specific requirement for hydrogen-bond-donor interactions with binding site of the receptor. </div><div class="NLM_p">The compounds shown in Table 3<a class="ref showTableEvent internalNav" data-ID="jm060065yt00003" href="#jm060065yt00003"></a> were prepared to investigate the influence of introducing additional substituents at the <a name="jm004901203727" id="jm004901203727"></a> 4- and 5-positions of the benzimidazole ring of the trifluoromethyl analogue <b>39</b>. We found that the introduction of additional substituents at position 5 of the benzimidazole ring seemed to provide limited benefits. For example, substitution of position 5 of <b>39 </b>with a bromine atom gave the analogue <b>43a</b>. This substitution led to a 1.5-fold decrease of potency in the capsaicin-mediated assay and a 7-fold increase in the pH-mediated assay. Introduction of the bulkier (4-trifluoromethyl)phenyl group (i.e., <b>46b</b>) resulted in additional loss of potency in the capsaicin-mediated assay, relative to <b>43a</b>; however, the potency was restored to that of <b>39</b> when the (4-trifluoromethyl)phenyl group was attached to position 5 via a −NHCH<sub>2</sub><sup>-</sup> linker (i.e., <b>46d</b>). <div class="NLM_table-wrap" id="jm060065yt00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  Inhibition of <sup>45</sup>Ca<sup>2+</sup> Influx:  Substituents on the Phenyl Ring of the Benzimidazole Ring<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yu00003a.gif" alt="" id="_i33" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">IC<sub>50</sub> (nM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">entry</td><td class="colsep2 rowsep2">R<sub>3</sub></td><td class="colsep2 rowsep2">capsaicin stimulus</td><td class="colsep2 rowsep2">pH stimulus </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">110 ± 22 </td><td class="colsep2 rowsep2">301 ± 14 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>43a</b></td><td class="colsep2 rowsep2">5-Br </td><td class="colsep2 rowsep2">166 ± 16 </td><td class="colsep2 rowsep2">43 ± 2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46b</b></td><td class="colsep2 rowsep2">5-(4-CF<sub>3</sub>-Ph) </td><td class="colsep2 rowsep2">8240 ± 13 </td><td class="colsep2 rowsep2">201 ± 41 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46d</b></td><td class="colsep2 rowsep2">5-[NHCH<sub>2</sub>(4-CF<sub>3</sub>-Ph)] </td><td class="colsep2 rowsep2">94 ± 9 </td><td class="colsep2 rowsep2">141 ± 26 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>44a</b></td><td class="colsep2 rowsep2">4-Br </td><td class="colsep2 rowsep2">131 ± 12 </td><td class="colsep2 rowsep2">74 ± 13 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>31a</b></td><td class="colsep2 rowsep2">4-NO<sub>2</sub></td><td class="colsep2 rowsep2">1660 ± 120 </td><td class="colsep2 rowsep2">878 ± 35 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>32a</b></td><td class="colsep2 rowsep2">4-NH<sub>2</sub></td><td class="colsep2 rowsep2">3380 ± NA </td><td class="colsep2 rowsep2">>4000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>48</b></td><td class="colsep2 rowsep2">4-CF<sub>3</sub></td><td class="colsep2 rowsep2">325 ± 21 </td><td class="colsep2 rowsep2">120 ± 11 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46q</b></td><td class="colsep2 rowsep2">4-(4-CF<sub>3</sub>-Ph) </td><td class="colsep2 rowsep2">51 ± 6 </td><td class="colsep2 rowsep2">37 ± 3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46m</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">33 ± 8 </td><td class="colsep2 rowsep2">26 ± 12 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46s</b></td><td class="colsep2 rowsep2">4-(3-CF<sub>3</sub>O-Ph) </td><td class="colsep2 rowsep2">26 ± 14 </td><td class="colsep2 rowsep2">21 ± 20 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46t</b></td><td class="colsep2 rowsep2">4-(4-<i>tert</i>-butyl-Ph) </td><td class="colsep2 rowsep2">13 ± 5 </td><td class="colsep2 rowsep2">4 ± 1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46r</b></td><td class="colsep2 rowsep2">4-Ph </td><td class="colsep2 rowsep2">141 ± 11 </td><td class="colsep2 rowsep2">68 ± 27 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46u</b></td><td class="colsep2 rowsep2">4-thiophen-2-yl </td><td class="colsep2 rowsep2">373 ± 92 </td><td class="colsep2 rowsep2">221 ± 44 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46n</b></td><td class="colsep2 rowsep2">4-thiazol-2-yl </td><td class="colsep2 rowsep2">688 ± 78 </td><td class="colsep2 rowsep2">454 ± 63 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46v</b></td><td class="colsep2 rowsep2">4-pyrid-4-yl </td><td class="colsep2 rowsep2">267 ± 23 </td><td class="colsep2 rowsep2">188 ± 138 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46w</b></td><td class="colsep2 rowsep2">4-pyrazin-2-yl </td><td class="colsep2 rowsep2">129 ± 32 </td><td class="colsep2 rowsep2">51 ± 20 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46x</b></td><td class="colsep2 rowsep2">4-[3-(6-methoxypyridyl)] </td><td class="colsep2 rowsep2">111 ± 15 </td><td class="colsep2 rowsep2">99 ± 19 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46y</b></td><td class="colsep2 rowsep2">4-benzo[<i>b</i>]thiophen-2-yl </td><td class="colsep2 rowsep2">26 ± 4 </td><td class="colsep2 rowsep2">22 ± 0.6 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46h</b></td><td class="colsep2 rowsep2">4-piperid-1-yl </td><td class="colsep2 rowsep2">29 ± 7 </td><td class="colsep2 rowsep2">21 ± 1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46j</b></td><td class="colsep2 rowsep2">4-morpholinyl </td><td class="colsep2 rowsep2">50 ± 2 </td><td class="colsep2 rowsep2">95 ± 11 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46p</b></td><td class="colsep2 rowsep2">4-[4-(trifluoromethyl)cyclohex-1-yl] </td><td class="colsep2 rowsep2">10 ± 3 </td><td class="colsep2 rowsep2">9 ± 0.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46z</b></td><td class="colsep2 rowsep2">4-(4-amino-Ph) </td><td class="colsep2 rowsep2">1900 ± 1 </td><td class="colsep2 rowsep2">308 ± 14 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46aa</b></td><td class="colsep2 rowsep2">4-(4-(dimethylamino)-Ph) </td><td class="colsep2 rowsep2">108 ± 8 </td><td class="colsep2 rowsep2">69 ± 19 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46o</b></td><td class="colsep2 rowsep2">4-[CH<sub>2</sub>(3,4-difluoro-Ph)] </td><td class="colsep2 rowsep2">71 ± 11 </td><td class="colsep2 rowsep2">52 ± 10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46ab</b></td><td class="colsep2 rowsep2">4-(CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH-Ph) </td><td class="colsep2 rowsep2">185 ± 81 </td><td class="colsep2 rowsep2">140 ± 12 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>32c</b></td><td class="colsep2 rowsep2">4-[NHCH<sub>2</sub>(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">132 ± 9 </td><td class="colsep2 rowsep2">81 ± 8</td></tr></tbody></table></div></div></div><div class="NLM_p">The introduction of substituents at position 4 of the trifluoromethyl analogue <b>39</b> initially did not look promising. For example, the 4-bromo derivative <b>44a </b>was nearly equipotent with the 5-bromo derivative <b>43a</b>. The 4-nitro derivative <b>31a</b> was approximately 13-fold less potent, and the 4-amino derivative <b>32a </b>was 26-fold less potent than the corresponding bromo derivative <b>44a </b>in the capsaicin-mediated assay, while the trifluoromethyl analogue <b>48</b> was approximately 2-fold less potent. We observed dramatic increase in potency (161-fold, IC<sub>50</sub> = 51 nM) in the capsaicin-mediated assay, and a 5-fold increase (IC<sub>50</sub> = 37 nM) in the pH-mediated assay when the (4-trifluoromethyl)phenyl group was transferred from position 5 (i.e., <b>46b</b>) to position 4 (i.e., <b>46q</b>) of the benzimidazole ring. This promising result prompted us to prepare an additional number of analogues substituted at position 4. </div><div class="NLM_p">Further improvement of the potency in the capsaicin-mediated assay was observed for the 3,4,5-trifluorophenyl analogue <b>46m</b> (IC<sub>50</sub> = 33 nM), the (3-trifluoromethoxy)phenyl analogue <b>46s </b>(IC<sub>50</sub> = 26 nM), and the 4-<i>tert</i>-butylphenyl analogue <b>46t</b> (IC<sub>50</sub> = 13 nM). In the case of <b>46r</b>, the lack of substitution of the phenyl ring resulted in a decrease of potency (IC<sub>50</sub> = 141 nM) in the capsaicin-mediated assay, in comparison with the substituted phenyl analogues (<b>46q</b>, <b>46m</b>, <b>46s</b>, and <b>46t</b>). Various five-membered aromatic heterocycles (i.e., thiophene derivative <b>46u</b> and thiazol derivative <b>46n</b>) and six-membered aromatic heterocycles (i.e., pyridine and pyrazine derivatives <b>46v</b><b>−</b><b>x</b>) were also tolerated at position 4 of the benzimidazole ring; however, their potencies in the capsaicin-mediated assay were almost equal or up to 5-fold lower than the potency of the corresponding phenyl analogue <b>46r</b>. The addition of a fused benzene ring to the thiophene heterocycle of <b>46u </b>(IC<sub>50</sub> = 373 nM) resulted in the fused bicyclic analogue <b>46y </b>(IC<sub>50</sub> = 26 nM) and a 14-fold increase of potency in the capsaicin-mediated assay. We found that saturated six-membered heterocycles such as the 1-piperidyl group of analogue <b>46h</b> and the morpholin-4-yl group of analogue <b>46j</b> were well-tolerated. Saturation of the phenyl ring of the 4-(trifluoromethyl)phenyl analogue <b>46q </b>(IC<sub>50</sub> = 51 nM) gave the 4-(trifluoromethyl)cyclohex-1-yl derivative <b>46p</b>, which was the most potent 4-substituted compound shown in Table 3 with IC<sub>50</sub>'s of 10 and 9 nM in the capsaicin-mediated and the pH-mediated assays, respectively. Introduction of amino group at para-position of the phenyl ring of <b>46r</b> gave the 12-fold less potent derivative <b>46z </b>(IC<sub>50</sub> = 1900 nM) in the capsaicin-mediated assay; however, the potency was almost restored in the case of the bulkier dimethylaminophenyl derivative <b>46aa</b>. </div><div class="NLM_p">Several<a class="ref showTableEvent internalNav" data-ID="jm060065yt00004" href="#jm060065yt00004"></a> analogues having aryl substituents linked via a linker group to position 4 of the benzimidazole ring were prepared. For example, the analogue <b>46o</b> having a −CH<sub>2</sub>− linker blocked the uptake of <sup>45</sup>Ca<sup>2+</sup> with an IC<sub>50</sub> of 71 nM in the capsaicin-mediated assay and with IC<sub>50</sub> of 52 nM in the pH-mediated assay. In the case of the styryl analogue <b>46ab</b>, the potency in the capsaicin-mediated assay was almost unchanged (IC<sub>50</sub> = 185 nM) in comparison with the potency of the phenyl analogue <b>46r </b>(IC<sub>50</sub> = 141 nM). However, introduction of a −NHCH<sub>2</sub>− linker between the 3,4,5-trifluorophenyl group and the benzimidazole ring of <b>46m</b> (IC<sub>50</sub> = 33 nM) gave the analogue <b>32c</b>, which was found to be 4-fold less potent (IC<sub>50</sub> = 132 nM) in the capsaicin-mediated assay. <div class="NLM_table-wrap" id="jm060065yt00004"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 4.  Inhibition of <sup>45</sup>Ca<sup>2+</sup> Influx:  Variations to the Benzimidazole Ring<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yu00004a.gif" alt="" id="_i34" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">IC<sub>50</sub> (nM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">entry</td><td class="colsep2 rowsep2">X</td><td class="colsep2 rowsep2">Y</td><td class="colsep2 rowsep2">capsaicin stimulus</td><td class="colsep2 rowsep2">pH stimulus </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">110 ± 22 </td><td class="colsep2 rowsep2">301 ± 14 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>49a</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">1,550 ± 65 </td><td class="colsep2 rowsep2">884 ± 560 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>49b</b></td><td class="colsep2 rowsep2">C </td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">1,090 ± 580 </td><td class="colsep2 rowsep2">1410 ± 58</td></tr></tbody></table></div></div></div><div class="NLM_p">In summary, the preliminary SAR observed for the compounds listed in Table 3 revealed the existence of a relatively large hydrophobic pocket in the TRPV1 receptor, since introduction of bulky lipophilic groups at position 4 of the benzimidazole ring gave TRPV1 antagonists with improved or retained potency, compared to compound <b>39</b>. Attachment of similar hydrophobic substituents at position 5 was less favorable (i.e., compound <b>46b</b>). However the potency could be improved when the bulky hydrophobic group was attached via a −NHCH<sub>2</sub>− linker (i.e., analogue <b>46d</b>). Presumably, the addition of this linker <a name="jm004901203728" id="jm004901203728"></a> allows the hydrophobic group of <b>46d</b> to reach the space occupied by the substituents at position 4. </div><div class="NLM_p">Next we examined modifications to the benzimidazole ring. As shown in Table 4, replacement of the phenyl ring of the benzimidazole analogue <b>39</b> with a pyridine ring was detrimental to activity. For example, the analogue <b>49a </b>(X = N; Y = C) was 14-fold less potent (IC<sub>50</sub> = 1550 nM), and its isomer <b>49b </b>(X = C; Y = N) was 10-fold less potent (IC<sub>50</sub> = 1090 nM) than the parent compound <b>39</b> (IC<sub>50</sub> = 110 nM) in the capsaicin-mediated assay. Similar reductions of potencies in the pH-mediated assay were also noted. </div><div class="NLM_p">Table 5<a class="ref showTableEvent internalNav" data-ID="jm060065yt00005" href="#jm060065yt00005"></a> reports the results of substituted piperazine ring analogues of type <b>III</b>, which carry trifluoromethyl, chloro, or bromo substituents on the pyridine ring. Analogue <b>50a</b>, which was formed by introduction of (<i>R</i>)-methyl group at the carbon atom of the piperazine ring adjacent to the nitrogen atom attached to the benzimidazole ring, was 2-fold more potent (IC<sub>50</sub> = 48 nM) than the unsubstituted analogue <b>39</b> (IC<sub>50</sub> = 110 nM) in the capsaicin-induced <sup>45</sup>Ca<sup>2+</sup> uptake assay. The potency of <b>50a </b>in the pH-mediated assay increased 9-fold (IC<sub>50</sub> = 35 nM) in comparison to that of the parent compound <b>39</b>. However, stepwise elongation of the alkyl substituent of the piperazine ring (e.g. compounds <b>50b </b>and <b>50c</b>) resulted in dramatic decrease of the activity in the capsaicin-induced <sup>45</sup>Ca<sup>2+</sup> uptake assay and loss of potency in the pH-mediated assay, suggesting that methyl is optimal in terms of length and size. Replacement of the trifluoromethyl group of the pyridine ring with bromine atom (R<sub>7</sub> = Br) together with the simultaneous introduction of a (<i>R</i>)- or (<i>S</i>)-methyl group onto the piperazine ring and the well-tolerated (3,4,5-trifluoromethyl)phenyl group at position 4 of the benzimidazole ring gave rise to the potent enantiomers <b>51a</b> and <b>51b</b>, respectively. The (<i>R</i>)-methyl enantiomer <b>51a</b> (IC<sub>50</sub> = 6.7 nM) was approximately 15-fold more potent than the (<i>S</i>)-methyl enantiomer<b> 51b</b> (IC<sub>50</sub> = 104 nM) in the capsaicin-mediated assay and 30-fold more potent in the pH-mediated assay. This result indicates that <i>R</i>-configuration of the R<sub>4</sub> substituent of the piperazine ring is preferred. This stereochemical effect was more pronounced for the enantiomers <b>51c </b>and <b>51d</b>, having a methyl group attached to the carbon atom of the piperazine ring adjacent to the nitrogen atom linked to the pyridine ring. For example, the (<i>R</i>)-methyl enantiomer <b>51c</b> (IC<sub>50</sub> = 4.3 nM) was found to be 178-fold more potent than the corresponding (<i>S</i>)-methyl enantiomer <b>51d</b> (IC<sub>50</sub> = 767 nM) in the capsaicin-mediated assay. <div class="NLM_table-wrap" id="jm060065yt00005"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 5.  Inhibition of <sup>45</sup>Ca<sup>2+</sup> Influx:  Substituents on the Piperazine Ring<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yu00005a.gif" alt="" id="_i35" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">IC<sub>50</sub> (nM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">entry</td><td class="colsep2 rowsep2">R<sub>3</sub></td><td class="colsep2 rowsep2">R<sub>4</sub></td><td class="colsep2 rowsep2">R<sub>5</sub></td><td class="colsep2 rowsep2">R<sub>7</sub></td><td class="colsep2 rowsep2">capsaicin stimulus</td><td class="colsep2 rowsep2">pH stimulus </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">110 ± 22 </td><td class="colsep2 rowsep2">301 ± 14 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>50a</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">(<i>R</i>)-CH<sub>3</sub></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">48 ± 8 </td><td class="colsep2 rowsep2">35 ± 9 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>50b</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">(<i>R</i>)-CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">648 ± 39 </td><td class="colsep2 rowsep2">>4000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>50c</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">(<i>R</i>)-CH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">3230 ± 130 </td><td class="colsep2 rowsep2">>4000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>51a</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">(<i>R</i>)-CH<sub>3</sub></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">6.7 ± 5 </td><td class="colsep2 rowsep2">2.6 ± 2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>51b</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">(<i>S</i>)-CH<sub>3</sub></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">104 ± 11 </td><td class="colsep2 rowsep2">75 ± 5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>51c</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">(<i>R</i>)-CH<sub>3</sub></td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">4.3 ± 2 </td><td class="colsep2 rowsep2">1.8 ± 0.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>51d</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">(<i>S</i>)-CH<sub>3</sub></td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">767 ± 693 </td><td class="colsep2 rowsep2">254 ± 17</td></tr></tbody></table></div></div></div><div class="NLM_p">Several analogues were prepared to explore alternative substitutions on the pyridine ring attached to the core piperazine ring of the 2-piperazin-1-yl-1<i>H</i>-benzimidazole template (Table 6<a class="ref showTableEvent internalNav" data-ID="jm060065yt00006" href="#jm060065yt00006"></a>). The 3‘-trifluoromethyl substituted analogue <b>39 </b>blocked the uptake of <sup>45</sup>Ca<sup>2+</sup> with an IC<sub>50</sub> of 110 nM in the capsaicin-mediated assay and with an IC<sub>50</sub> of 301 nM in the pH-mediated assay, while the unsubstituted at the pyridine ring analogue <b>52a</b> was significantly less potent in both assays. The transfer of the trifluoromethyl group from the 3‘-position to the 4‘-, 5‘-, and 6‘-positions of the pyridine ring also gave substantially less active analogues (i.e., <b>52b</b>, <b>52c</b>, and <b>52d</b>, respectively). These results indicate that substitution of the pyridine ring is essential for the potency, and that position 3‘ is the optimum site. Therefore, we focused our attention to 3-substituted analogues. Unfortunately, modifications of the trifluoromethyl group of the 3‘-substituted analogue <b>39</b> did not lead to an increase of potency, as exemplified by the analogues <b>52e</b><b>−</b><b>i</b>.<sup>46</sup> The chloro analogue <b>52e</b> was 3-fold less potent (IC<sub>50</sub> = 309 nM), and the bulkier iodo-substituted analogue <b>52f </b>was 2-fold less potent (IC<sub>50</sub> = 221 nM) than <b>39</b> (IC<sub>50</sub> = 110 nM) in the capsaicin-mediated assay. The methyl analogue <b>52g</b> (IC<sub>50</sub> = 402 nM) was also significantly less potent than <b>39</b>, while a more dramatic reduction of potency was observed for the cyano- and the ethoxycarbonyl analogues <b>52h</b> and <b>52i</b>, respectively. <div class="NLM_table-wrap" id="jm060065yt00006"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 6.  Inhibition of <sup>45</sup>Ca<sup>2+</sup> Influx:  Substituents on the Pyridine Ring<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yu00006a.gif" alt="" id="_i36" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">IC<sub>50</sub> (nM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">entry</td><td class="colsep2 rowsep2">R<sub>6</sub></td><td class="colsep2 rowsep2">R<sub>7</sub></td><td class="colsep2 rowsep2">capsaicin stimulus</td><td class="colsep2 rowsep2">pH stimulus </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">3-CF<sub>3</sub></td><td class="colsep2 rowsep2">110 ± 22 </td><td class="colsep2 rowsep2">301 ± 14 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52a</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">5790 ± 4290 </td><td class="colsep2 rowsep2">>40000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52b</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">4-CF<sub>3</sub></td><td class="colsep2 rowsep2">>5640 ± 58 </td><td class="colsep2 rowsep2">11930 ± 14660 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52c</b></td><td class="colsep2 rowsep2">5-CF<sub>3</sub></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">11290 ± 270 </td><td class="colsep2 rowsep2">>40000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52d</b></td><td class="colsep2 rowsep2">6-CF<sub>3</sub></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">>40000 </td><td class="colsep2 rowsep2">>40000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52e</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">3-Cl </td><td class="colsep2 rowsep2">309 ± 25 </td><td class="colsep2 rowsep2">705 ± 165 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52f</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">3-I </td><td class="colsep2 rowsep2">221 ± 15 </td><td class="colsep2 rowsep2">310 ± 50 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52g</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">3-CH<sub>3</sub></td><td class="colsep2 rowsep2">402 ± 117 </td><td class="colsep2 rowsep2">1140 ± 580 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52h</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">3-CN </td><td class="colsep2 rowsep2">6290 ± 500 </td><td class="colsep2 rowsep2">7080 ± 280 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52i</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">3-CO<sub>2</sub>C<sub>2</sub>H<sub>5</sub></td><td class="colsep2 rowsep2">23780 ± 6800 </td><td class="colsep2 rowsep2">>40000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>37b</b></td><td class="colsep2 rowsep2">5-C(<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>O)CH<sub>3</sub></td><td class="colsep2 rowsep2">3-Cl </td><td class="colsep2 rowsep2">581 ± 13 </td><td class="colsep2 rowsep2">832 ± 75 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>38b</b></td><td class="colsep2 rowsep2">(<i>R</i>,<i>S</i>)-5-CH(OH)CH<sub>3</sub></td><td class="colsep2 rowsep2">3-Cl </td><td class="colsep2 rowsep2">461 ± 43 </td><td class="colsep2 rowsep2">652 ± 92 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52j</b></td><td class="colsep2 rowsep2">5-CH<sub>2</sub>OH </td><td class="colsep2 rowsep2">3-Cl </td><td class="colsep2 rowsep2">64 ± 10 </td><td class="colsep2 rowsep2">98 ± 14 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52k</b></td><td class="colsep2 rowsep2">5-C(<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>O)NH<sub>2</sub></td><td class="colsep2 rowsep2">3-Cl </td><td class="colsep2 rowsep2">430 ± 23 </td><td class="colsep2 rowsep2">1000 ± 200 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52l</b></td><td class="colsep2 rowsep2">5-C(<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>O)NHCH<sub>3</sub></td><td class="colsep2 rowsep2">3-Cl </td><td class="colsep2 rowsep2">493 ± 58 </td><td class="colsep2 rowsep2">>40000</td></tr></tbody></table></div></div></div><div class="NLM_p">The second set of compounds shown in Table 6 was prepared to study the influence of a second substituent on the pyridine ring. The 3‘-chloro-5‘-acetyl derivative <b>37b </b>was prepared as the first compound of this series, since we had access to its synthetic <a name="jm004901203729" id="jm004901203729"></a> precursor, the 1-(3-chloro-5-acetylpyridin-2-yl)piperazine (<b>8n</b>) (Scheme 2). Compound <b>37b</b> was found to be almost 2-fold less potent (IC<sub>50</sub> = 581 nM) in the capsaicin-mediated assay and nearly equipotent (IC<sub>50</sub> = 831 nM) to the 5‘-unsubstituted analogue <b>52e</b> in the pH-mediated assay. This result suggested that introduction of a second substituent at position 5‘ of the pyridine ring might be tolerated to some extent. Therefore, the remaining compounds shown in Table 6 were prepared to probe the influence of additional substituents at position 5‘ of the pyridine ring on the functional activity of the 3‘-chloro-substituted analogue <b>52e</b>. For example, the potency of the hydroxyethyl analogue <b>38b</b> (IC<sub>50</sub> = 461 nM) was about the same as that of <b>52e </b>(IC<sub>50</sub> = 309 nM) in the capsaicin-mediated assay. However, a substantial improvement of the activity of the 3‘-chloro analogue <b>52e</b> was observed when a hydroxymethyl group was introduced at position 5‘ of the pyridine ring. Compound <b>52j </b>was 5-fold more potent than <b>52e</b> in the capsaicin-mediated assay (IC<sub>50</sub> = 64 nM) and 7-fold more potent in the pH-mediated assay (IC<sub>50</sub> = 98 nM). On the other hand, the potency of the chloro analogue <b>52e</b> was not improved in the case of the 5‘-amides <b>52k</b> and <b>52l</b>. </div><div class="NLM_p">In summary, the SAR for the compounds included in Table 6 showed that position 3‘ of the pyridine moiety is the optimum site for substitution and that a trifluoromethyl group or chlorine or iodine atoms are the most preferable substituents. Introduction of a second substituent, preferably a hydroxymethyl group, at position 5‘ of the pyridine ring led to an increase in potency. </div><div class="NLM_p">Table 7<a class="ref showTableEvent internalNav" data-ID="jm060065yt00007" href="#jm060065yt00007"></a> displays the results of compounds <b>53a</b><b>−</b><b>f</b>, which were designed to explore the influence of an alternative type of aromatic group attached to the piperazine ring on the functional TRPV1 activity. The 2-trifluoromethyl-substituted phenyl analogue <b>53a </b>(IC<sub>50</sub> = 2060 nM) was 20-fold less potent than the parent 2-(3-trifluoromethyl)pyridinyl analogue <b>39</b> (IC<sub>50</sub> = 110 nM) in the capsaicin-mediated assay but nearly equipotent in the pH-mediated assay. Moving the nitrogen atom from the ortho- to the para-position of the pyridine ring was detrimental to activity (i.e., the 4-(3-trifluoromethyl)pyridinyl analogue <b>53b</b>). This result suggests that the presence of a hydrogen-bond-accepting nitrogen atom at the ortho-position is important for the binding with the TRPV1 receptor. This observation is in agreement with the SAR of the pyridine fragment of the BCTC series of TRPV1 antagonists reported previously.<sup>36</sup> Replacement of the trifluoromethyl group of <b>53b</b> with a chlorine atom gave the slightly less active analogue <b>53c</b>. However, subsequent addition of a second chlorine atom to <b>53c</b> gave the analogue <b>53d</b>, which showed about a 3-fold increase of potency (IC<sub>50</sub> = 1370 nM) in the capsaicin-mediated assay. As exemplified by the dichlorophenyl analogue <b>53e</b>, removal of the nitrogen atom of <b>53d</b> led to a dramatic loss of potency in the capsaicin-mediated assay, while the potency in the pH-mediated assay was increased 2-fold. As might be expected, the pyrimidine analogue <b>53f</b> showed 2-fold potency improvement relative to the pyridine analogue <b>53c</b> in the capsaicin-mediated assay; however, this trend did not extend to the pH-mediated assay, in which <b>53f</b> showed a dramatic loss of activity. <div class="NLM_table-wrap" id="jm060065yt00007"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 7.  Inhibition of <sup>45</sup>Ca<sup>2+</sup> Influx:  Variations to the Aromatic Ring</p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yu00007a.gif" alt="" id="_i37" /></img></td></tr></tbody></table></div></div></div><div class="NLM_p">Finally, the analogues included in Table 8<a class="ref showTableEvent internalNav" data-ID="jm060065yt00008" href="#jm060065yt00008"></a> were prepared to study the influence of combining the best substituents (see Tables 2−6) on the core and the flanking moieties of the novel template of TRPV1 antagonists. The analogues were designed by maintaining the optimum trifluoromethyl and (<i>R</i>)-methyl groups for the substituent R<sub>2</sub> of the benzimidazole ring and for the substituent R<sub>4</sub> of the piperazine ring, respectively, while the substituents R<sub>3</sub>, R<sub>6</sub>, and R<sub>7</sub> were varied. This effort led to the identification of TRPV1 antagonists with substantially improved potency. For example, the introduction of the 3,4,5-trifluorophenyl group at the 4-position of the benzimidazole ring and the hydroxymethyl group at the 5‘-position of the pyridine ring gave the potent analogue <b>35</b>. This compound was 34-fold more potent (IC<sub>50</sub> = 1.4 nM) then the parent 2-(3-trifluoromethyl)pyridinyl analogue <b>50</b> (IC<sub>50</sub> = 48 nM) in the capsaicin-mediated assay and 50-fold more potent (IC<sub>50</sub> = 0.7 nM) in the pH-mediated assay. Similar increases in potencies were also observed for the analogues <b>32d</b><b>−</b><b>g </b>that retained the hydroxymethyl group at R<sub>6</sub> and have various bulky hydrophobic groups as R<sub>3</sub>. It is worth noting that the bulkier <i>N</i>,<i>N</i>-dibenzylamino-substituted analogue <b>32g</b> (IC<sub>50</sub> = 1.9 nM) was approximately 4-fold more potent than the benzylamino analogue <b>32f </b>(IC<sub>50</sub> = 7 nM), which provides an additional insight on the size of the hydrophobic pocket of the TRPV1 receptor. Also well-tolerated was the replacement of the hydroxymethyl group of <b>35</b> with the bulkier (<i>R</i>,<i>S</i>)-[1-(1-hydroxyethyl)] and (<i>R</i>,<i>S</i>)-1-hydroxy-1-phenylmethyl groups (i.e., <b>38c </b>and <b>38d</b>). The diastereoisomers <b>46k</b> and <b>46l</b> were prepared and separated to probe the influence of the configuration of the chiral [1-(1-hydroxyethyl)] substituent on the antagonistic activity. The isomer <b>46k</b> was 4-fold more potent (IC<sub>50</sub> = 0.6 nM) than the isomer <b>46l</b> (IC<sub>50</sub> = 2.6 nM) in the capsaicin-mediated assay and almost equipotent in the pH-mediated assay. Addition of a second hydroxyl group to the (<i>R</i>,<i>S</i>)-[1-(1-hydroxyethyl)] substituent of <b>38c</b> gave the (<i>R</i>,<i>S</i>)-1,2-dihydroxyethyl-substituted diastereomeric mixture <b>46ad</b>, which was approximately equipotent with <b>38c</b> in both assays. Replacement of the amino group of the analogue <b>46e</b> (IC<sub>50</sub> = 98 nM) with the bulkier hydroxyacetylamino group gave the analogue <b>46f </b>(IC<sub>50</sub> = 30 nM) and resulted in 3-fold increase of the potency in the capsaicin-mediated assay. <div class="NLM_table-wrap" id="jm060065yt00008"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 8.  Inhibition of <sup>45</sup>Ca<sup>2+</sup> Influx:  Substituents on the Benzimidazole, Piperazine and Pyridine Rings<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yu00008a.gif" alt="" id="_i38" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">IC<sub>50</sub> (nM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">entry</td><td class="colsep2 rowsep2">R<sub>3</sub></td><td class="colsep2 rowsep2">R<sub>6</sub></td><td class="colsep2 rowsep2">R<sub>7</sub></td><td class="colsep2 rowsep2">capsaicin stimulus</td><td class="colsep2 rowsep2">pH stimulus </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>50</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">48 ± 8 </td><td class="colsep2 rowsep2">35 ± 9 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>35</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">CH<sub>2</sub>OH </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">1.4 ± 0.6 </td><td class="colsep2 rowsep2">0.7 ± 0.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>32d</b></td><td class="colsep2 rowsep2">NHCO-cyclohexyl </td><td class="colsep2 rowsep2">CH<sub>2</sub>OH </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">1.6 ± 0.3 </td><td class="colsep2 rowsep2">1.2 ± 0.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>32e</b></td><td class="colsep2 rowsep2">4-NHCO<sub>2</sub>-t-Bu </td><td class="colsep2 rowsep2">CH<sub>2</sub>OH </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">2.1 ± 0.6 </td><td class="colsep2 rowsep2">1.1 ± 0.6 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>32f</b></td><td class="colsep2 rowsep2">NHCH<sub>2</sub>-Ph </td><td class="colsep2 rowsep2">CH<sub>2</sub>OH </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">7.0 ± 0.4 </td><td class="colsep2 rowsep2">6.7 ± 1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>32g</b></td><td class="colsep2 rowsep2">N(CH<sub>2</sub>-Ph)<sub>2</sub></td><td class="colsep2 rowsep2">CH<sub>2</sub>OH </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">1.9 ± 0.3 </td><td class="colsep2 rowsep2">0.9 ± 0.1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>38c</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">(<i>R</i>,<i>S</i>)-CH(OH)CH<sub>3</sub></td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">1.5 ± 0.5 </td><td class="colsep2 rowsep2">1.0 ± 0.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>38d</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">(<i>R</i>,<i>S</i>)-CH(OH)Ph </td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">2.8 ± 0.3 </td><td class="colsep2 rowsep2">3.7 ± 0.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46k</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">(<i>R</i>)-CH(OH)CH<sub>3</sub><i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">0.6 ± 0.4 </td><td class="colsep2 rowsep2">2.3 ± 0.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46l</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">(<i>S</i>)-CH(OH)CH<sub>3</sub><i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">2.6 ± 0.4 </td><td class="colsep2 rowsep2">3.0 ± 0.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46ad</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">(<i>R</i>,<i>S</i>)-CH(OH)CH<sub>2</sub>OH </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">0.9 ± 0.7 </td><td class="colsep2 rowsep2">0.9 ± 0.7 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46e</b></td><td class="colsep2 rowsep2">4-(4-F-Ph) </td><td class="colsep2 rowsep2">NH<sub>2</sub></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">98 ± 3.2 </td><td class="colsep2 rowsep2">33 ± 3.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46f</b></td><td class="colsep2 rowsep2">4-(4-F-Ph) </td><td class="colsep2 rowsep2">NHCOCH<sub>2</sub>OH </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">30 ± 2.1 </td><td class="colsep2 rowsep2">9.2 ± 1.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>37a</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">0.3 ± 0.0 </td><td class="colsep2 rowsep2">0.3 ± 0.1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>38a</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">CO<sub>2</sub>H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">46 ± 19 </td><td class="colsep2 rowsep2">27 ± 2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>45</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">Br </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">3.4 ± 1.1 </td><td class="colsep2 rowsep2">3.3 ± 0.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46ac</b></td><td class="colsep2 rowsep2">4-(3,4,5-trifluoro-Ph) </td><td class="colsep2 rowsep2">CH<img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CH<sub>2</sub></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">1.3 ± 0.1 </td><td class="colsep2 rowsep2">1.7 ± 0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> The configuration was assigned at random.</p></div></div></div><div class="NLM_p">These results indicate that relatively large, heteroatom-<a name="jm004901203730" id="jm004901203730"></a> containing substituents are well-tolerated at position 5‘ of the pyridine ring. We also found that the receptor-binding site is even able to tolerate charged substituents at position 5‘ of the pyridine ring. For example, the substituted with a carboxylic group analogue <b>38a</b> maintained significant activity at the TRPV1 receptor. Nonpolar substituents, as exemplified with the bromide <b>45</b> and the vinyl-substituted analogue <b>46ac</b>, were also well-tolerated at position 5‘ of the pyridine ring. </div><div class="NLM_p"><b>Pharmacokinetic Profile.</b> Compound <b>46ad</b> was selected for in vivo pharmacokinetic (PK) study with intravenous (iv) and oral (po) dosing in Sprague−Dawley rats, since it was one of the most potent in vitro analogues in the capsaicin-mediated assay (IC<sub>50</sub> = 0.9 nM) and in the pH-mediated assay (IC<sub>50</sub> = 0.9 nM). Following iv administration of 1 mg/kg, <b>46ad</b> demonstrated a low rate of clearance (CL = 270 mL/h/kg), a relatively low volume of distribution (<i>V</i><sub>ss</sub> = 1893 mL/kg), and an elimination half-life (<i>t</i><sub>1/2</sub>) of 5.6 h. Compound <b>46ad </b>was relatively well-absorbed (<i>t</i><sub>max</sub> = 4 h, <i>C</i><sub>max</sub> = 617 ng/mL) following oral administration of 5 mg/kg and was found to be orally bioavailable (<i>F</i> = 17%). </div><div class="NLM_p"><b>In Vivo Profile. </b>Compound <b>46ad</b> was evaluated in two animal models of nociception. The first model examined the ability of <b>46ad</b> to block the capsaicin-induced paw flinching in rats, while the second investigated the effect of <b>46ad</b> on complete Freund's adjuvant (CFA)-induced thermal hyperalgesia. </div><div class="NLM_p">When dosed orally, the potent TRPV1 antagonist <b>46ad </b>was efficacious in vivo by blocking capsaicin-induced flinching in rats (capsaicin 0.5 μg/0.25 mL per paw, eight animals per group) with ED<sub>50</sub> of 8.8 mg/kg (Figure 2<a data-tab="pane-pcw-Figures" href="#jm060065yf00002" id="" class=" internalNav"></a>). <div id="_i39"><figure id="jm060065yf00002" data-index="13" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yf00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00002.jpeg" id="_i40" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Effect of compound <b>46ad</b> on capsaicin-induced flinching in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yf00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">In the CFA-induced thermal hyperalgesia model, <b>46ad </b>significantly reversed thermal hyperlgesia produced by administration of CFA at a dose of 30 mg/kg, po (Figure 3<a data-tab="pane-pcw-Figures" href="#jm060065yf00003" id="" class=" internalNav"></a>). <div id="_i41"><figure id="jm060065yf00003" data-index="14" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yf00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00003.jpeg" id="_i42" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Effect of compound <b>46ad</b> on CFA-induced thermal hyperalgesia in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yf00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A novel class of TRPV1 antagonists was identified by constraining analogues of BCTC (<b>4</b>) into a 2-(4-pyridin-2-ylpiperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole template. A series of compounds was prepared, first, by stepwise introduction of various substituents on the benzimidazole, the piperazine, and the pyridine rings of the template and, second, by combining the optimum substituents on all preferred sites of the template. A summary of the SAR obtained in this study is illustrated in Figure 4<a data-tab="pane-pcw-Figures" href="#jm060065yf00004" id="" class=" internalNav"></a>. <div id="_i44"><figure id="jm060065yf00004" data-index="15" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yf00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00004.jpeg" id="_i45" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Summary of SAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yf00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">We found that<i> N</i>-benzylation of the benzimidazole ring was detrimental to activity, suggesting certain steric limitations and/or specific requirement for hydrogen-bond-donor interactions with binding site at the receptor. On the other hand, substitution at position 6 of the benzimidazole ring was well-tolerated, and <a name="jm004901203731" id="jm004901203731"></a> trifluoromethyl, bromo, and <i>tert</i>-butyl groups were identified as the optimal substituents. The introduction of an additional substituent at position 5 of the benzimidazole ring seemed to provide limited benefit, due to steric limitations. On the other hand, the introduction of an additional substituent at position 4 of the benzimidazole ring led to significant enhancement of the activity. For example, bulky hydrophobic groups were found to be the preferred substituents at position 4, which revealed the existence of a new, relatively large hydrophobic pocket in the TRPV1 receptor. </div><div class="NLM_p">We found that substitution of the piperazine ring with a methyl group resulted in enhancement of potency and that the preferred configuration of the substituents R<sub>4</sub> and R<sub>5</sub> was <i>R</i>. A methyl group was found as the optimal R<sub>4</sub> substituent, since increase of the size and length of this substituent to ethyl and <i>n</i>-propyl led to substantial decrease of activity. </div><div class="NLM_p">Next we studied the structural features of the pyridine ring that influence the functional activity of the novel template of TRPV1 antagonists. The presence of substituents on the pyridine ring and ortho-attachment of the pyridine ring to the piperazine core were critical for potency. We found that position 3‘ of the pyridine ring was the most tolerated site for substitution, and a trifluoromethyl group or chlorine or iodine atoms were the most preferred substituents. Additional substitution of the pyridine ring at position 5‘ with various polar, charged, or hydrophobic groups maintained or increased the potency. </div><div class="NLM_p">Finally, the simultaneous introduction of bulky lipophilic substituents at position 4 of the benzimidazole ring, a methyl group as the substituent R<sub>4</sub> of the piperazine core, and polar or charged groups at position 5‘ of the pyridine ring gave rise to the most potent compounds in the series. </div><div class="NLM_p last">As a result of this SAR investigation, we identified the potent analogue <b>46ad</b>, which showed good pharmacokinetic profile and was found to be orally bioavailable. In vivo, compound <b>46ad</b> was found to be effective at preventing capsaicin-induced flinching in rats in a dose-dependent manner, and it reversed thermal hyperalgesia in a model of inflammatory pain, which was induced by complete Freund's adjuvant (CFA). </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. Anhydrous solvents were obtained from Aldrich or EM Science and used directly. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen or argon atmosphere. All microwave-assisted reactions were conducted with a Smith synthesizer from Personal Chemistry, Uppsala, Sweden. All final compounds were purified to >95% purity as determined by LC/MS obtained on Agilent 1100 and HP 1100 specrometers. Purity of the compounds was determined on an Agilent 1100 spectrometer by method A [Phenomenex Luna C<sub>8</sub> column (100 × 4.6 mm) at a 1.0 mL/min flow rate using a gradient of 5−100% 5 mM ammonium acetate (pH 5.5) in acetonitrile and 20 mM ammonium acetate (pH 5.5) in water] and method B [Phenomenex Luna C<sub>8</sub> column (100 × 4.6 mm) at a 1.0 mL/min flow rate using a gradient of 10−100% 0.1% formic acid in acetonitrile and 0.1% formic acid in water]. The purity of the compounds was determined on an HP 1100 spectrometer by method C [Gemini C<sub>18</sub> column (150 × 4.6 mm) at a 1.25 mL/min flow rate using a gradient of 10−95% 5 mM ammonium acetate (pH 5.5) in acetonitrile and 20 mM ammonium acetate (pH 5.5) in water] and method D [Synergi Max-RP column (150 × 4.6 mm) at a 1.0 mL/min flow rate using a gradient of 10−90% 0.1% formic acid in acetonitrile and 0.1% formic acid in water]. Silica gel chromatography was performed using either glass columns packed with silica gel (200−400 mesh, Aldrich Chemical) or prepacked silica gel cartridges (Biotage). Melting points were determined on a Buchi-545 melting point apparatus and are uncorrected. <sup>1</sup>H NMR spectra were determined with a Bruker DRX 400 MHz spectrometer. Chemical shifts are reported in parts per million (ppm, δ units). Low-resolution mass spectral (MS) data were determined on a Perkin-Elmer-SCIEX API 165 mass spectrometer using ES ionization modes (positive or negative). Combustion analysis was performed by Atlantic Microlab, Inc., Norcross, GA, and were within ±0.4% of calculated values unless otherwise noted. Combustion analysis and <sup>1</sup>H NMR spectra showed that fractional molar amounts of water or organic solvents were tenaciously retained in some analytical samples, even after prolonged drying under reduced pressure. </div><div class="NLM_p"><b>6-</b><b><i>tert</i></b><b>-Butyl-2-(4-(3-chloropyridin-4-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (5).</b> A mixture of the 2-chlorobenzoimidazole <b>20a</b> (209 mg, 1 mmol), piperazine <b>8b</b> (305 mg, 1.5 mmol), and <i>N,N</i>-diisopropylethylamine (0.7 mL, 4 mmol) in DMSO (5 mL) was stirred at 80 °C for 24 h. The mixture was then cooled to room temperature, diluted with water (10 mL), and extracted with EtOAc (2 × 20 mL). The combined organic phases were washed with water (2 × 10 mL) and brine (5 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo and the residue was purified by silica gel chromatography, eluting with 20% EtOAc/hexane to give 0.17 g (46%) of the title compound as a yellow amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  370 (M + 1). <sup>1</sup>H NMR (DMSO<i>-d</i><sub>6</sub>):  δ 1.31 (s, 9 H), 3.36−3.42 (m, 4 H), 3.60−3.80 (m, 4 H), 7.00 (dd, <i>J</i> = 8.2, 2.0 Hz, 1 H), 7.04 (dd, <i>J</i> = 7.8, 4.7 Hz, 1 H), 7.14 (d, <i>J</i> = 8.2 Hz, 1 H), 7.23 (d, <i>J</i> = 1.6 Hz, 1 H), 7.84 (dd, <i>J</i> = 7.8, 1.6 Hz, 1 H), 8.25 (dd, <i>J</i> = 4.7, 2.0 Hz, 1 H). LC/MS retention time:  A, 9.60 min; B, 6.77 min. </div><div class="NLM_p"><b>4-Nitro-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (31a).</b> A mixture of 2-chlorobenzoimidazole <b>20c </b>(1.5 g, 5.7 mmol), 1-(3-trifluoromethylpyridin-2-yl)piperazine (1.8 g, 7.8 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (1 mL, 5.7 mmol) in 1,4-dioxane (1 mL) was <a name="jm004901203732" id="jm004901203732"></a> heated in a microwave synthesizer at 200 °C for 40 min. The mixture was evaporated in vacuo and the residue was purified by silica gel column chromatography, eluting with 30% EtOAc/hexane to give 2.1 g (80%) of the title compound as an orange solid. Mp:  192.9−193 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  461 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 3.26−3.38 (m, 4 H), 3.76−3.88 (m, 4 H), 7.13 (dd, <i>J</i> = 6.0, 5.6 Hz, 1 H), 7.68 (br s, 1 H), 7.97 (d, <i>J</i> = 8.0 Hz, 1 H), 8.02 (s, 1 H), 8.42 (d, <i>J</i> = 4.0 Hz, 1 H). Anal. (C<sub>18</sub>H<sub>14</sub>F<sub>6</sub>N<sub>6</sub>O<sub>2</sub>):  C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-(5-Chloro-6-(3-methyl-4-(4-nitro-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)piperazi</b><b>n-1-yl)pyridin-3-yl)methanol (31b).</b> A mixture of 2-chlorobenzoimidazole <b>20c</b> (1.33 g, 5 mmol), piperazine <b>8t</b> (1.21 g, 5 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (1.75 mL, 10 mmol) in EtOH (4 mL) was heated in a microwave synthesizer at 175 °C for 60 min. The mixture was evaporated in vacuo and the residue was purified by silica gel column chromatography, eluting with 60% EtOAc/hexane to give 1.81 g (77%) of the title compound as a yellow solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  471 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.51 (d, <i>J</i> = 6.7 Hz, 3 H), 3.07 (dt, <i>J</i> = 12.1, 2.7 Hz, 1 H), 3.17 (dd, <i>J</i> = 12.5, 2.7 Hz, 1 H), 3.70 (dt, <i>J</i> = 12.1, 2.7 Hz, 1 H), 3.83 (t, <i>J</i> = 11.5 Hz, 2 H), 4.19 (d, <i>J</i> = 12.9 Hz, 1 H), 4.56 (s, 2 H), 4.65 (br s, 1 H), 7.69−7.80 (m, 2 H), 8.10 (br s, 1 H), 8.17 (br s, 1 H). </div><div class="NLM_p"><b>6-(Trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imida</b><b>zol-4-amine (32a). </b>Compound <b>31a</b> (1.8 g, 3.9 mmol) was added to a suspension of 10% Pd/C (0.16 g) in EtOH (50 mL) under a hydrogen atmosphere. The reaction mixture was stirred at room temperature for 4 h and filtered through a pad of Celite. The filtrate was evaporated under reduced pressure and the residue was purified by silica gel column chromatography, eluting with 45% EtOAc/hexane to give 1.1 g (66%) of the title compound as a off-white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  431 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.58−3.66 (m, 4 H), 3.90−4.00 (m, 4 H), 6.90 (s, 1 H), 7.13 (s, 1 H), 7.45 (dd, <i>J</i> = 7.6, 5.0 Hz, 1 H), 8.28 (dd, <i>J</i> = 7.6, 1.4 Hz, 1 H), 8.74 (d, <i>J</i> = 3.6 Hz, 1 H). Anal. (C<sub>18</sub>H<sub>16</sub>F<sub>6</sub>N<sub>6</sub>):  C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-(6-(4-(4-Amino-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)-3-methylpiperazin-1-yl)-</b><b>5-chloropyridin-3-yl)methanol (32b). </b>Following the procedure described for compound <b>32a</b>, compound <b>31b</b> provided the title compound (96%) as a yellow gum. MS (ESI, pos. ion) <i>m</i>/<i>e</i>:  441 (M + 1). </div><div class="NLM_p"><b><i>N</i></b><b>-(3,4,5-Trifluorobenzyl)-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazi</b><b>n-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-4-amine (32c).</b> NaBH(OAc)<sub>3</sub> (211 mg, 1 mmol) was added to a mixture of compound <b>32a</b> (215 mg, 0.5 mmol) and 3,4,5-trifluorobenzaldehyde (88 mg, 0.55 mmol) in chloroform (2 mL) in one portion. The reaction mixture was stirred at room temperature for 2 h and concentrated in vacuo. The residue was dissolved in EtOAc (30 mL), washed successively with 1 N NaOH (15 mL) and brine (15 mL), dried over MgSO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo and the residue was purified by silica gel chromatography, eluting with 25% EtOAc/hexane to give 175 mg (61%) of the title compound as a white solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  575 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.36−3.42 (m, 4 H), 3.60−4.72 (m, 4 H), 6.39 (s, 1 H), 6.92 (s, 1 H), 7.10−7.30 (m, 3 H), 8.06 (dd, <i>J</i> = 7.8 Hz, 1.5 Hz, 1 H), 8.51 (d, <i>J</i> = 3.7 Hz, 1 H). Anal. (C<sub>25</sub>H<sub>19</sub>F<sub>9</sub>N<sub>6</sub>) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-</b><b><i>N</i></b><b>-(2-(4-(3-Chloro-5-(hydroxymethyl)pyridin-2-yl)-2-methylpiperazin-1-yl)-6-(trifluoro</b><b>methyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-4-yl)cyclohexanecarboxamide (32d).</b> A mixture of compound <b>32b</b> (221 mg, 0.5 mmol), cyclohexanecarboxylic acid (71 mg, 0.55 mmol), and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (76 mg, 0.4 mmol) in dichloromethane (5 mL) was stirred at room temperature for 36 h. Water (20 mL) was added and the mixture was extracted with EtOAc (2 × 40 mL). The combined organic phases were washed with brine (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The solvent was removed in vacuo and the residue was purified by silica gel chromatography, eluting with 80% EtOAc/hexanes to give 94 mg (34%) of the title compound as a white solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  551 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.26−1.75 (m, 8 H), 1.78−1.88 (m, 1 H), 1.90−2.00 (m, 2 H), 2.00−2.10 (m, 2 H), 2.59 (t, <i>J</i> = 12.1 Hz, 1 H), 3.17 (dt, <i>J</i> = 12.1, 3.1 Hz, 1 H), 3.27 (dd, <i>J</i> = 12.1, 2.9 Hz, 1H), 3.75 (dt, <i>J</i> = 12.1, 3.1 Hz, 1 H), 3.83 (t, <i>J</i> = 12.5 Hz, 2 H), 3.95 (d, <i>J</i> = 11.3 Hz, 1 H), 4.49 (br s, 1 H), 4.65 (s, 2 H), 7.35 (br s, 1 H), 7.87 (d, <i>J</i> = 2.9 Hz, 1 H), 8.27 (s, 1 H), 8.34 (br s, 1 H). LC/MS retention time:  A, 10.32 min; B, 8.42 min. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-</b><b><i>tert</i></b><b>-Butyl </b><b>2-(4-(3-Chloro-5-(hydroxymethyl)pyridin-2-yl)-2-methylpiperazin-1-yl)-6-(trifluoromethyl)-</b><b>1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-4-ylcarbamate (32e).</b> To a mixture of compound <b>32b</b> (221 mg, 1.0 mmol) and 1 N NaOH (1 mL) in THF (5 mL) was added di-<i>tert</i>-butyl dicarbonate (131 mg, 0.6 mmol) in one portion with stirring at room temperature. The mixture was stirred at room temperature for 30 min, diluted with water (20 mL), and extracted with EtOAc (2 × 40 mL). The combined organic extracts were washed with brine (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo and the residue was purified by silica gel column chromatography, eluting with 60% EtOAc/hexane to give 110 mg (41%) of the title compound as a light-yellow solid. MS (ESI, pos. ion) <i>m</i>/<i>e</i>:  541 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.47 (d, <i>J</i> = 6.6 Hz, 3 H), 1.55 (s, 9 H), 3.06 (dt, <i>J</i> = 12.1, 3.1 Hz, 1 H), 3.17 (dd, <i>J</i> = 12.3, 3.3 Hz, 1 H), 3.63 (dt, <i>J</i> = 12.1, 3.5 Hz, 1 H), 3.82 (t, <i>J</i> = 12.3 Hz, 2 H), 3.92 (d, <i>J</i> = 12.7 Hz, 1 H), 4.37 (br s, 1 H), 4.56 (s, 2 H), 7.20 (br s, 1 H), 7.77 (s, 1 H), 7.91 (br s, 1 H), 8.17 (s, 1 H). LC/MS retention time:  A, 10.59 min; B, 8.51 min. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-(5-Chloro-6-(4-(4-(dibenzylamino)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)-3-met</b><b>hylpiperazin-1-yl)pyridin-3-yl)methanol (32</b><b>g</b><b>). </b>To a solution of compound <b>32b</b> (221 mg, 0.5 mmol) in MeCN (2 mL) was added benzaldehyde (0.085 mL, 0.55 mmol) dropwise with stirring at room temperature. After the addition, the mixture was stirred at room temperature for 20 min and then NaBH(OAc)<sub>3</sub> (127 mg, 0.6 mmol) was added in one portion. The mixture was stirred for 4 h at room temperature, 1 N NaOH (5 mL) was added, and the mixture was extracted with EtOAc (2 × 40 mL). The combined organic phases were washed with brine (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo and the residue was purified by silica gel chromatography, eluting with 60% EtOAc/hexane to give 112 mg (42%) of the title compound as a light-yellow solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  621 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.44 (d, <i>J</i> = 6.3 Hz, 3 H), 3.06 (dt, 12.1, 3.1 Hz, 1 H), 3.16 (dd, <i>J</i> = 12.5, 2.4 Hz, 1 H), 3.58 (dt, <i>J</i> = 12.1, 2.4 Hz, 1 H), 3.79 (t, <i>J</i> = 10.6, Hz, 2 H), 3.99 (d, <i>J</i> = 12.9, Hz, 1 H), 4.44 (br s, 1 H), 4.55 (s, 2 H), 4.55−4.70 (m, 2 H), 6.49 (br s, 2 H), 6.89 (br s, 1 H), 7.10−7.30 (m, 10 H), 7.76 (s, 1 H), 8.16 (s, 1 H). LC/MS retention time:  A, 12.03 min; B, 9.81 min. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-(6-(4-(4-(Benzylamino)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)-3-methylpiperazi</b><b>n-1-yl)-5-chloropyridin-3-yl)methanol (32f).</b> Compound<b> 32f</b> was formed as a second product of the reaction described for compound <b>32g</b> and was isolated as a light-yellow solid (yield 98 mg, 36%). MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  531 (M + 1).<sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.44 (d, <i>J</i> = 6.3 Hz, 3 H), 3.06 (dt, 12.1, 3.1 Hz, 1 H), 3.16 (dd, <i>J</i> = 12.5, 2.4 Hz, 1 H), 3.58 (dt, <i>J</i> = 12.1, 2.4 Hz, 1 H), 3.73−3.93 (m, 3 H), 4.33 (br s, 1 H), 4.45 (s, 2 H), 4.55 (s, 2 H), 6.49 (s, 1 H), 6.89 (br s, 1 H), 7.25 (t, <i>J</i> = 7.1 Hz, 1 H), 7.33 (t, <i>J</i> = 7.4 Hz, 2 H), 7.45 (d, <i>J</i> = 7.4 Hz, 2 H), 7.76 (s, 1 H), 8.16 (s, 1 H). LC/MS retention time:  A, 10.36 min; B, 7.86 min. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-4-Bromo-2-(4-(3-chloro-5-nitropyridin-2-yl)-2-methylpiperazin-1-yl)-6-(trifluoromethyl</b><b>)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (33).</b> A mixture of piperazine <b>8ad</b> (970 mg, 3.79 mmol), 2-chlorobenzoimidazole <b>20f</b> (1.1 g, 3.79 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.79 mL, 4.55 mmol), and copper(I) iodide (1 mg) in 3-methylbutan-1-ol (5 mL) was heated in a microwave synthesizer at 200 °C for 60 min. The solvent was evaporated under reduced pressure and the residue was purified by silica gel column chromatography (gradient 5−100% EtOAc/CH<sub>2</sub>Cl<sub>2</sub>) to give 1.1 g (58%) of the title compound as a brown solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  519, 521 (M + 1). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-6-(4-(4-Bromo-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)-3-methylpiperazin-1-yl)-5</b><b>-chloropyridin-3-amine (34).</b> A <a name="jm004901203733" id="jm004901203733"></a> mixture of compound <b>33</b> (1.1 g, 2.12 mmol) and tin(II) chloride dihydrate (0.957 g, 4.24 mmol) in DMF (7 mL) was heated to 80 °C with stirring for 3 h. The reaction mixture was allowed to cool to room temperature and was diluted with EtOAc (100 mL). To the stirred mixture was added slowly a saturated aqueous solution of NaHCO<sub>3</sub> (200 mL) and Celite (10 g). The mixture was stirred at room temperature for 18 h and was filtered. The organic layer was separated from the filtrate and the aqueous layer was extracted with EtOAc (2 × 100 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by flash silica gel column chromatography (gradient 0−20% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to give 0.444 g (44%) of the title compound as a brown solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  489, 491 (M + 1). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-(6-(3-Methyl-4-(6-(trifluoromethyl)-4-(3,4,5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)</b><b>piperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl)methanol (35).</b> A mixture of piperazine <b>8aa</b> (825 mg, 3.0 mmol), 2-chlorobenzoimidazole <b>20i</b> (1.05 g, 3.0 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (1.05 mL, 6 mmol) in EtOH (5 mL) was heated in a microwave synthesizer at 175 °C for 4 h. The mixture was evaporated in vacuo and the residue was purified by silica gel column chromatography, eluting with 60% EtOAc/hexane to give 1.45 g (41%) of the title compound as a white solid. MS (ESI, pos. ion) <i>m</i>/<i>e</i>:  590 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.43 (d, <i>J</i> = 6.6 Hz, 3 H), 3.14 (dt, <i>J</i> = 12.5, 3.1 Hz, 1 H), 3.32−3.42 (m, 3 H), 3.48 (d, <i>J</i> = 11.7 Hz, 1 H), 3.62 (dt, <i>J</i> = 12.1, 3.1 Hz, 1 H), 4.05 (dd, <i>J</i> = 13.1, 2.1 Hz, 1 H), 4.46 (br s, 1 H), 4.65 (s, 2 H), 7.45 (s, 1 H), 7.49 (s, 1 H), 7.82−7.94 (m, 2 H), 8.06 (s, 1 H), 8.50 (s, 1 H). LC/MS retention time:  A, 12.01 min; B, 11.86 min. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-6-(3-Methyl-4-(6-(trifluoromethyl)-4-(3,4,5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)p</b><b>iperazin-1-yl)-5-(trifluoromethyl)nicotinaldehyde (36). </b>A suspension of compound <b>35</b> (1.18 g, 2 mmol) and MnO<sub>2</sub> (3.48 g, 40 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was stirred at room temperature for 4 h. The reaction mixture was filtered though a pad of Celite and the filter cake was washed with EtOAc. The filtrate was evaporated in vacuo to give 1.01 g (86%) of the title compound as a white solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  588 (M + 1). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-Methyl </b><b>5-Chloro-6-(3-methyl-4-(6-(trifluoromethyl)-4-(3,4,5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-</b><b>2-yl)piperazin-1-yl)nicotinate (37a). </b>A mixture of piperazine <b>8s</b> (271 mg, 1.0 mmol), 2-chlorobenzoimidazole <b>20i</b> (350 mg, 1.0 mmol),<i> N</i>,<i>N</i>-diisopropylethylamine (0.35 mL, 2 mmol) in EtOH (1 mL) was heated in a microwave synthesizer at 175 °C for 1 h. The reaction mixture was evaporated in vacuo and the residue was purified by silica gel column chromatography (60% EtOAc/hexane) to give 163 mg (28%) of the title compound as a white solid. MS ESI, pos. ion) <i>m</i>/<i>e</i>:  584 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.42 (d, <i>J</i> = 6.3 Hz, 3 H), 3.21 (dt, <i>J</i> = 12.5, 3.1 Hz, 1 H), 3.31−3.38 (m, 1 H), 3.70 (dt, <i>J</i> = 12.5, 3.1 Hz, 1 H), 3.89 (s, 3 H), 4.08 (d, <i>J</i> = 12.1 Hz, 1 H), 4.18 (t, <i>J</i> = 14.0 Hz, 2 H), 4.50 (br s, 1 H), 7.47 (s, 2 H), 7.85 (br s, 2 H), 8.19 (d, <i>J</i> = 2.0 Hz, 1 H), 8.73 (d, <i>J</i> = 2.0 Hz, 1 H). LC/MS retention time:  A, 12.85 min; B, 13.28 min. </div><div class="NLM_p"><b>1-(5-Chloro-6-(4-(5-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)piperazin-1-yl)pyridin-3-yl)</b><b>ethanone (37b). </b>A mixture of piperazine <b>8n</b> (0.6 g, 1.92 mmol), 2-chlorobenzoimidazole <b>20n</b> (0.423 g, 1.92 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (1 mL, 6 mmol) in dioxane (1 mL) was heated in a microwave synthesizer at 190 °C for 45 min. The reaction mixture was diluted with EtOAc (100 mL), washed with saturated aqueous solution of NaHCO<sub>3</sub> (50 mL) and brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by silica gel column chromatography (30% EtOAc in hexane) to give 0.67 g (82%) of the title compound as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  424 (M + 1). <sup>1</sup>H NMR (DMSO-<i>d</i><i><sub>6</sub></i>):  δ 2.62 (s, 3 H), 3.70−3.81 (m, 8 H), 7.33−7.37 (m, 1 H), 7.41−7.45 (m, 1 H), 7.55 (s, 1 H), 8.25 (s, 1 H), 8.85 (s, 1 H). Anal. (C<sub>19</sub>H<sub>17</sub>ClF<sub>3</sub>N<sub>5</sub>O·H<sub>2</sub>O):  C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-5-Chloro-6-(3-methyl-4-(6-(trifluoromethyl)-4-(3,4,5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imida</b><b>zol-2-yl)piperazin-1-yl)nicotinic Acid (38a). </b>A mixture of ester <b>37a</b> (58 mg, 0.1 mmol) and 1 N NaOH (0.11 mL) in THF (1 mL) was stirred at 50 °C for 16 h. HCl (1 N, 0.11 mL) was added and the mixture was extracted with EtOAc (2 × 20 mL). The combined organic phases were washed with brine (5 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo and the residue was purified by silica gel chromatography (10% MeOH/EtOAc) to give 38 mg (57%) of the title compound as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  570 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.43 (d, <i>J</i> = 6.7 Hz, 3 H), 3.16 (dt, <i>J</i> = 12.1, 3.1 Hz, 1 H), 3.24−3.34 (m, 1 H), 3.65 (dt, <i>J</i> = 12.6, 3.1 Hz, 1 H), 4.02−4.22 (m, 3 H), 4.49 (br s, 1 H), 7.46 (br s, 2 H), 7.76−7.87 (m, 2 H), 8.18 (br s, 1 H), 8.73 (br s, 1 H). LC/MS retention time:  A, 9.89 min; B, 11.74 min. </div><div class="NLM_p"><b>1-(5-Chloro-6-(4-(6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)piperazin-1-yl)pyridin-3-yl)</b><b>ethanol (38b). </b>To a solution of ketone <b>37b</b> (0.3 g, 0.71 mmol) in MeOH (20 mL) was added portionwise NaBH<sub>4</sub> (0.037 g, 1.0 mmol) with stirring at 0 °C. The reaction mixture was stirred at 0 °C for 30 min, quenched with 20 mL of saturated aqueous solution of NaHCO<sub>3</sub>, and diluted with EtOAc (50 mL). The organic phase was separated, washed with brine (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was crystallized from 1:1 EtOAc/hexane mixture to give 0.27 g (90%) of the title compound. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  426 (M + 1). <sup>1</sup>H NMR (DMSO<i>-d</i><sub>6</sub>):  δ 1.26−1.37 (m, 3 H), 3.28−3.42 (m, 4 H), 3.62−3.74 (m, 4 H), 4.74 (dt, <i>J</i> = 11.0, 6.3 Hz, 1 H), 5.34 (d, <i>J</i> = 4.7 Hz, 1 H), 7.27 (d, <i>J</i> = 7.8 Hz, 1 H), 7.31−7.39 (m, 1 H), 7.47 (s, 1 H), 7.79 (s, 1 H), 8.21 (s, 1 H), 11.89 (br s, 1 H). LC/MS retention time:  A, 8.81 min; B, 4.47 min. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-1-(6-((</b><b><i>R</i></b><b>)-3-Methyl-4-(6-(trifluoromethyl)-4-(3,4,5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol</b><b>-2-yl)piperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl)ethanol and </b><b>(</b><b><i>S</i></b><b>)-1-(6-((</b><b><i>R</i></b><b>)-3-Methyl-4-(6-(trifluoromethyl)-4-(3,4,5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol</b><b>-2-yl)piperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl)ethanol (38c).</b> To a solution of aldehyde <b>36</b> (88 mg, 0.15 mmol) in THF (2 mL) was added CH<sub>3</sub>MgBr (0.063 mL, 0.19 mmol, 3.0 M in ether) at 0 °C, and the mixture was stirred at 0 °C for 10 min. After the addition of a saturated aqueous solution of NH<sub>4</sub>Cl (5 mL), the mixture was extracted with EtOAc (2 × 20 mL). The combined organic extracts were washed with water (10 mL) and brine (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo and the residue was purified by silica gel chromatography, eluting with 60% EtOAc/hexane to give 78 mg (86%) of the title compound as a mixture of diastereomers. MS (ESI, pos. ion) <i>m</i>/<i>e</i>:  604 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.45 (d, <i>J</i> = 6.6 Hz, 3 H), 1.46 (d, <i>J</i> = 6.6 Hz, 3 H), 3.13 (dt, <i>J </i>= 12.2, 2.8 Hz, 1 H), 3.30−3.40 (m, 2 H), 3.48 (d, <i>J</i> = 12.7 Hz, 1 H), 3.63 (dt, <i>J</i> = 12.5, 3.1 Hz, 1 H), 4.04 (d, <i>J</i> = 12.1 Hz, 1 H), 4.46 (br s, 1 H), 4.92 (q, <i>J</i> = 6.6 Hz, 1 H), 7.45 (s, 1 H), 7.50 (s, 1 H), 7.82−7.96 (m, 2 H), 8.07 (s, 1 H), 8.52 (s, 1 H). LC/MS retention time:  A, 12.28 min; B, 12.22 min. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-(6-((</b><b><i>R</i></b><b>)-3-Methyl-4-(6-(trifluoromethyl)-4-(3,4,5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2</b><b>-yl)piperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl)phenylmethanol and </b><b>(</b><b><i>S</i></b><b>)-(6-((</b><b><i>R</i></b><b>)-3-Methyl-4-(6-(trifluoromethyl)-4-(3,4,5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2</b><b>-yl)piperazin-1-yl)-5-(trifluoromethyl)pyridin-3-yl)phenylmethanol (38d).</b> To a solution of the aldehyde <b>36 </b>(88 mg, 0.15 mmol) in THF (2 mL) was added C<sub>6</sub>H<sub>5</sub>MgBr (0.19 mL, 0.19 mmol, 1.0 M solution in THF) at 0 °C. After the addition, the mixture was stirred at 0 °C for 10 min. A saturated aqueous solution of NH<sub>4</sub>Cl (5 mL) was added, and the mixture was extracted with EtOAc (2 × 20 mL). The combined organic extracts were washed with water (10 mL) and brine (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The fitrate was removed in vacuo and the residue was purified by silica gel column chromatography (60% EtOAc/hexane) to give 81 mg (89%) of the title compound as a mixture of diastereoisomers. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  666 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.33 (d, <i>J</i> = 6.7 Hz, 3 H), 3.13 (dt, <i>J</i> = 12.1, 3.5 Hz, 1 H), 3.20−3.30 (m, 2 H), 3.48 (d, <i>J</i> = 11.3 Hz, 1 H), 3.52 (dt, <i>J</i> = 12.1, 3.1 Hz, 1 H), 3.95 (d, <i>J</i> = 12.5 Hz, 1 H), 4.36 (br s, 1 H), 5.78 (s, 1 H), 7.27 (t, <i>J</i> = 6.7 Hz, 1 H), 7.20−7.45 (m, 4 H), 7.80 (br s, 2 H), 7.93 (s, 2 H), 8.40 (s, 2 H). LC/MS retention time:  A, 12.81 min; B, 13.20 min. </div><div class="NLM_p"><a name="jm004901203734" id="jm004901203734"></a><b>6-(Trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imida</b><b>zole (39).</b> A solution of 1-(3-trifluoromethylpyridin-2-yl)piperazine (0.38 g, 1.6 mmol), 2-chlorobenzoimidazole <b>20n</b> (0.3 g, 1.36 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (0.28 mL, 1.6 mmol) in DMSO (10 mL) was heated to 80 °C for 16 h. The reaction mixture was left to reach room temperature and was diluted with EtOAc (50 mL), washed with brine (2 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated under reduced pressure and the residue was purified by silica gel column chromatography (30% EtOAc/hexane) to afford 0.18 g (30%) of the title compound as a solid. Mp:  221−224 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  416 (M + 1). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>):  δ 3.26−3.45 (m, 4 H), 3.67−3.74 (m, 4 H), 7.27 (d, <i>J</i> = 7.0 Hz, 2 H), 7.34−7.38 (m, 1 H), 7.48 (s, 1 H), 8.12 (d, <i>J</i> = 7.8 Hz, 1 H), 8.57 (d, <i>J</i> = 4.3 Hz, 1 H), 11.94 (br s, 1 H). Anal. (C<sub>18</sub>H<sub>15</sub>F<sub>6</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>1-Benzyl-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo</b><b>[</b><b><i>d</i></b><b>]imidazole (40).</b> To a solution of compound <b>39</b> (415 mg, 1.0 mmol) in anhydrous DMF (5 mL) was added sodium hydride (72 mg, 50% in mineral oil, 1.5 mmol) at 0 °C. The reaction mixture was stirred at room temperature for 0.5 h and cooled to 0 °C. Benzyl bromide (171 mg, 1.0 mmol) was added, and the mixture was stirred at room temperature for 16 h. The reaction mixture was then quenched with saturated aqueous solution of NaHCO<sub>3</sub> (30 mL) and extracted with EtOAc (2 × 50 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by silica gel column chromatography (25% EtOAc/hexane) to give 84 mg (17%) of the title compound as a white solid. Mp:  154−157 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  506 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.30−3.40 (m, 4 H), 3.40−3.50 (m, 4 H), 5.30 (s, 2 H), 7.05 (dd, <i>J</i> = 8.0, 4.8 Hz, 1 H), 7.18 (d, <i>J</i> = 7.0 Hz, 2 H), 7.26−7.40 (m, 5 H), 7.47 (d, <i>J</i> = 8.2 Hz, 1 H), 7.70 (d, <i>J</i> = 8.2 Hz, 1 H), 7.89 (dd, <i>J</i> = 7.6, 1.8 Hz, 1 H), 8.45 (dd, <i>J</i> = 4.8, 1.2 Hz, 1 H), LC/MS retention time:  A, 12.05 min; B, 11.93 min. </div><div class="NLM_p"><b>1-Benzyl-5-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo</b><b>[</b><b><i>d</i></b><b>]imidazole (41).</b> The title compound was obtained as a second product of the reaction described for the preparation of compound <b>40</b> and isolated as a white solid (yield 11 mg, 2%). MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  506 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.36−3.48 (m, 8 H), 5.29 (s, 2 H), 7.03 (dd, <i>J</i> = 7.6, 4.5 Hz, 1 H), 7.08 (d, <i>J</i> = 8.2 Hz, 1 H), 7.17 (d, <i>J</i> = 7.0 Hz, 2 H), 7.27−7.44 (m, 4H), 7.87 (dd, <i>J</i> = 7.8, 2.0 Hz, 1 H), 7.92 (s, 1 H), 8.45 (dd, <i>J</i> = 4.8, 1.2 Hz, 1 H). Anal. (C<sub>25</sub>H<sub>21</sub>F<sub>6</sub>N<sub>5</sub>·0.2EtOAc):  C, H, N. </div><div class="NLM_p"><b>6-Bromo-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (42).</b> Following the procedure described for compound <b>39</b>, 1-(3-trifluoromethylpyridin-2-yl)piperazine and 2-chlorobenzoimidazole <b>20o</b> provided the title compound (66%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  428 (M + 1). <sup>1</sup>H NMR (DMSO<i>-d</i><sub>6</sub>):  δ 3.28−3.38 (m, 4 H), 3.60−3.70 (m, 4 H), 7.06 (s, 1 H), 7.14 (m, 1 H), 7.19−7.30 (m, 1 H), 7.36 (s, 1 H), 8.10 (d, <i>J</i> = 7.4 Hz, 1 H), 8.56 (d, <i>J</i> = 3.5 Hz, 1 H), 11.66 (s, 1 H). Anal. (C<sub>17</sub>H<sub>15</sub>BrF<sub>3</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>5-Bromo-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benz</b><b>o[</b><b><i>d</i></b><b>]imidazole (43a).</b> Following the procedure described for compound <b>39</b>, 1-(3-trifluoromethylpyridin-2-yl)piperazine and 2-chlorobenzoimidazole <b>20b</b> provided the title compound (83%) as a white solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  496 (M + 1). <sup>1</sup>H NMR (DMSO<i>-d</i><sub>6</sub>):  δ 3.35−3.46 (m, 4 H), 3.67−3.74 (m, 4 H), 7.27 (dd, <i>J</i> = 7.8, 4.7 Hz, 1 H), 7.56 (s, 1 H), 7.59 (s, 1 H), 8.13 (dd, <i>J</i> = 7.8, 2.0 Hz, 1 H), 8.57 (d, <i>J</i> = 3.5 Hz, 1 H). LC/MS retention time:  A, 10.75 min; B, 9.05 min. </div><div class="NLM_p"><b>5-Bromo-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1-((2-(tri</b><b>methylsilyl)ethoxy)methyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (43b).</b> To a solution of compound <b>43a</b> (203 mg, 0.41 mmol) in dichloromethane (6 mL) were added <i>N</i>,<i>N</i>-diisopropylethylamine (148 mg, 1.15 mmol) and 2-(trimethylsilyl)ethoxymethyl chloride (94 mg, 0.57 mmol). The reaction mixture was stirred at room temperature for 16 h. The solvent was removed in vacuo and the residue was purified by silica gel column chromatography (30% EtOAc/hexane) to afford 176 mg (69%) of the title compound as an amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  624 (M + 1). </div><div class="NLM_p"><b>4-Bromo-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benz</b><b>o[</b><b><i>d</i></b><b>]imidazole (44a).</b> Following the procedure described for compound <b>39</b>, 1-(3-trifluoromethylpyridin-2-yl)piperazine and 2-chlorobenzoimidazole <b>20f</b> provided the title compound (90%) as a white solid. Mp:  196 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  494 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.40−3.50 (m, 4 H), 3.70−3.80 (m, 4 H), 7.09 (dd, <i>J</i> = 8.0, 4.0 Hz, 1 H), 7.48 (s, 1 H), 7.53 (s, 1 H), 7.93 (d, <i>J</i> = 8.0 Hz, 1 H), 8.48 (d, <i>J</i> = 4.0 Hz, 1 H). Anal. (C<sub>18</sub>H<sub>14</sub>BrF<sub>6</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>4-Bromo-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1-((2-(tri</b><b>methylsilyl)ethoxy)methyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (44b).</b> Following the procedure described for compound <b>43b</b>, compound <b>44a</b> and 2-(trimethylsilyl)ethoxymethyl chloride provided the title compound (34%) as a light-brown oil. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  564 (M + 1). <b>(</b><b><i>R</i></b><b>)-1-(6-((</b><b><i>R</i></b><b>)-4-(4-Bromo-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)-3-methylpiperazin-</b><b>1-yl)-5-chloropyridin-3-yl)ethanol and </b><b>(</b><b><i>S</i></b><b>)-1-(6-((</b><b><i>R</i></b><b>)-4-(4-Bromo-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)-3-methylpiperazin-</b><b>1-yl)-5-chloropyridin-3-yl)ethanol (44c). </b>A mixture of the piperazines <b>8ag</b> (766 mg, 3 mmol), 2-chlorobenzoimidazole <b>20f</b> (902 mg, 3 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (1.05 mL, 6 mmol) in EtOH (2 mL) was heated in a microwave synthesizer at 175 °C for 1 h. The reaction mixture was evaporated in vacuo and the residue was purified by silica gel chromatography (60% EtOAc/hexane) to give 638 mg (41%) of the title compound as a mixture of diastereoisomers. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  518 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.44 (d, <i>J</i> = 6.3 Hz, 3 H), 1.48 (d, <i>J</i> = 6.7 Hz, 3 H), 3.05 (dt, <i>J</i> = 12.5, 3.1 Hz, 1 H), 3.15 (dd, <i>J</i> = 12.6, 3.8 Hz, 1 H), 3.64 (dt, <i>J</i> = 12.5, 3.1 Hz, 1 H), 3.80 (t, <i>J</i> = 12.5 Hz, 2 H), 4.49 (br s, 1 H), 4.78−4.85 (m, 1 H), 7.43 (br s, 1 H), 7.44 (br s, 1 H), 7.78 (d, <i>J </i>= 2.0 Hz, 1 H), 8.18 (d, <i>J</i> = 2.0 Hz, 1 H). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2-(4-(5-Bromo-3-chloropyridin-2-yl)-2-methylpiperazin-1-yl)-6-(trifluoromethyl)-4-(3,4,</b><b>5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (45). </b>A mixture of piperazine <b>8af</b> (875 mg, 3 mmol), 2-chlorobenzoimidazole <b>20i</b> (1.05 g, 3 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (1.05 mL, 6 mmol) in EtOH (5 mL) was heated in a microwave synthesizer at 180 °C for 4 h. The reaction mixture was evaporated in vacuo and the residue was purified by silica gel chromatography (40% EtOAc/hexane) to give 3.09 g (34%) of the title compound as a white solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  606 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 1.50 (d, <i>J</i> = 6.6 Hz, 3 H), 3.10 (dt, <i>J</i> = 12.1, 3.1 Hz, 1 H), 3.21 (dd, <i>J</i> = 12.5, 3.5 Hz, 1 H), 3.68 (dt, <i>J</i> = 12.1, 3.1 Hz, 1 H), 3.80−4.00 (m, 2 H), 4.05 (br s, 1 H), 4.35 (br s, 1 H), 7.40−7.55 (m, 2 H), 7.70−7.90 (m, 1 H), 7.79 (d, <i>J</i> = 2.3 Hz, 1 H), 8.25 (d, <i>J</i> = 2.0 Hz, 1 H), 8.25−8.40 (m, 1 H). LC/MS retention time:  A, 13.39 min; B, 14.06 min. </div><div class="NLM_p"><b>6-(3,4-Difluorophenyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imi</b><b>dazole (46a).</b> To a mixture of 3,4-difluorophenylboronic acid (111 mg, 0.7 mmol) and 6-bromo-benzoimidazole <b>42</b> (213 mg, 0.5 mmol) in ethylene glycol dimethyl ether (2 mL) were added lithium chloride (63 mg, 1.5 mmol) and 2 M aqueous solution of sodium carbonate (0.75 mL, 1.5 mmol). Nitrogen gas was bubbled through the mixture for 10 min and tetrakis(triphenylphosphine)palladium (58 mg, 0.05 mmol) was added. The reaction mixture was stirred at 80 °C under nitrogen atmosphere for 16 h, cooled to room temperature, diluted with EtOAc (50 mL), and filtered through Celite pad. The filtrate was washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by silica gel column chromatography (55% EtOAc/hexane) to give 96 mg (42%) of the title compound as a white solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  460 (M + 1). <sup>1</sup>H NMR (DMSO<i>-d</i><sub>6</sub>):  δ 3.28−3.38 (m, 4 H), 3.60−3.70 (m, 4 H), 7.18−7.34 (m, 3 H), 7.40−7.51 (m, 3 H), 7.68−7.60 (m, 1 H), 8.09 (dd, <i>J</i> = 7.8, 1.6 Hz, 1 H), 8.55 (dd, <i>J</i> = 4.8, 1.2 Hz, 1 H). LC/MS retention time:  A, 10.42 min; B, 7.54 min. </div><div class="NLM_p"><b>6-(Trifluoromethyl)-5-(4-(trifluoromethyl)phenyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)pipe</b><b>razin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole, Trifluoroacetic Acid Salt (46b). </b>A mixture of 5-<a name="jm004901203735" id="jm004901203735"></a> bromobenzoimidazole <b>43a</b> (120 mg, 0.24 mmol), 4-(trifluoromethyl)phenylboronic acid (60 mg, 0.32 mmol), tetrakis(triphenylphosphine)palladium(0) (28 mg, 0.02 mmol), and sodium carbonate (0.25 mL, 2 M solution in water) in dioxane (1.75 mL) was heated to 170 °C in a microwave synthesizer for 20 min. The reaction mixture was cooled to room temperature, diluted with EtOAc (10 mL), and filtered through a Varian Chem-Elut (3 mL) diatomaceous earth cartridge, and the filtrate was evaporated in vacuo. The residue was purified by preparative HPLC (gradient 0.1% trifluoroacetic acid in acetonitrile) to give 98 mg (72%) of the title compound as an amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  560 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.47−3.51 (m, 4 H), 3.85−3.89 (m, 4 H), 7.29 (dd, <i>J</i> = 7.6, 4.5 Hz, 1 H), 7.34 (s, 1 H), 7.55 (d, <i>J</i> = 7.8 Hz, 2 H), 7.73−7.81 (m, 3 H), 8.11 (d, <i>J</i> = 7.8 Hz, 1 H), 8.56 (d, <i>J</i> = 3.9 Hz, 1 H). Anal. (C<sub>25</sub>H<sub>18</sub>F<sub>9</sub>N<sub>5</sub>·CF<sub>3</sub>CO<sub>2</sub>H):  C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-(Trifluoromethyl)benzyl)-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)pip</b><b>erazin-1-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-5-amine, </b><b>Trifluoroacetic Acid Salt (46c). </b>A mixture of 5-bromobenzoimidazole <b>43b</b> (88 mg, 0.14 mmol), 4-(trifluoromethyl)benzylamine (37 mg, 0.21 mmol), tris(dibenzylideneacetone)dipalladium(0) (8 mg, 0.01 mmol), 2-(di-<i>tert</i>-butylphosphino)biphenyl (8 mg, 0.03 mmol), and sodium-<i>tert</i>-butoxide (31 mg, 0.33 mmol) in toluene (2 mL) was heated at 150 °C in a microwave synthesizer for 14 min. The reaction mixture was cooled to room temperature, diluted with EtOAc (5 mL), and filtered through a Celite pad. The filtrate was concentrated in vacuo, and the residue was dissolved in MeOH (4 mL) and purified by preparative HPLC (gradient 0.1% trifluoroacetic acid in acetonitrile) to give the title compound as pale-yellow oil. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  719 (M + 1). </div><div class="NLM_p"><b><i>N</i></b><b>-(4-(Trifluoromethyl)benzyl)-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)pip</b><b>erazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-5-amine, Trifluoroacetic Acid Salt (46d). </b>Compound <b>46c</b> was treated with 1:1 mixture of CF<sub>3</sub>CO<sub>2</sub>H/CH<sub>2</sub>Cl<sub>2</sub> (3 mL) and stirred at room temperature for 12 h. The reaction mixture was concentrated to yield a gummy residue, which was dissolved in MeOH (4 mL) and purified by preparative HPLC (gradient 0.1% trifluoroacetic acid in acetonitrile) to give 7 mg (8%) of the title compound as a yellow amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  589 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.43−3.49 (m, 4 H), 3.75−3.82 (m, 4 H), 4.67 (s, 2 H), 6.49 (s, 1 H), 7.32 (dd, <i>J</i> = 7.6, 4.9 Hz, 1 H), 7.53 (s, 1 H), 7.61 (d, <i>J</i> = 8.0 Hz, 2 H), 7.67 (d, <i>J</i> = 8.0 Hz, 2 H), 8.13 (d, <i>J</i> = 8.0 Hz, 1 H), 8.58 (d, <i>J</i> = 4.3 Hz, 1 H). LC/MS retention time:  A, 11.21 min; B, 8.27 min. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-5-Chloro-6-(4-(4-(4-fluorophenyl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)-3-met</b><b>hylpiperazin-1-yl)pyridin-3-amine (46e).</b> A mixture of compound <b>34</b> (444 mg, 0.909 mmol), 4-fluorophenylboronic acid (191 mg, 1.36 mmol), dichloro-bis(triphenylphosphine)palladium(II) (128 mg, 0.181 mmol), and Na<sub>2</sub>CO<sub>3</sub> (385 mg, 3.64 mmol) in a solution of 7:3:2 1,2-dimethoxyethane/H<sub>2</sub>O/EtOH (4.5 mL) was heated to 82 °C for 3 h. The reaction mixture was cooled to room temperature and filtered. The filter cake was washed with MeOH (20 mL), and the combined filtrates were concentrated in vacuo. The residue was purified by silica gel column chromatography (gradient 15−100% EtOAc/hexane) to give 301 mg (66%) of the title compound as a brown solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  505, 507 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.39 (d, <i>J</i> = 6.3 Hz, 3 H), 2.84−2.96 (m, 2 H), 3.30−3.50 (m, 3 H), 3.80−4.00 (m, 1 H), 4.30−4.70 (m, 1 H), 7.08−7.60 (m, 7 H), 7.9 (br s, 1 H). Anal. (C<sub>24</sub>H<sub>21</sub>ClF<sub>4</sub>N<sub>6</sub>·0.5EtOAc·0.05H<sub>2</sub>O):  C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-</b><b><i>N</i></b><b>-(5-Chloro-6-(4-(4-(4-fluorophenyl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)-3-</b><b>methylpiperazin-1-yl)pyridin-3-yl)-2-hydroxyacetamide (46f).</b> A mixture of compound <b>46e</b> (117 mg, 0.232 mmol), acetoxyacetic acid (27 mg, 0.232 mmol), benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate (154 mg, 0.348 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (0.08 mL, 0.464 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL) was stirred at room temperature for 18 h. The reaction mixture was evaporated under reduced pressure and the residue was purified by silica gel column chromatography (gradient 0−100% EtOAc/hexane) to give 139 mg (99%) of (<i>R</i>)-2-(5-chloro-6-(4-(4-(4-fluorophenyl)-6-(trifluoromethyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-3-methylpiperazin-1-yl)pyridin-3-ylamino)-2-oxoethyl acetate as a brown solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  605 (M + 1). </div><div class="NLM_p">A mixture of the acetate from the previous step (139 mg, 0.23 mmol) and potassium carbonate (63 mg, 0.46 mmol) in MeOH (1.5 mL) was stirred at room temperature for 30 min. The reaction mixture was filtered and the filter cake was washed with MeOH (2 mL). The combined filtrates were concentrated in vacuo, and the residue was purified by silica gel column chromatography (gradient 40−60% EtOAc/hexane) to give 45 mg (35%) of the title compound as an orange solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  563 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.56 (d, <i>J</i> = 6.4 Hz, 3 H), 3.05−3.3 (m, 2 H), 3.60−3.90 (m, 3 H), 4.05−4.30 (m, 3 H), 4.55 (br s, 1 H), 7.20−7.60 (m, 5 H), 8.0−8.17 (m, 2 H) 8.29 (d, <i>J</i> = 2.4 Hz, 1 H), 8.53 (d, <i>J</i> = 2.4 Hz, 1 H). LC/MS retention time:  A, 10.54 min; B, 5.81 min. </div><div class="NLM_p"><b>4-Piperidin-1-yl-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1-</b><b>((2-(trimethylsilyl)ethoxy)methyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (46</b><b>g</b><b>).</b> Following the procedure described for compound <b>46c</b>, compound <b>44b</b> and piperidine provided the title compound (19%) as an oil. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  629 (M + 1). </div><div class="NLM_p"><b>4-Piperidin-1-yl-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole, Trifluoroacetic Acid Salt (46h).</b> Following the procedure described for compound <b>46d</b>, compound <b>46g</b> and trifluoroacetic acid provided the crude product, which was purified by preparative HPLC (gradient 0.1% trifluoroacetic acid in acetonitrile) to give the title compound (20%) as a colorless film. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  499 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.69 (s, 2 H), 1.89 (s, 4 H), 3.30−3.50 (m, 8 H), 3.87 (s, 4 H), 7.16−7.30 (m, 2 H), 7.3 (s, 1H), 8.05 (s, 1 H), 8.50 (s, 1 H). LC/MS retention time:  A, 12.22 min; B, 8.61 min. </div><div class="NLM_p"><b>4-Morpholino-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1-((</b><b>2-(trimethylsilyl)ethoxy)methyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (46i).</b> Following the procedure described for compound <b>46c</b>, compound <b>44b</b> and morpholine provided the title compound (34%) as an amorphous solid. </div><div class="NLM_p"><b>4-Morpholino-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-</b><b>benzo[</b><b><i>d</i></b><b>]imidazole (46j).</b> Following the procedure described for compound <b>46d</b>, compound <b>46i</b> and trifluoroacetic acid provided the title compound (8%) as an amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  501 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.11−3.17 (m, 4 H), 3.43−3.50 (m, 4 H), 3.92 (dd, <i>J</i> = 11.7, 5.1 Hz, 8 H), 7.20 (s, 1 H), 7.28 (dd, <i>J</i> = 7.4, 5.1 Hz, 1 H), 7.36 (s, 1 H), 8.04−8.12 (m, 1 H), 8.55 (d, <i>J</i> = 3.9 Hz, 1 H). LC/MS retention time:  C, 16.61 min; D, 11.86 min. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-1-(5-Chloro-6-((</b><b><i>R</i></b><b>)-3-methyl-4-(6-(trifluoromethyl)-4-(3,4,5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)piperazin-1-yl)pyridin-3-yl)ethanol (46k).</b> The title compound was isolated by preparative HPLC separation of the diastereoisomeric mixture of products of the reaction for the preparation of compound <b>46l</b>. The <i>R</i>-configuration of the chiral secondary alcohol was assigned at random. MS (ESI, neg ion) <i>m</i>/<i>z</i>:  570 (M − 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.44 (d, <i>J</i> = 6.7 Hz, 3 H), 1.49 (d, <i>J</i> = 6.6 Hz, 3 H), 3.06 (dt, <i>J</i> = 12.5, 3.2 Hz, 1 H), 3.15 (dd, <i>J</i> = 12.1, 3.3 Hz, 1 H), 3.64 (dt, <i>J</i> = 12.5, 3.1 Hz, 1 H), 3.80 (t, <i>J</i> = 12.5 Hz, 2 H), 4.06 (d, <i>J</i> = 12.9 Hz, 1 H), 4.40−4.52 (m, 1 H), 4.82 (q, <i>J</i> = 6.4 Hz, 1 H), 7.46 (s, 2 H), 7.78 (d, <i>J</i> = 1.9 Hz, 1 H), 7.86 (br s, 2 H), 8.18 (d, <i>J</i> = 1.6 Hz, 1 H). LC/MS retention time:  A, 12.04 min; B, 11.58 min. </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-1-(5-Chloro-6-((</b><b><i>R</i></b><b>)-3-methyl-4-(6-(trifluoromethyl)-4-(3,4,5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)piperazin-1-yl)pyridin-3-yl)ethanol (46l). </b>To a solution of the diastereomeric mixture <b>44c</b> (416 mg, 0.8 mmol) in MeCN (3 mL) was added 3,4,5-trifluorophenylboronic acid (282 mg, 1.6 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (84 mg, 0.08 mmol), and Na<sub>2</sub>CO<sub>3</sub> (4 mL, 0.4 M in water, 1.6 mmol). The mixture was stirred at 90 °C under N<sub>2</sub> atmosphere for 20 h, cooled to room temperature, and diluted with water (20 mL). The reaction mixture was extracted with EtOAc (2 × 40 mL). The combined organic extracts were washed with brine (20 mL), dried over <a name="jm004901203736" id="jm004901203736"></a> Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo and the residue was purified by silica gel column chromatography (50% EtOAc/hexane) to give 277 mg (61%) of the product of the reaction as a mixture of diastereoisomers. Separation of the mixture by preparative HPLC on a Chiralcel OD column (10% EtOH/hexane) afforded the fast-running diastereoisomer <b>46l</b>. The <i>S</i>-configuration of the chiral secondary alcohol of the isomer <b>46l </b>was assigned at random. MS (ESI, neg ion) <i>m</i>/<i>z</i>:  570 (M-1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.44 (d, <i>J</i> = 6.6 Hz, 3 H), 1.49 (d, <i>J</i> = 6.6 Hz, 3 H), 3.06 (dt, <i>J</i> = 12.5, 3.1 Hz, 1 H), 3.15 (dd, <i>J</i> = 12.1, 3.3 Hz, 1 H), 3.64 (dt, <i>J</i> = 12.5, 3.1 Hz, 1 H), 3.80 (t, <i>J</i> = 12.5 Hz, 2 H), 4.06 (d, <i>J</i> = 12.9 Hz, 1 H), 4.40−4.52 (m, 1 H), 4.82 (q, <i>J</i> = 6.4 Hz, 1 H), 7.46 (s, 2 H), 7.78 (d, <i>J</i> = 1.9 Hz, 1 H), 7.86 (br s, 2 H), 8.18 (d, <i>J</i> = 1.6 Hz, 1 H). LC/MS retention time:  A, 12.05 min; B, 11.57 min. </div><div class="NLM_p"><b>6-(Trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-4-(3,4,5-trifluorop</b><b>henyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (46m). </b>A mixture of compound <b>44a</b> (2.22 g, 4.5 mmol), 3,4,5-trifluorophenylboronic acid (1.1 g, 6 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (35 mg, 0.05 mmol), Na<sub>2</sub>CO<sub>3</sub> monohydrate (1 g, 8 mmol), dimethoxyethane (7 mL), H<sub>2</sub>O (3 mL), and EtOH (2 mL) was subjected to microwave irradiation at 120 °C with stirring for 10 min. The mixture was diluted with water (10 mL) and extracted with EtOAc (2 × 20 mL). The combined organic phases were washed with brine (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated in vacuo and the residue was purified by silica gel chromatography, eluting with 35% EtOAc/hexane to give 1.7 g (69%) of the title compound as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  546 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.34−3.42 (m, 4 H), 3.74−3.84 (m, 4 H), 7.22 (dd, <i>J</i> = 7.4, 4.9 Hz, 1 H), 7.47 (br s, 2 H), 7.88 (br s, 2 H), 8.06 (dd, <i>J</i> = 7.8, 1.5 Hz, 1 H), 8.51 (d, <i>J</i> = 3.7 Hz, 1 H). Anal. (C<sub>24</sub>H<sub>16</sub>F<sub>9</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>4-Thiazol-2-yl-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-</b><b>benzo[</b><b><i>d</i></b><b>]imidazole, Trifluoroacetic Acid Salt (46n).</b> A mixture of compound <b>44a</b> (148 mg, 0.3 mmol), 2-tributylstannylthiazole (187 mg, 0.5 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (46 mg, 0.04 mmol), and 1,4-dioxane (1 mL) was subjected to microwave irradiation at 140 °C with stirring for 60 min. The solvent was removed in vacuo and the residue was purified by preparative HPLC (gradient 0.1% trifluoroacetic acid in acetonitrile) to give 120 mg (80%) of the title compound as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  499 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.40−3.52 (m, 4 H), 3.84 (br s, 4 H), 7.10 (dd, <i>J</i> = 8.0, 4.0 Hz, 1 H), 7.60−7.80 (m, 2 H), 7.81 (s, 1 H), 7.93 (dd, <i>J</i> = 8.0, 4.0 Hz, 1 H), 8.49 (d, <i>J</i> = 4.0 Hz, 1 H), 9.00 (d, <i>J </i>= 4.0 Hz, 1 H), 10.55 (br s, 1 H). Anal. (C<sub>21</sub>H<sub>16</sub>F<sub>6</sub>N<sub>6</sub>S·0.11TFA·0.22H<sub>2</sub>O):  C, H, N. </div><div class="NLM_p"><b>4-(3,4-Difluorobenzyl)-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1</b><b>-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole, Trifluoroacetic Acid Salt (46o). </b>A mixture of 4-bromobenzoimidazole <b>44a</b> (148 mg, 0.3 mmol), a 0.5 M solution of 3,4-difluorobenzylzinc bromide in THF (2 mL, 1 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (35 mg, 0.03 mmol) was heated at reflux for 12 h. The solvent was removed in vacuo and the residue was purified by preparative HPLC (gradient 0.1% trifluoroacetic acid in acetonitrile) to give 25 mg (13%) of the title compound as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  542 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.20−3.30 (m, 4 H), 3.60−3.70 (m, 4 H), 4.15 (s, 2 H), 7.01−7.13 (m, 5 H), 7.26 (s, 1 H), 7.93 (d, <i>J</i> = 8.0 Hz, 1 H), 8.45 (d, <i>J</i> = 4.4 Hz, 1 H). LC/MS retention time:  A, 11.93 min; B, 6.42 min. </div><div class="NLM_p"><b>6-(Trifluoromethyl)-4-(4-(trifluoromethyl)cyclohexyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)</b><b>piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (46p).</b> To 4-trifluoromethylcyclohexanone (4.98 g, 30 mmol) in THF (100 mL) was added lithium bistrimethylsilylamide (30 mL, 1 M solution in THF) over a period of 30 min with stirring at −78 °C. After stirring for 1 h at −78 °C, a solution of <i>N</i>-phenyltrifluoromethanesulfonimide (10.71 g, 30 mmol) in THF (100 mL) was added over a period of 30 min. The reaction mixture was stirred at −78 °C for 2 h and slowly warmed to room temperature over a period of 6 h. The reaction mixture was extracted with EtOAc, and the combined organic extracts were washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated and the residue was purified by silica gel column chromatography (10% ethyl acetate/hexane) to give 5.6 g (63%) of 4-(trifluoromethyl)cyclohex-1-enyl trifluoromethanesulfonate as an oil. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  299 (M + 1). </div><div class="NLM_p">To a solution of the triflate from the previous step (5.6 g, 18.8 mmol) in dioxane (100 mL) were added bisboronpinacolate (5.6 g, 22 mmol), potassium acetate (6 g, 61 mmol), PdCl<sub>2</sub>(dppf) (315 mg, 0.6 mml), and dppf (332 mg, 0.6 mmol), and the contents were flushed with nitrogen. The reaction mixture was heated at 80 °C overnight. The solvents were removed in vacuo, and the residue was extracted with EtOAc and washed with water. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated and the residue was purified by silica gel column chromatography (10% ethyl acetate/hexane) to give 4.23 g (81%) of 4,4,5,5-tetramethyl-2-(4-trifluoromethyl-cyclohex-1-enyl)[1,3,2]dioxaborolane as white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  277 (M + 1). </div><div class="NLM_p">A mixture of 4-bromobenzoimidazole <b>44a </b>(100 mg, 0.5 mmol), 4,4,5,5-tetramethyl-2-(4-trifluoromethyl-cyclohex-1-enyl)[1,3,2]dioxaborolane from the previous step (200 mg, 0.72 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (58 mg, 0.05 mmol), and Na<sub>2</sub>CO<sub>3</sub> (80 mg, 0.75 mmol) in dimethoxyethane (1 mL) was subjected to microwave irradiation at 200 °C with stirring for 40 min. The solvent was removed in vacuo and the residue purified by silica gel chromatography (60% EtOAc/hexane) to give 58 mg (52%) of 6-(trifluoromethyl)-4-(4-(trifluoromethyl)cyclohex-1-enyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole, trifluoroacetic acid salt, as a white solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  564 (M + 1). Mp:  214−217 °C. </div><div class="NLM_p">6-(Trifluoromethyl)-4-(4-(trifluoromethyl)cyclohex-1-enyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imid azole, trifluoroacetic acid salt, from the previous step (10 mg) was subjected to catalytic hydrogenation in EtOH (1 mL) using 10% Pd/C (10 mg) as catalyst. The reaction was conducted at room temperature under 1 atm of hydrogen for 2 days. The catalyst was filtered through a Celite pad and the filter cake was washed with methanol. The combined filtrates were evaporated in vacuo to give 10 mg (100%) of the title compound as a film. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  565 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.50−2.10 (m, 10 H), 3.31 (s, 4 H), 3.67 (s, 4 H), 7.00−7.20 (m, 2 H), 7.27 (s, 1 H), 7.97 (d, <i>J</i> = 7.8 Hz, 1 H), 8.42 (s, 1 H). LC/MS retention time:  A, 12.28 min; B, 3.21 min. </div><div class="NLM_p"><b>6-(Trifluoromethyl)-4-(4-(trifluoromethyl)phenyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)pipe</b><b>razin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (46q).</b> Following the procedure described for compound <b>46m</b>, compound <b>44a</b> and 4-trifluoromethylphenylboronic acid provided the title compound (83%) as a white solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  548 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.32−3.40 (m, 4 H), 3.76−3.82 (m, 4 H), 7.22 (dd, <i>J</i> = 7.7, 2.8 Hz, 1 H), 7.47 (s, 1 H), 7.51 (s, 1 H), 7.77 (s, 1 H), 7.79 (s, 1 H), 8.08−8.04 (m, 3 H), 8.51 (d, <i>J</i> = 3.9 Hz, 1 H). Anal. (C<sub>25</sub>H<sub>18</sub>F<sub>9</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>4-Phenyl-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benz</b><b>o[</b><b><i>d</i></b><b>]imidazole (46r).</b> Following the procedure described for compound <b>46m</b>, compound <b>44a</b> and phenylboronic acid provided the title compound (65%) as an amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  492 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.34−3.42 (m, 4 H), 3.72−3.80 (m, 4 H), 7.21 (dd, <i>J</i> = 7.5, 2.5 Hz, 1 H), 8.00−7.39 (m, 7 H), 8.04 (d, <i>J</i> = 6.8 Hz, 1 H), 8.50 (d, <i>J</i> = 4.5 Hz, 1 H). Anal. (C<sub>24</sub>H<sub>19</sub>F<sub>6</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>4-(3-(Trifluoromethoxy)phenyl)-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)pi</b><b>perazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole, Trifluoroacetic Acid Salt (46s).</b> Following the procedure described for compound <b>46m</b>, compound <b>44a</b> and 3-(trifluoromethoxy)phenylboronic acid provided the crude product which was purified by preparative HPLC (gradient 0.1% trifluoroacetic acid in acetonitrile) to give the title compound (60%) as an off-white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  576 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.40−3.50 (m, 4 H), 3.68−3.80 (m, 4 H), 7.08 (dd, <i>J</i> = 8.0, 4.0 Hz, 1 H), 7.12−8.40 (m, 7 H), 8.50 (d, <i>J</i> = 4.0 Hz, 1 H). Anal. (C<sub>25</sub>H<sub>18</sub>F<sub>9</sub>N<sub>5</sub>O·0.15TFA):  C, H, N. </div><div class="NLM_p"><a name="jm004901203737" id="jm004901203737"></a><b>4-(4-</b><b><i>tert</i></b><b>-Butylphenyl)-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-</b><b>yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (46t).</b> Following the procedure described for compound <b>46m</b>, compound <b>44a</b> and 4-<i>tert</i>-butylphenylboronic acid provided the title compound (76%) as a white solid. Mp:  214 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  548 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 1.37 (s, 9 H), 3.43 (br s, 4 H), 3.70−3.82 (m, 4 H), 7.08 (br s, 1 H), 7.33 (s, 1 H), 7.50−7.60 (m, 3 H), 7.68 (s, 1 H), 7.92 (d, <i>J</i> = 7.6 Hz, 1 H), 8.30 (s, 1 H), 8.47 (d, <i>J</i> = 3.6 Hz, 1 H). Anal. (C<sub>28</sub>H<sub>27</sub>F<sub>6</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>4-Thiophen-2-yl-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole, Trifluoroacetic Acid Salt (46u).</b> Following the procedure described for compound <b>46m</b>, compound <b>44a</b> and (thiophen-2-yl)boronic acid provided the crude product, which was purified by preparative HPLC (gradient 0.1% trifluoroacetic acid in acetonitrile) to give the title compound (57%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  498 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 3.40−3.50 (m, 4 H), 3.80−3.90 (m, 4 H), 7.20−7.25 (m, 2 H), 7.58 (d, <i>J</i> = 10.5 Hz, 2 H), 7.61 (dd, <i>J</i> = 5.2, 1.0 Hz, 1 H), 7.65 (dd, <i>J</i> = 7.8, 1.5 Hz, 1 H), 8.54 (d, <i>J</i> = 4.7 Hz, 1 H). Anal. (C<sub>22</sub>H<sub>16</sub>F<sub>6</sub>N<sub>6</sub>S·1.5TFA):  C, H, N. </div><div class="NLM_p"><b>4-Pyridin-4-yl-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-</b><b>benzo[</b><b><i>d</i></b><b>]imidazole (46v).</b> Following the procedure described for compound <b>46m</b>, compound <b>44a</b> and pyridin-4-ylboronic acid provided the title compound (50%) as a white solid. Mp:  293 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  493 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 3.32−3.42 (m, 4 H), 3.74−3.86 (m, 4 H), 7.22 (dd, <i>J</i> = 7.7, 4.9 Hz, 1 H), 7.51 (br s, 1 H), 7.65 (br s, 1 H), 8.06 (d, <i>J</i> = 7.8 Hz, 1 H), 8.18 (br s, 2 H), 8.51 (d, <i>J</i> = 4.2 Hz, 1 H), 8.61 (br s, 2 H). Anal. (C<sub>23</sub>H<sub>18</sub>F<sub>5</sub>N<sub>6</sub>):  C, H, N. </div><div class="NLM_p"><b>4-Pyrazin-2-yl-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-</b><b>benzo[</b><b><i>d</i></b><b>]imidazole (46w).</b> Following the procedure described for compound <b>46n</b>, compound <b>44a</b> and 2-tributylstannylpyrazine provided the title compound (51%) as a yellow amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  494 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.40−3.52 (m, 4 H), 3.78−3.86 (m, 4 H), 7.08−7.14 (m, 1 H), 7.80 (s, 1 H), 7.90−7.96 (m, 2 H), 8.46−8.52 (m, 1 H), 8.58 (s, 1 H), 8.68 (s, 1 H), 9.36 (br s, 1 H), 10.75 (br s, 1 H). Anal. (C<sub>22</sub>H<sub>17</sub>F<sub>6</sub>N<sub>7</sub>):  C, H, N. </div><div class="NLM_p"><b>4-(6-Methoxypyridin-3-yl)-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperaz</b><b>in-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole, Trifluoroacetic Acid Salt (46x). </b>Following the procedure described for compound <b>46m</b>, compound <b>44a</b> and 3-(6-methoxypyridyl)boronic acid provided the crude product, which was purified by preparative HPLC (gradient 0.1% trifluoroacetic acid in acetonitrile) to give the title compound (32%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  523 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.40−3.50 (m, 4 H), 3.80−3.90 (m, 4 H), 3.99 (s, 3 H), 6.82 (d, <i>J</i> = 8.6 Hz, 1 H), 7.26 (dd, <i>J</i> = 8.1, 5.3 Hz, 1 H), 7.53 (s, 1 H), 7.62 (s, 1 H), 8.00 (dd, <i>J</i> = 8.4, 2.2 Hz, 1 H), 8.08 (d, <i>J</i> = 7.7 Hz, 1 H), 8.49 (d, <i>J</i> = 1.9 Hz, 1 H), 8.53 (d, <i>J</i> = 4.6 Hz, 1 H). Anal. (C<sub>24</sub>H<sub>20</sub>F<sub>6</sub>N<sub>6</sub>O·0.95TFA·0.2H<sub>2</sub>O):  C, H, N. </div><div class="NLM_p"><b>4-Benzo[</b><b><i>b</i></b><b>]thiophen-2-yl-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin</b><b>-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (46y).</b> Following the procedure described for compound <b>46m</b>, compound <b>44a</b> and benzo[<i>b</i>]thiophen-2-ylboronic acid provided the title compound (61%) as an off-white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  548 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 3.24−3.34 (m, 4 H), 3.70−3.80 (m, 4 H), 7.13 (dd, <i>J</i> = 8.0, 1.2 Hz, 1 H), 7.20−7.34 (m, 3 H), 7.56 (s, 1 H), 7.72−7.80 (m, 2 H), 7.98 (d, <i>J</i> = 7.6 Hz, 1 H), 8.32 (s, 1 H), 8.42 (d, <i>J</i> = 4.0 Hz, 1 H). Anal. (C<sub>26</sub>H<sub>19</sub>F<sub>6</sub>N<sub>5</sub>S):  C, H, N. </div><div class="NLM_p"><b>4-(6-(Trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imi</b><b>dazol-4-yl)benzenamine (46z).</b> Following the procedure described for compound <b>46m</b>, compound <b>44a</b> and 4-aminophenylboronic acid provided the title compound (48%) as amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  507 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 3.61−3.65 (m, 4 H), 4.01−4.03 (m, 4 H), 4.03 (s, 6 H), 7.11 (d, <i>J</i> = 8.6 Hz, 2 H), 7.48 (dd, <i>J</i> = 7.6, 4.5 Hz, 1 H), 7.54 (s, 1 H), 7.67 (s, 1 H), 7.81 (d, <i>J</i> = 7.2 Hz, 2 H), 8.31 (d, <i>J</i> = 7.4 Hz, 1 H), 8.77 (d, <i>J</i> = 5.5 Hz, 1 H). Anal. (C<sub>24</sub>H<sub>20</sub>F<sub>6</sub>N<sub>6</sub>·0.12TFA) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>,</b><b><i>N</i></b><b>-Dimethyl-4-(6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-4-yl)benzenamine (46aa).</b> Following the procedure described for compound <b>46m</b>, compound <b>44a</b> and 4-dimethylaminophenylboronic acid provided the title compound (45%) as a tan amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  535 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.07 (s, 6 H), 3.10−3.20 (m, 4 H), 3.44−3.54 (m, 4 H), 6.98 (d, <i>J</i> = 8.0 Hz, 2 H), 7.18−7.24 (m, 1 H), 7.28 (br s, 1 H), 7.41 (br s, 1 H), 7.50−7.60 (m, 2 H), 8.05 (d, <i>J</i> = 8.0 Hz, 1 H), 8.50 (d, <i>J</i> = 4.8 Hz, 1 H). </div><div class="NLM_p"><b>(</b><b><i>E</i></b><b>)-4-Styryl-6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-be</b><b>nzo[</b><b><i>d</i></b><b>]imidazole (46ab).</b> Following the procedure described for compound <b>46m</b>, compound <b>44a</b> and <i>trans</i>-2-phenylvinylboronic acid provided the title compound (53%) as a solid. Mp:  117.9−118 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  518 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.18 (s, 4 H), 3.63 (s, 4 H), 7.10−7.20 (m, 2H), 7.25−7.35 (m, 3 H), 7.50−7.60 (m, 5 H), 7.92 (s, 1 H), 8.43 (s, 1 H). Anal. (C<sub>26</sub>H<sub>21</sub>F<sub>6</sub>N<sub>5</sub>·0.1H<sub>2</sub>O·0.3EtOAc):  C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2-(4-(3-Chloro-5-vinylpyridin-2-yl)-2-methylpiperazin-1-yl)-6-(trifluoromethyl)-4-(3,4,5</b><b>-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (46ac).</b> A mixture of compound<b> 45 </b>(2.73 g, 4.5 mmol), tributylvinylstannane (1.5 mL, 5.0 mmol), Pd(Ph<sub>3</sub>P)<sub>4</sub> (255 mg, 0.23 mmol), LiCl (570 mg, 13.5 mmol), and a few crystals of 2,6-di-<i>tert</i>-butylphenol in dioxane (40 mL) was stirred at 95 °C for 5 h. The reaction mixture was cooled to room temperature, diluted with EtOAc (200 mL), washed with water (50 mL) and brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo and the residue was purified by silica gel chromatography (20% EtOAc/hexane) to give 1.75 g (72%) of the title compound as a gum. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  552 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 1.51 (d, <i>J</i> = 6.6 Hz, 3 H), 3.11 (dt, <i>J</i> = 12.5, 3.1 Hz, 1 H), 3.22 (dd, <i>J</i> = 12.5, 4.0 Hz, 1 H), 3.69 (dt, <i>J</i> = 12.5, 3.1 Hz, 1 H), 3.72 (s, 1 H), 3.60−4.08 (m, 3 H), 4.38 (br s, 1 H), 5.32 (d, <i>J </i>= 11.0 Hz, 1 H), 5.71 (d, <i>J</i> = 17.6 Hz, 1 H), 6.63 (dd, <i>J</i> = 17.6, 11.0 Hz, 1 H), 7.44 (br s, 1 H), 7.50 (br s, 1 H), 7.74 (d, <i>J</i> = 2.0 Hz, 1 H), 7.84 (br s, 1 H), 8.18 (d, <i>J</i> = 1.6 Hz, 1 H), 8.37 (br s, 1 H). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-1-(5-Chloro-6-((</b><b><i>R</i></b><b>)-3-methyl-4-(6-(trifluoromethyl)-4-(3,4,5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)piperazin-1-yl)pyridin-3-yl)ethane-1,2-diol and </b><b>(</b><b><i>S</i></b><b>)-1-(5-Chloro-6-((</b><b><i>R</i></b><b>)-3-methyl-4-(6-(trifluoromethyl)-4-(3,4,5-trifluorophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)piperazin-1-yl)pyridin-3-yl)ethane-1,2-diol (46ad). </b>A mixture of compound <b>46ac</b> (1.65 g, 3 mmol), OsO<sub>4</sub> (0.95 mL, 0.15 mmol, 4% in water), and <i>N</i>-methylmorpholine <i>N</i>-oxide (421 mg, 3.6 mmol) in acetone (20 mL) was stirred at room temperature for 5 h. The reaction mixture was treated with saturated NaHSO<sub>3</sub> (20 mL) and extracted with EtOAc (2 × 50 mL). The combined organic extracts were washed with brine (30 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was evaporated in vacuo and the residue was purified by silica gel column chromatography (EtOAc) to give 1.09 g (62%) of the desired product as a mixture of diastereoisomers. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  586 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.49 (d, <i>J</i> = 6.3 Hz, 3 H), 3.06 (dt, <i>J</i> = 12.5, 3.5 Hz, 1 H), 3.15 (dd, <i>J</i> = 12.5, 3.3 Hz, 1 H), 3.56−3.70 (m, 3 H), 3.81 (t, <i>J</i> = 11.7 Hz, 2 H), 4.07 (d, <i>J </i>= 11.7 Hz, 1 H), 4.47 (br s, 1 H), 4.66 (t, <i>J</i> = 5.5 Hz, 1 H), 7.40−7.52 (m, 2 H), 7.79 (s, 1 H), 7.88 (br s, 2 H), 8.19 (s, 1 H). Anal. (C<sub>26</sub>H<sub>22</sub>ClN<sub>5</sub>F<sub>6</sub>O<sub>2</sub>·0.8H<sub>2</sub>O):  C, H, N. </div><div class="NLM_p"><b>6-</b><b><i>tert</i></b><b>-Butyl-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole </b><b>(47a).</b> A mixture of 2-chlorobenzoimidazole <b>20a </b>(0.209 g, 1 mmol), 1-(3-trifluoromethylpyridin-2-yl)piperazine (0.346 g, 1.65 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (0.28 mL, 1.6 mmol) in MeCN (1 mL) was heated in a microwave synthesizer at 180 °C for 30 min. The reaction mixture was evaporated under vacuo and the residue was purified by silica gel column chromatography (30% EtOAc/hexane) to give 0.137 g (34%) of the title compound as a white solid. Mp:  247−249 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  404 (M + 1). <sup>1</sup>H NMR (DMSO<i>-d</i><sub>6</sub>):  δ 1.31 (s, 9 H), 3.25−3.35 (m, 4 H), 3.57−3.65 (m, 4 H), 7.01 (d, <i>J</i> = 8.2 Hz, 1 H), 7.13 (d, <i>J </i>= 8.2 Hz, 1 H), 7.22 (s, 1 H), 7.26 (dd, <i>J</i> = 7.8, 4.7 Hz, 1 H), 8.12 (d, <i>J</i> = 7.8 Hz, 1 H), 8.57 (d, <i>J</i> = 4.3 Hz, 1 H). LC/MS retention time:  A, 9.91 min; B, 6.83 min. </div><div class="NLM_p"><a name="jm004901203738" id="jm004901203738"></a><b>6-Methyl-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole </b><b>Hydrochloride (47b).</b> Following the procedure described for compound <b>47a</b>, 2-chlorobenzoimidazole <b>20k</b> and 1-(3-trifluoromethylpyridin-2-yl)piperazine provided the crude reaction product. A solution of the product in EtOAc was treated with a 1 M solution of hydrogen chloride in Et<sub>2</sub>O and the mixture was evaporated under reduced pressure. The residue was dried in vacuo to give the title compound (39%) as a white solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  362 (M + 1). <sup>1</sup>H NMR (DMSO<i>-d</i><sub>6</sub>):  δ 2.33 (s, 3 H), 3.20−3.30 (m, 4 H), 3.50−3.64 (m, 4 H), 6.76 (d, <i>J</i> = 7.4 Hz, 1 H), 7.02 (s, 1 H), 7.09 (d, <i>J</i> = 7.4 Hz, 1 H), 7.20−7.30 (m, 1 H), 8.12 (d, <i>J</i> = 7.4 Hz, 1 H), 8.57 (d, <i>J</i> = 3.5 Hz, 1 H), 11.33 (br s, 1 H). Anal. (C<sub>18</sub>H<sub>18</sub>F<sub>3</sub>N<sub>5</sub>·HCl):  C, H, N. </div><div class="NLM_p"><b>6-Fluoro-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole, </b><b>Trifluoroacetic Acid Salt (47c). </b>A mixture of the 2-chlorobenzimidazole <b>20</b><b>g</b> (170 mg, 1.0 mmol), 1-(3-trifluoromethylpyridin-2-yl)piperazine (347 mg, 1.5 mmol), and sodium bicarbonate (250 mg, 2.9 mmol) in isoamyl alcohol (2 mL) was heated at 150 °C in a microwave synthesizer for 10 min. The reaction mixture was cooled to room temperature, diluted with MeOH (3 mL), and filtered. The filtrate was evaporated under reduced pressure and the residue was purified by preparative HPLC (gradient 0.1% trifluoroacetic acid in acetonitrile) to give 90 mg (25%) of the title compound as an amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  366 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.43−3.49 (m, 4 H), 3.79−3.85 (m, 4 H), 7.07−7.14 (m, 1 H), 7.20 (dd, <i>J</i> = 8.2, 2.3 Hz, 1 H), 7.28 (dd, <i>J</i> = 7.8, 5.1 Hz, 1 H), 7.40 (dd, <i>J</i> = 9.0, 4.3 Hz, 1 H), 8.10 (d, <i>J</i> = 8.0 Hz, 1 H), 8.55 (d, <i>J</i> = 4.0 Hz, 1 H). Anal. (C<sub>17</sub>H<sub>15</sub>F<sub>4</sub>N<sub>5</sub>·1.3CF<sub>3</sub>COOH):  C, H, N. </div><div class="NLM_p"><b>6-Chloro-2-[4-(3-trifluoromethylpyridin-2-yl)piperazin-1-yl]-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (47d).</b> Following the procedure described for compound <b>47a</b>, 2-chlorobenzoimidazole <b>20j</b> and 1-(3-trifluoromethylpyridin-2-yl)piperazine provided the title compound (47%) as a white solid. Mp:  228−231 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  382 (M + 1).). <sup>1</sup>H NMR (DMSO-<i>d</i><i><sub>6</sub></i>):  δ 3.18−3.28 (m, 4 H), 3.58−3.68 (m, 4 H), 6.85−7.00 (m, 1 H), 7.10−7.30 (m, 3 H), 8.15 (d, <i>J</i> = 6.7 Hz, 1 H), 8.57 (d, <i>J</i> = 3.9 Hz, 1 H), 11.65 (br s, 1 H). Anal. (C<sub>17</sub>H<sub>15</sub>ClF<sub>3</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>2-(4-(3-(Trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-3</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole-5-carbonitrile, </b><b>Trifluoroacetic Acid Salt (47e).</b> Following the procedure described for compound <b>47c</b>, 2-chlorobenzoimidazole <b>20h</b> and 1-(3-trifluoromethylpyridin-2-yl)piperazine provided the title compound (4%) as an amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  373 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.46−3.54 (m, 4 H), 3.86−3.93 (m, 4 H), 7.31 (dd, <i>J</i> = 7.8, 4.7 Hz, 1 H), 7.57 (d, <i>J</i> = 8.2 Hz, 1 H), 7.71 (dd, <i>J</i> = 8.2, 1.6 Hz, 1 H), 7.78 (s, 1 H), 8.10−8.14 (m, 1 H), 8.58 (d, <i>J</i> = 3.5 Hz, 1 H). Anal. (C<sub>18</sub>H<sub>15</sub>F<sub>3</sub>N<sub>6</sub>·1.4CF<sub>3</sub>CO<sub>2</sub>H):  C, H, N. </div><div class="NLM_p"><b>Methyl </b><b>2-(4-(3-(Trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-3</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole-5-carboxylate, </b><b>Trifluoroacetic Acid Salt (47f).</b> Following the procedure described for compound <b>47c</b>, 2-chlorobenzoimidazole <b>20l</b> and 1-(3-trifluoromethylpyridin-2-yl)piperazine provided the title compound (33%) as an amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  406 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.48−3.51 (m, 4 H), 3.86−3.90 (m, 4 H), 3.96 (s, 3 H), 7.30 (dd, <i>J</i> = 7.4, 5.1 Hz, 1 H), 7.50 (d, <i>J</i> = 8.2 Hz, 1 H), 8.01−8.06 (m, 2 H), 8.09−8.14 (m, 1 H), 8.57 (d, <i>J</i> = 3.5 Hz, 1 H). LC/MS retention time:  C, 14.25 min, D, 8.14 min. </div><div class="NLM_p"><b>4,6-Bis(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]i</b><b>midazole (48).</b> Following the procedure described for compound <b>47a</b>, 2-chlorobenzoimidazole <b>20m</b> and 1-(3-trifluoromethylpyridin-2-yl)piperazine provided the title compound (47%) as a white solid. Mp:  142 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  484 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.34−3.44 (m, 4 H), 3.78−3.88 (m, 4 H), 7.22 (dd, <i>J</i> = 7.8, 4.9 Hz, 1 H), 7.52 (s, 1 H), 7.65 (br s, 1 H), 8.06 (dd, <i>J</i> = 7.9, 1.5 Hz, 1 H), 8.51 (d, <i>J</i> = 3.7 Hz, 1 H). Anal. (C<sub>18</sub>H<sub>15</sub>F<sub>6</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>6-(Trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-imidazo[4,5-</b><b><i>b</i></b><b>]</b><b>pyridine, Trifluoroacetic Acid Salt (49a).</b> A mixture of 2-chloroimidazopyridine <b>20d</b> (45 mg, 0.203 mmol), 1-(3-trifluoromethyl-pyridin-2-yl)piperazine (47 mg, 0.203 mmol), triethylamine (59 μL, 0.406 mmol), and copper(I) iodide (1 mg, 0.005 mmol) in 3-methyl-butan-1-ol (0.5 mL) was heated in a microwave synthesizer at 220 °C for 0.5 h. The reaction mixture was cooled to room temperature and was filtered. The filtrate was evaporated in vacuo and the residue was purified by preparative HPLC (gradient 0.1% CF<sub>3</sub>CO<sub>2</sub>H/MeCN) to give 55 mg (65%) of the title compound as a colorless solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>:  417 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.40−3.50 (m, 4 H), 3.90−4.00 (m, 4 H), 7.26−7.31 (m, 1 H), 7.91 (s, 1 H), 8.11 (d, <i>J </i>= 7.8 Hz, 1 H), 8.40−8.60 (m, 2 H). LC/MS retention time:  A, 9.22 min; B, 5.93 min. </div><div class="NLM_p"><b>5-(Trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-3</b><b><i>H</i></b><b>-imidazo[4,5-</b><b><i>b</i></b><b>]</b><b>pyridine, Trifluoroacetic Acid Salt (49b). </b>Following the procedure described for compound <b>47c</b>, 2-chlorobenzoimidazole <b>20e</b> and 1-(3-trifluoromethylpyridin-2-yl)piperazine provided the title compound (2%) as an amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  417 (M + 1). <sup>1</sup>H NMR (DMSO-<i>d</i><i><sub>6</sub></i>):  δ 3.32−3.36 (m, 4 H), 3.76−3.79 (m, 4 H), 7.28 (dd, <i>J</i> = 7.7, 4.8 Hz, 1 H), 7.47 (d, <i>J</i> = 8.0 Hz, 1 H), 7.68 (d, <i>J</i> = 7.8 Hz, 1 H), 8.13 (dd, <i>J</i> = 7.8, 1.6 Hz, 1 H), 8.57 (d, <i>J</i> = 4.0 Hz, 1 H). LC/MS retention time:  A, 9.39 min; B, 8.75 min. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2-(2-Methyl-4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-b</b><b>enzo[</b><b><i>d</i></b><b>]imidazole (50a). </b>A mixture of piperazine <b>8u</b> (245 mg, 1 mmol), 2-chlorobenzoimidazole <b>20n</b> (176 mg, 0.8 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.34 mL, 2 mmol), and copper iodide (19 mg, 0.1 mmol) in dioxane (2 mL) was heated in a microwave synthesizer at 200 °C for 1.5 h. The reaction mixture was evaporated in vacuo and the residue was purified by silica gel column chromatography (EtOAc) to give 163 mg (38%) of the title compound as a solid. Mp:  216.3-218.7 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  430 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 1.44 (d, <i>J</i> = 6.6 Hz, 3 H), 3.13−3.25 (dt, <i>J</i> = 12.1, 3.5 Hz, 1 H), 3.35−3.52 (m, 2 H), 3.55−3.75 (m, 2 H), 3.83−3.97 (m, 1 H), 4.35 (br s, 1 H), 7.12 (dd, <i>J</i> = 7.9, 4.9 Hz, 1 H), 7.20−7.30 (m, 2 H), 7.36−7.53 (m, 2 H), 7.71 (s, 1 H), 7.95 (dd, <i>J</i> = 7.8, 2.0 Hz, 1 H), 8.25 (br s, 1 H) 8.51 (dd, <i>J</i> = 4.9, 1.4 Hz, 1 H). LC/MS retention time:  A, 10.39 min; B, 7.36 min. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2-(2-Ethyl-4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-be</b><b>nzo[</b><b><i>d</i></b><b>]imidazole (50b). </b>A mixture of 2-chlorobenzoimidazole <b>20n</b> (0.082 g, 0.37 mmol) and piperazine <b>8ab</b> (0.096 g, 0.37 mmol) in ethanol (2 mL) was heated at 170 °C in a microwave sythesizer for 2 h. The reaction mixture was evaporated in vacuo and the residue was purified by by preparative HPLC (gradient 0.1% CF<sub>3</sub>CO<sub>2</sub>H/MeCN) to give 10 mg of a colorless film. The film was dissolved in dichloromethane (2 mL) and the solution was washed with a saturated aqueous solution of NaHCO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by silica gel column chromatography (gradient 0−15% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to give 5 mg (3%) of the title compound as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  444 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 0.93 (t, <i>J</i> = 7.1 Hz, 3 H), 1.80−2.00 (m, 2 H), 3.17 (dt, <i>J</i> = 12.1, 3.3 Hz, 1 H), 3.30−3.40 (m, 1 H), 3.52 (t, <i>J</i> = 12.3 Hz, 2 H), 3.64 (dt, <i>J</i> = 12.5, 3.2 Hz, 1 H), 3.96 (d, <i>J</i> = 12.8 Hz, 1 H), 4.10 (br s, 1 H), 7.24 (dd, <i>J</i> = 7.7, 5.0 Hz, 1 H), 7.25−7.37 (m, 2 H), 7.46 (br s, 1 H), 8.06 (d, <i>J</i> = 7.8 Hz, 1 H), 8.52 (d, <i>J</i> = 3.8 Hz, 1 H). LC/MS retention time:  A, 10.63 min; B, 7.37 min. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2-(2-Propyl-4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-b</b><b>enzo[</b><b><i>d</i></b><b>]imidazole (50c). </b>Following the procedure described for compound <b>50b</b>, 2-chlorobenzoimidazole <b>20i</b> and piperazine <b>8ac </b>provided the title compound (2%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  458 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 0.92 (t, <i>J</i> = 7.3 Hz, 3 H), 1.20−1.40 (m, 2 H), 1.76−2.00 (m, 2 H), 3.10−3.16 (m, 1 H), 3.28−3.32 (m, 1 H), 3.47 (br s, 1 H), 3.52 (br s, 1 H), 3.62 (dt, <i>J</i> = 12.3, 2.6 Hz, 1 H), 3.96 (d, <i>J</i> = 12.7 Hz, 1 H), 4.26 (br s, 1 H), 7.25 (dd, <i>J</i> = 7.8, 4.8 Hz, 1 H), 7.26−7.36 (m, 2 H), 7.47 (br s, 1 H), 8.07 (d, <i>J</i> = 7.9 Hz, 1 H), 8.52 (d, <i>J</i> = 3.9 Hz, 1 H). LC/MS retention time:  A, 11.31 min; B, 8.20 min. </div><div class="NLM_p"><a name="jm004901203739" id="jm004901203739"></a><b>(</b><b><i>R</i></b><b>)-2-(4-(3-Bromopyridin-2-yl)-2-methylpiperazin-1-yl)-6-(trifluoromethyl)-4-(3,4,5-trifluor</b><b>ophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (51a).</b> Following the procedure described for compound <b>47a</b>, 2-chlorobenzoimidazole <b>20n</b> and piperazine <b>8q</b> provided the title compound (73%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  570 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.53 (d, <i>J</i> = 6.8 Hz, 3 H), 3.09 (dt, <i>J</i> = 12.4, 3.6 Hz, 1 H), 3.21 (dd, <i>J</i> = 12.8, 3.4 Hz, 1 H), 3.60−3.98 (m, 3 H), 4.10 (d, <i>J</i> = 11.2 Hz, 1 H), 4.51 (br s, 1 H), 6.97 (dd, <i>J</i> = 8.0, 4.8 Hz, 1 H), 7.47 (br s, 2 H), 7.92 (br s, 2 H), 7.98 (dd, <i>J</i> = 8.0, 1.2 Hz, 1 H) 8.28 (d, <i>J</i> = 4.8 Hz, 1 H). Anal. (C<sub>24</sub>H<sub>18</sub>BrF<sub>6</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-2-(4-(3-Bromopyridin-2-yl)-2-methylpiperazin-1-yl)-6-(trifluoromethyl)-4-(3,4,5-trifluor</b><b>ophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (51b).</b> Following the procedure described for compound <b>47a</b>, 2-chlorobenzoimidazole <b>20i</b> and piperazine <b>8r</b> provided the title compound (84%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  570 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.51 (d, <i>J</i> = 6.4 Hz, 3 H), 3.00−3.05 (m, 1 H), 3.19 (dd, <i>J</i> = 12.0, 3.2 Hz, 1 H), 3.60−3.86 (m, 3 H), 4.07 (d, <i>J</i> = 11.2 Hz, 1 H), 4.49 (br s, 1 H), 6.94 (dd, <i>J</i> = 8.0, 4.8 Hz, 1 H), 7.36−7.60 (m, 2 H), 7.80−7.90 (m, 2 H), 7.96 (d, <i>J</i> = 8.0 Hz, 1 H), 8.25 (dd, <i>J</i> = 4.8, 1.6 Hz, 1 H). MS <i>m</i>/<i>z</i>:  571 (M + 1). Anal. (C<sub>24</sub>H<sub>18</sub>BrF<sub>6</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2-(4-(3-Bromopyridin-2-yl)-3-methylpiperazin-1-yl)-6-(trifluoromethyl)-4-(3,4,5-trifluor</b><b>ophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (51c).</b> Following the procedure described for compound <b>47a</b>, 2-chlorobenzoimidazole <b>20i</b> and piperazine <b>9</b> provided the title compound (64%) as white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  570 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.12 (d, <i>J</i> = 6.0 Hz, 3 H), 3.10−3.30 (m, 1 H), 3.50−3.65 (m, 2 H), 3.70−3.90 (m, 3 H), 4.05 (br s, 1H), 6.98 (dd, <i>J</i> = 8.0, 4.8 Hz, 1 H), 7.47 (s, 2 H), 7.86 (br s, 2 H), 7.99 (dd, <i>J</i> = 7.6, 1.6 Hz, 1 H), 8.29 (dd, <i>J</i> = 4.4, 1.6 Hz, 1 H). LC/MS retention time:  A, 12.89 min; B, 6.82 min. </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-2-(4-(3-Bromopyridin-2-yl)-3-methylpiperazin-1-yl)-6-(trifluoromethyl)-4-(3,4,5-trifluor</b><b>ophenyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (51d).</b> Following the procedure described for compound <b>47a</b>, piperazine <b>30b</b> and 2-chloropyridine <b>6b</b> provided the title compound (18%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  570 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 1.12 (d, <i>J</i> = 6.0 Hz, 3 H), 3.10−3.30 (m, 1 H), 3.50−3.65 (m, 2 H), 3.70−3.90 (m, 3 H), 4.05 (br s, 1H), 6.98 (dd, <i>J</i> = 8.0, 4.8 Hz, 1 H), 7.47 (s, 2 H), 7.86 (br s, 2 H), 7.98 (dd, <i>J</i> = 7.6, 1.6 Hz, 1 H), 8.28 (dd, <i>J</i> = 4.4, 1.6 Hz, 1 H). LC/MS retention time:  A, 12.81 min; B, 7.86 min. </div><div class="NLM_p"><b>2-(4-Pyridin-2-ylpiperazin-1-yl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (52a).</b> Following the procedure described for compound <b>5</b>, 2-chlorobenzimidazole <b>20n </b>and 1-(pyridin-2-yl)piperazine provided the title compound (19%) as amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  570 (M + 1).<sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>):  δ 3.52−3.86 (m, 8 H), 6.62−6.72 (m, 1 H), 6.93 (d, <i>J</i> = 8.6 Hz, 1 H), 7.28 (s, 1 H), 7.36 (d, <i>J</i> = 8.2 Hz, 1 H), 7.47 (br s, 1 H), 7.58 (t, <i>J</i> = 7.2 Hz, 1 H), 8.15 (d, <i>J</i> = 3.5 Hz, 1 H), 11.89 (br s, 1 H). Anal. (C<sub>17</sub>H<sub>16</sub>F<sub>3</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>6-(Trifluoromethyl)-2-(4-(4-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imida</b><b>zole (52b).</b> Following the procedure described for compound <b>31a</b>, 2-chloro-4-(trifluoromethyl)pyridine and piperazine <b>30a</b> provided the title compound (66%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  416 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.66−3.76 (m, 4 H), 3.78−3.88 (m, 4 H), 6.88 (d, <i>J</i> = 5.2 Hz, 1 H), 7.10 (s, 1 H), 7.30 (d, <i>J</i> = 8.2 Hz, 1 H), 7.36 (d, <i>J</i> = 8.2 Hz, 1 H), 7.50 (s, 1 H), 8.32 (d, <i>J</i> = 5.2 Hz, 1 H). Anal. (C<sub>18</sub>H<sub>15</sub>F<sub>6</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>6-(Trifluoromethyl)-2-(4-(5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1 </b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (52c).</b> Following the procedure described for compound <b>47a</b>, 1-(5-(trifluoromethyl)pyridin-2-yl)piperazine and 2-chlorobenzimidazole <b>20n</b> provided the title compound (98%) as a white solid. Mp:  214 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  416 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.74 (d, <i>J</i> = 7.2 Hz, 2 H), 3.76−3.86 (m, 4 H), 3.86−3.96 (m, 4 H), 6.74 (d, <i>J</i> = 9.2 Hz, 2 H), 7.39 (br s, 1 H), 7.66 (br s, 1 H), 7.72 (dd, <i>J</i> = 8.8, 2.0 Hz, 1 H), 8.45 (s, 1 H). Anal. (C<sub>18</sub>H<sub>15</sub>F<sub>6</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>6-(Trifluoromethyl)-2-(4-(6-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imida</b><b>zole (52d).</b> Following the procedure described for compound <b>47a</b>, piperazine <b>8f </b>and 2-chlorobenzimidazole<b> 20n </b>provided the title compound (68%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  416 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.64−3.74 (m, 4 H), 3.78−3.88 (m, 4 H), 6.85 (d, <i>J</i> = 8.0 Hz, 1 H), 7.02 (d, <i>J</i> = 8.0 Hz, 1 H), 7.37 (br s, 2 H), 7.58 (br s, 1 H), 7.64 (t, <i>J</i> = 8.0 Hz, 1 H). Anal. (C<sub>18</sub>H<sub>15</sub>F<sub>6</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>2-(4-(3-Chloropyridin-2-yl)piperazin-1-yl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (52e).</b> Following the procedure described for compound <b>47a</b>, piperazine <b>8b </b>and 2-chlorobenzimidazole <b>20n </b>provided the title compound (41%) as a white solid. Mp:  208−210 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  382 (M + 1). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>):  δ 3.37−3.43 (m, 4 H), 3.65−3.75 (m, 4 H), 7.06 (dd, <i>J</i> = 7.8, 4.7 Hz, 1 H), 7.28 (br s, 1 H), 7.32−7.42 (m, 1 H), 7.48 (br s, 1 H), 7.86 (d, <i>J</i> = 7.8 Hz, 1 H), 8.26 (d, <i>J</i> = 4.7 Hz, 1 H), 11.89 (br s, 1 H). Anal. (C<sub>17</sub>H<sub>15</sub>ClF<sub>3</sub>N<sub>5</sub>·0.25H<sub>2</sub>O):  C, H, N. </div><div class="NLM_p"><b>2-(4-(3-Iodopyridin-2-yl)piperazin-1-yl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (52f).</b> Following the procedure described for compound <b>47a</b>, piperazine <b>8c </b>and 2-chlorobenzimidazole <b>20n </b>provided the title compound (58%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  474 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.00−3.10 (m, 4 H), 3.18−3.28 (m, 4 H), 6.64 (d, <i>J</i> = 7.6 Hz, 1 H), 6.66 (d, <i>J</i> = 7.6 Hz, 1 H), 8.06 (d, <i>J</i> = 7.6 Hz, 1 H), 8.07 (d, <i>J</i> = 7.6 Hz, 1 H), 8.27 (d, <i>J</i> = 4.4 Hz, 1 H), 8.28 (d, <i>J</i> = 4.8 Hz, 1 H). Anal. (C<sub>17</sub>H<sub>15</sub>F<sub>3</sub>IN<sub>5</sub>·0.2H<sub>2</sub>O):  C, H, N. </div><div class="NLM_p"><b>2-(4-(3-Methylpyridin-2-yl)piperazin-1-yl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole, </b><b>Trifluoroacetic Acid Salt (52</b><b>g</b><b>).</b> Following the procedure described for compound <b>47a</b>, piperazine <b>30a </b>and 2-chloro-3-methylpyridine provided the crude product, which was purified by preparative HPLC (gradient 0.1% trifluoroacetic acid in acetonitrile) to give the title compound (73%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  362 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.48−3.52 (m, 4 H), 3.94 (br s, 4 H), 7.19 (dd, <i>J</i> = 8.0 Hz, 4.0 Hz, 1 H), 7.40−7.48 (m, 2 H), 7.60 (s, 1 H), 7.84 (d, <i>J</i> = 8.0 Hz, 1 H), 8.11 (d, <i>J</i> = 4.0 Hz, 1 H). Anal. (C<sub>18</sub>H<sub>18</sub>F<sub>3</sub>N<sub>5</sub>·2.3TFA·1.4H<sub>2</sub>O):  C, H, N. </div><div class="NLM_p"><b>2-(4-(6-(Trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)piperazin-1-yl)nicotinonitrile (52h).</b> Following the procedure described for compound <b>47a</b>, 2-piperazin-1-ylnicotinonitrile and 2-chlorobenzimidazole <b>20n </b>provided the title compound (56%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  373 (M + 1). <sup>1</sup>H NMR (DMSO<i>-d</i><sub>6</sub>):  δ 3.75 (m, 8 H), 6.98 (dd, <i>J</i> = 7.4, 4.7 Hz, 1 H), 7.20−7.60 (m, 3 H), 8.12 (d, <i>J</i> = 7.8 Hz, 1 H), 8.45 (d, <i>J</i> = 4.0 Hz, 1 H), 11.90 (s, 1 H). LC/MS retention time:  A, 8.87 min; B, 5.71 min. </div><div class="NLM_p"><b>Ethyl 2-(4-(6-(Trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)piperazin-1-yl)nicotinate </b><b>Hydrochloride (52i).</b> Following the procedure described for compound <b>47a</b>, piperazine <b>8e</b> and 2-chlorobenzimidazole <b>20n </b>provided the crude reaction product. A solution of the product in EtOAc was treated with a 1 M solution of hydrogen chloride in Et<sub>2</sub>O and the mixture was evaporated under reduced pressure. The residue was dried in vacuo to give the title compound title compound (71%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  420 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 1.34 (t, <i>J</i> = 7.2 Hz, 3 H), 3.45−3−55 (m, 4 H), 3.69−3.81 (m, 4 H), 4.32 (q, <i>J</i> = 7.0 Hz, 2 H), 6.83 (dd, <i>J</i> = 7.6, 4.9 Hz, 1 H), 7.26−7.36 (m, 2 H), 7.49 (br s, 1 H), 8.06 (dd, <i>J </i>= 7.8, 2.0 Hz, 1 H), 8.28 (dd, <i>J</i> = 4.7, 2.0 Hz, 1 H). Anal. (C<sub>20</sub>H<sub>20</sub>N<sub>5</sub>F<sub>3</sub>O<sub>2</sub>):  C, H, N. </div><div class="NLM_p"><b>(5-Chloro-6-(4-(6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)piperazin-1-yl)pyridin-3-yl)m</b><b>ethanol (52j).</b> Following the procedure described for compound <b>31a</b>, piperazine <b>8h</b> and 2-chlorobenzimidazole <b>20n</b> provided the title compound (42%) as a solid. Mp:  162−165 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  412 (M + 1). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>):  δ 3.30−3.40 (m, 4 H), 3.65−3.75 (m, 4 H), 4.47 (d, <i>J</i> = 5.8 Hz, 2 H), 5.30 (t, <i>J</i> = 5.5 Hz, 1 H), 7.20−7.50 (m, 3 H), 7.78 (d, <i>J</i> = 2.0 Hz, 1 H), 8.19 (d, <i>J</i> = 2.0 Hz, 1 H). Anal. (C<sub>18</sub>H<sub>17</sub>ClN<sub>5</sub>F<sub>3</sub>O):  C, H, N. </div><div class="NLM_p"><b>5-Chloro-6-(4-(6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)piperazin-1-yl)nicotinamide </b><b>(52k).</b> Following the procedure described for compound <b>31a</b>, piperazine <b>8p </b>and 2-chlorobenzimidazole <b>20n </b>provided the title compound (81%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  425 (M + 1). <sup>1</sup>H NMR (DMSO<i>-<a name="jm004901203740" id="jm004901203740"></a> d</i><sub>6</sub>):  δ 3.70−3.80 (m, 4 H), 3.80−4.00 (m, 4 H), 7.49−7.54 (m, 1 H), 7.58−7.62 (m, 1 H), 7.71 (s, 1 H), 7.76 (s, 1 H), 8.28 (br s, 1 H), 8.45 (s, 1 H), 8.93 (br s, 1 H). Anal. (C<sub>18</sub>H<sub>16</sub>ClN<sub>6</sub>F<sub>3</sub>O·0.4H<sub>2</sub>O):  C, H, N. </div><div class="NLM_p"><b>5-Chloro-</b><b><i>N</i></b><b>-methyl-6-(4-(6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazol-2-yl)piperazin-1-yl)nicot</b><b>inamide (52l).</b> Following the procedure described for compound <b>31a</b>, piperazine <b>8l </b>and 2-chlorobenzimidazole <b>20n </b>provided the title compound (62%) as a white amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  439 (M + 1). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>):  δ 2.85 (d, <i>J</i> = 3.9 Hz, 3 H), 3.60−3.70 (m, 4 H), 3.72−3.82 (m, 4 H), 7.34 (br s, 1 H), 7.38−7.59 (m, 2 H), 8.25 (s, 1 H), 8.59 (br s, 1 H), 8.72 (s, 1 H), 11.95 (br s, 1 H). Anal. (C<sub>19</sub>H<sub>18</sub>ClN<sub>6</sub>F<sub>3</sub>O·0.1EtOAc):  C, H, N. </div><div class="NLM_p"><b>6-(Trifluoromethyl)-2-(4-(2-(trifluoromethyl)phenyl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole </b><b>(53a).</b> Following the procedure described for compound <b>31a</b>, 1-(2-(trifluoromethyl)phenyl)piperazine and 2-chlorobenzimidazole <b>20n </b>provided the title compound (37%) as a white solid. Mp:  268−269 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  415 (M + 1). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>):  δ 3.01 (br s, 4 H), 3.69 (br s, 4 H), 7.20−7.80 (m, 7 H), 11.86 (d, <i>J</i> = 12.0 Hz, 1 H). Anal. (C<sub>19</sub>H<sub>16</sub>N<sub>4</sub>F<sub>6</sub>):  C, H, N. </div><div class="NLM_p"><b>6-(Trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-4-yl)piperazin-1-yl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imida</b><b>zole</b><b>(53b).</b> Following the procedure described for compound <b>47a</b>, piperazine <b>11d</b> and 2-chlorobenzimidazole <b>20n </b>provided the title compound (20%) as a light-yellow solid. Mp:  220−224 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  416 (M + 1). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>):  δ 2.46−2.56 (m, 4 H), 2.83−2.93 (m, 4 H), 6.30−6.50 (m, 3 H), 6.61 (br s, 1 H), 7.66 (d, <i>J</i> = 5.9 Hz, 1 H), 7.78 (s, 1 H). Anal. (C<sub>18</sub>H<sub>15</sub>F<sub>6</sub>N<sub>5</sub>):  C, H, N. </div><div class="NLM_p"><b>2-(4-(3-Chloropyridin-4-yl)piperazin-1-yl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole, </b><b>Trifluoroacetic Acid Salt (53c). </b>Following the procedure described for compound <b>47a</b>, piperazine <b>11b</b> and 2-chlorobenzimidazole <b>20n </b>provided the title compound (63%) as trifluoroacetic acid salt after purification by preparative HPLC (gradient 0.1% trifluoroacetic acid in acetonitrile). Mp:  159−161 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  382 (M + 1). <sup>1</sup>H NMR (DMSO<i>-d</i><sub>6</sub>):  δ 3.60−3.80 (m, 4 H), 3.86−3.96 (m, 4 H), 7.33 (d, <i>J</i> = 5.9 Hz, 1 H), 7.54−7.63 (m, 2 H), 7.70 (s, 1 H), 8.45 (d, <i>J</i> = 5.9 Hz, 1 H), 8.63 (s, 1 H). LC/MS retention time:  A, 8.70 min; B, 3.74 min. </div><div class="NLM_p"><b>2-(4-(3,5-Dichloropyridin-4-yl)piperazin-1-yl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole </b><b>(53d). </b>Following the procedure described for compound <b>5</b>, 1-(3,5-dichloropyridin-4-yl)piperazine and 2-chlorobenzimidazole <b>20n </b>provided the title compound (33%) as amorphous solid. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  416 (M + 1). <sup>1</sup>H NMR (CD<sub>3</sub>OD):  δ 3.60−3.64 (m, 4 H), 3.83−3.88 (m, 4 H), 7.52−7.62 (m, 2 H), 7.65 (s, 1 H), 8.44 (s, 2 H). LC/MS retention time:  A, 9.76 min; B, 6.47 min. </div><div class="NLM_p"><b>2-(4-(2,6-Dichlorophenyl)piperazin-1-yl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole (53e).</b> Following the procedure described for compound <b>5</b>, piperazine <b>14</b> and 2-chlorobenzimidazole <b>20n </b>provided the title compound (63%) as a white solid. Mp:  263−265 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  415 (M + 1). <sup>1</sup>H NMR (CDCl<sub>3</sub>):  δ 3.36−3.46 (m, 4 H), 3.72−3.82 (m, 4 H), 7.00−7.09 (m, 1 H), 7.20−7.56 (m, 3 H), 7.72 (s, 1 H), 8.28 (br s, 1 H). LC/MS retention time:  A, 10.98 min; B, 7.66 min. </div><div class="NLM_p"><b>2-(4-(5-Chloropyrimidin-4-yl)piperazin-1-yl)-6-(trifluoromethyl)-1</b><b><i>H</i></b><b>-benzo[</b><b><i>d</i></b><b>]imidazole </b><b>(53f).</b> Following the procedure described for compound <b>5</b>, piperazine <b>11f</b> and 2-chlorobenzimidazole <b>20n </b>provided the title compound (69%) as white solid. Mp:  66.6−66.7 °C. MS (ESI, pos. ion) <i>m</i>/<i>z</i>:  383 (M + 1). <sup>1</sup>H NMR (DMSO<i>-d</i><sub>6</sub>):  δ 3.01 (br s, 4 H), 3.17 (br s, 4 H), 6.59 (d, <i>J</i> = 8.0 Hz, 1 H), 6.67 (d, <i>J</i> = 8.0 Hz, 1 H), 6.78 (s, 1 H), 7.68 (s, 1 H), 7.86 (s, 1 H). Anal. (C<sub>16</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>6</sub>·0.75H<sub>2</sub>O):  C, H, N. </div><div class="NLM_p"><b>Functional </b><b><sup><a onclick="showRef(event, 'jm060065yb00045'); return false;" href="javascript:void(0);" class="ref jm060065yb00045">45</a></sup></b><sup></sup><b>Ca</b><b><sup>2+</sup></b><sup></sup><b> Uptake Assays.</b> Rat TRPV1-expressing CHO cells were routinely maintained in DMEM medium with 10% dialyzed fetal bovine serum, 1× nonessential amino acids, penicillin, streptomycin, and <span class="smallcaps smallerCapital">l</span>-glutamine. Two days before the assays were run, the cells were seeded in Cytostar 96-well plates (Amersham) at a density of 20 000 cells per well. All of the <sup>45</sup>Ca<sup>2+</sup> uptake assays had a final <sup>45</sup>Ca<sup>2+</sup> concentration of 10 μCi/mL. For the capsaicin-mediated <sup>45</sup>Ca<sup>2+</sup> uptake assay, the cells were preincubated with compound at room temperature for 2 min prior to the addition of <sup>45</sup>Ca<sup>2+</sup> (ICN) and capsaicin (Sigma) in F12 medium, with a final capsaicin concentration of 500 nM, and then left for an additional 2 min prior to compound washout. For the pH-mediated <sup>45</sup>Ca<sup>2+</sup> uptake assay, the cells were preincubated with compound at room temperature for 2 min prior to the addition of <sup>45</sup>Ca<sup>2+</sup> in 30 mM HEPES/MES buffer (final assay pH 5) and then left for an additional 2 min prior to compound washout. For the measurement of agonist activity, the cells were incubated with compound in the presence of <sup>45</sup>Ca<sup>2+</sup> in a 1:1 ratio of F12 medium to HBSS (Hanks buffered saline solution) supplemented with BSA (0.1 mg/mL) and 1 mM HEPES at pH 7.4 at room temperature for 2 min prior to compound washout. For compound washout, the assay plates were washed twice with phosphate-buffered saline containing BSA (0.1 mg/mL) using an ELX405 plate washer (Bio-Tek Instruments Inc.). Radioactivity remaining in the 96-well plates after washout was measured using a MicroBeta Jet (Perkin-Elmer). IC<sub>50</sub> data were calculated using XLfit version 2.0.6 (ID Business Solutions Ltd). </div><div class="NLM_p"><b>Pharmacokinetic Studies.</b> Male Sprague−Dawley rats (weight range 225−280 g) with surgically implanted femoral vein and jugular vein cannulae were obtained from Hilltop Lab Animals Inc. (Scottsdale, PA). Animals were fasted overnight and the following day compounds were administered either by oral gavage or by intravenous bolus injection. Oral formulations were made 24−48 h prior to dosing, while intravenous formulations were made on the day of dosing. Blood samples were collected over 8 h via jugular cannula into a heparinized tube. Following centrifugation, plasma samples were stored in a freezer to maintain −70 °C until analysis. Lithium heparinized plasma samples (40 μL) were precipitated with acetonitrile containing the internal standard (IS). The supernatant was transferred into a 96-well plate, and an aliquot of 20 μL was injected onto an LC−MS/MS system. The analytes were separated by a reversed-phase on a C-18 analytical column. The analyte ions were generated by an atmospheric pressure chemical ionization (APCI) source and detected by a Sciex API3000 triple quadrupole mass spectrometer operated in the multiple reaction monitoring (MRM) mode. Study sample concentrations were determined from a weighted (1/<i>x</i><sup>2</sup>) linear regression of peak area ratios (analyte peak area/IS peak area) versus the theoretical concentrations of the calibration standards. Pharmacokinetic parameters were calculated by noncompartmental methods using WinNonLin (Pharsight Corp., Mountainview, CA). </div><div class="NLM_p"><b>Method for Capsaicin-Induced Flinching Model. </b>Male rats (Sprague−Dawley; Charles River Laboratories, Wilmington, MA) were allowed 5−7 days acclimation to the LAR prior to use in the experiment. The day prior to the experiment, animals were numbered sequentially by marking the tail with a permanent marker. For the dose response study, the combined data from three separate studies was used for analysis. The treatment groups are listed below. </div><div class="NLM_p">The first treatment was either vehicle or <b>46ad</b> administered via oral gavage using a dose volume of 5 mL/kg in an Ora-Plus/5% Tween 80 vehicle solution. Following the first treatment, rats were placed into acclimation cages (12 cm × 26 cm × 12 cm front height/15 cm rear height) that were identical to those to be used for the behavioral scoring. Animals acclimated for 2 h prior to the second treatment. </div><div class="NLM_p">The second treatment for all groups was an intraplantar injection of capsaicin, except in the vehicle/vehicle group, which received an intraplantar injection of the vehicle [5% EtOH in phosphate-buffered saline (PBS) without Ca<sup>2+</sup>, Mg<sup>2+</sup>] used for capsaicin. The dose of capsaicin utilized was 0.5 μg administered in a volume of 25 μL. This dose of capsaicin was based on earlier characterization work and found to be a minimally effective reproducible dose. The intraplantar injection was made with a 3/10 cm<sup>3</sup> insulin syringe fitted with a 28.5-gauge needle. For the intraplantar injection, rats were placed headfirst into a rat restrainer and the right foot was marked (top and bottom) with a permanent marker to make a clear identification of the injected foot. Next, with the foot extended, the injection was made into the center of the bottom of the foot (i.e., intraplantar). The rat was then immediately placed into an <a name="jm004901203741" id="jm004901203741"></a> observation chamber for flinch counting. At all times, animals were treated gently as to minimize stress. </div><div class="NLM_p">The behavioral measure scored was number of flinches. Flinches were recorded for 1 min by observers (2) who were blinded to the treatment conditions. A flinch was defined as a “flick” of the paw either when the animal lifts it from the floor or when the paw was held-up. If the paw was just held up, the counting continued at a constant pace until the paw was placed again on the chamber's surface. If the paw was held up and biting occurred, it was counted as a response. Immediately following the 1-min test period, the animals were transferred to another person who took blood for determination of plasma levels of compound. Blood was taken via a cardiac stick in animals anesthetized with CO<sub>2</sub>. Blood was collected in heparinized tubes and kept on ice until centrifugation at 14 000<i>g</i> for 5 min. Plasma (200 μL) was removed, kept at 4 °C during experiment, and frozen at − 80 °C until submission for blood level determinations. Percent maximal possible effect (%MPE) was computed as ((Veh/Cap − Veh/Veh) − (Drug/Cap-Veh/Veh))/(Veh/Cap − Veh/Veh). </div><div class="NLM_p"><b>Method for CFA-Induced Thermal Hyperalgesia. </b>Prior to being tested, male rats (Harlan Sprague−Dawley, Harlan Industries, Indianapolis, IN) were allowed at least a 4-day acclimation period to the testing environment, followed by a 2-day habituation to the testing equipment and paradigm. The paw withdrawal latencies were tested using a commercially available paw thermal stimulator (Yaksh hot box, Anesthesiology Research Laboratory, Department of Anesthesiology, University of California at San Diego). The device consists of rat compartments (plexiglass cubicles) over a glass surface maintained at a constant temperature of 30 °C; underneath the glass lays a radiant heat source consisting of a high intensity projector lamp bulb (EIKO CXL/CXR, 8V 50W). An attached, angled mirror facilitates visualization of the footpad and positioning of the radiant heat to the plantar surface of the paw. Nociception was measured as the latency for the rat to remove its paw when the radiant light is activated (current set at 4.75 A). A daily calibration of the hot box's settings was done in order to produce a consistent paw withdrawal latency (PWL) of approximately 8−10 s as the baseline response. A 20-s cutoff was imposed on the stimulus duration to prevent tissue damage. On the day of testing, after 45 min of additional acclimation in the plexiglass cubicles, thermal stimuli were delivered four times to each hind paw in an alternating manner at a 5-min interstimulus interval. The first PWL measurement was discarded (it tended to be unusually high and variable), and the three subsequent measurements were averaged to obtain baseline PWL. </div><div class="NLM_p last">After PWL baseline testing, inflammation was induced by subplantar injection of CFA into the left hind paw using a 1-mL syringe with a 27-gauge <sup>1</sup>/<sub>2</sub> in. needle. Care was taken to avoid a backflow of injected solution after needle withdrawal. CFA injection produces an intense inflammation; behavioral hyperalgesia develops 3−5 h after the injection, peaks at 6−24 h, and lasts for more than 5 days. For this study, animals were dosed (po) with <b>46ad</b> at a dosing volume of 5 mL/kg 21 h after CFA injection. The vehicle for <b>46ad</b> was OraPlus/5% Tween 80. Rats were tested 2 h following treatment, and investigators conducting PWL testing were blinded to the treatment conditions. </div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm060065y/suppl_file/jm060065ysi20060331_062737.pdf">jm060065ysi20060331_062737.pdf (116.86 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm060065y" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vassil I. Ognyanov</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chenera Balan</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony W. Bannon</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yunxin Bo</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celia Dominguez</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Fotsch</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vijay K. Gore</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lana Klionsky</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vu V. Ma</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi-Xin Qian</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rami Tamir</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xianghong Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ning Xi</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shimin Xu</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dawn Zhu</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Narender R. Gavva</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James J. S. Treanor</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark H. Norman</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry Research and Discovery and Department of Neuroscience, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank our colleagues Sekhar Surapaneni, Annette Bak. and their co-workers in the PKDM and pharmaceutics departments and Duncan Smith for providing the 2D-NOESY NMR analyses. We also acknowledge Randy Hungate and Jean-Claude Louis for their support.</p></div><div class="refs-header-label"><a name="jm004901203742" id="jm004901203742"></a></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="jm060065yb00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm060065yb00001_1"><span><span class="NLM_string-ref">Vanilloid receptor-1 is referred to as TRPV1 in this report according to the recently adopted nomenclature:  Montell, C.; Birnbaumer, L.; Flockerzi, V.; Bindels, R. J.; Bruford, E. A.; Caterina, M. J.; Clapham, D. E.; Harteneck, C.; Heler, S.; Julius, D.; Kojima, I.; Mori, Y.; Penner, R.; Prawitt, D.; Scharenberg, A. M.; Schultz, G.; Shimizu, N.; Zhu, M. X. A unified nomenclature for the superfamily of TRP cation channels. <i>  Mol. Cell</i><b>2002</b>, <i>9</i>, 229−231.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=+Vanilloid&author=L.+Birnbaumer&author=V.+Flockerzi&author=R.+J.+Bindels&author=E.+A.+Bruford&author=M.+J.+Caterina&author=D.+E.+Clapham&author=C.+Harteneck&author=S.+Heler&author=D.+Julius&author=I.+Kojima&author=Y.+Mori&author=R.+Penner&author=D.+Prawitt&author=A.+M.+Scharenberg&author=G.+Schultz&author=N.+Shimizu&author=M.+X.+Zhu&title=A+unified+nomenclature+for+the+superfamily+of+TRP+cation+channels.+Mol.+Cell"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVanilloid%26btitle%3DA%2520unified%2520nomenclature%2520for%2520the%2520superfamily%2520of%2520TRP%2520cation%2520channels.%2520Mol.%2520Cell%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm060065yb00002_1"><span><span class="NLM_string-ref">Szallasi, A.; Blumberg, P. M. Vanilloid (capsaicin) receptors and mechanisms. <i>  Pharmacol. Rev</i>. <b>1999</b>, <i>51</i>, 159−212.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=212&author=A.+Szallasi&author=P.+M.+Blumberg&author=+Vanilloid&title=receptors+and+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26atitle%3Dreceptors%2520and%2520mechanisms%26jtitle%3DPharmacol.%2520Rev.%26date%3D1999%26volume%3D51%26spage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm060065yb00003_1"><span><span class="NLM_string-ref">Caterina, M. J.; Julius, D. The vanilloid receptor:  A molecular gateway to the pain pathway. <i>  Annu. Rev. Neurosci</i>. <b>2001</b>, <i>24</i>, 487−517.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=517&author=M.+J.+Caterina&author=D+Julius&title=The+vanilloid+receptor%3A%E2%80%89+A+molecular+gateway+to+the+pain+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaterina%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520vanilloid%2520receptor%253A%25E2%2580%2589%2520A%2520molecular%2520gateway%2520to%2520the%2520pain%2520pathway%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D24%26spage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm060065yb00004_1"><span><span class="NLM_string-ref">Szallasi, A. Vanilloid (capsaicin) receptors in health and disease. <i>  Am. J. Clin. </i><i>Pathol</i>. <b>2002</b>, <i>118</i>, 110−121.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2002&pages=121&author=A.+Szallasi&author=+Vanilloid&title=receptors+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26atitle%3Dreceptors%2520in%2520health%2520and%2520disease%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D2002%26volume%3D118%26spage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm060065yb00005_1"><span><span class="NLM_string-ref">Tominaga, M.; Caterina, M. J.; Malmberg, A. B.; Rosen, T. A.; Gilbert, H.; Skinner, K.; Raumann, B. E.; Basbaum, A. I.; Julius, D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. <i>  Neuron </i><b>1998</b>, <i>21</i>, 531−543.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=543&author=M.+Tominaga&author=M.+J.+Caterina&author=A.+B.+Malmberg&author=T.+A.+Rosen&author=H.+Gilbert&author=K.+Skinner&author=B.+E.+Raumann&author=A.+I.+Basbaum&author=D+Julius&title=The+cloned+capsaicin+receptor+integrates+multiple+pain-producing+stimuli"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTominaga%26aufirst%3DM.%26atitle%3DThe%2520cloned%2520capsaicin%2520receptor%2520integrates%2520multiple%2520pain-producing%2520stimuli%26jtitle%3DNeuron%26date%3D1998%26volume%3D21%26spage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm060065yb00006_1"><span><span class="NLM_string-ref">Ji, R. R.; Samad, T. A.; Jin, S. X.; Schmoll, R.; Woolf, C. J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. <i>  Neuron</i><b>2002</b>, <i>36</i>, 57−68.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=68&author=R.+R.+Ji&author=T.+A.+Samad&author=S.+X.+Jin&author=R.+Schmoll&author=C.+J.+Woolf&title=MAPK+activation+by+NGF+in+primary+sensory+neurons+after+inflammation+increases+TRPV1+levels+and+maintains+heat+hyperalgesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DR.%2BR.%26atitle%3DMAPK%2520activation%2520by%2520NGF%2520in%2520primary%2520sensory%2520neurons%2520after%2520inflammation%2520increases%2520TRPV1%2520levels%2520and%2520maintains%2520heat%2520hyperalgesia%26jtitle%3DNeuron%26date%3D2002%26volume%3D36%26spage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm060065yb00007_1"><span><span class="NLM_string-ref">Hudson, L. J.; Bevan, S.; Witherspoon, G.; Gentry, C.; Fox, A.; Winter, J. VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. <i>  Eur. J. Neurosci</i>. <b>2001</b>, <i>13</i>, 2105−2114.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=2114&author=L.+J.+Hudson&author=S.+Bevan&author=G.+Witherspoon&author=C.+Gentry&author=A.+Fox&author=J.+Winter&title=protein+expression+increases+in+undamaged+DRG+neurons+after+partial+nerve+injury"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DL.%2BJ.%26atitle%3Dprotein%2520expression%2520increases%2520in%2520undamaged%2520DRG%2520neurons%2520after%2520partial%2520nerve%2520injury%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2001%26volume%3D13%26spage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm060065yb00008_1"><span><span class="NLM_string-ref">Tympanidis, P.; Casula, M. A.; Yiangou, Y.; Terenghi, G.; Dowd, P.; Anand, P. Increased vanilloid receptor VR1 in nervation in vulvodynia. <i>  Eur. J. Pain</i><b>2004</b>, <i>8</i>, 129−133.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2004&pages=133&author=P.+Tympanidis&author=M.+A.+Casula&author=Y.+Yiangou&author=G.+Terenghi&author=P.+Dowd&author=P+Anand&title=Increased+vanilloid+receptor+VR1+in+nervation+in+vulvodynia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTympanidis%26aufirst%3DP.%26atitle%3DIncreased%2520vanilloid%2520receptor%2520VR1%2520in%2520nervation%2520in%2520vulvodynia%26jtitle%3DEur.%2520J.%2520Pain%26date%3D2004%26volume%3D8%26spage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm060065yb00009_1"><span><span class="NLM_string-ref">Chan, C. L.; Facer, P.; Davis, J. B.; Smith, G. D.; Egerton, J.; Bountra, C.; Williams, N. S.; Anand, P. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. <i>  Lancet</i><b>2003</b>, <i>361 </i>(9355), 385−391.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2003&pages=391&issue=9355&author=C.+L.+Chan&author=P.+Facer&author=J.+B.+Davis&author=G.+D.+Smith&author=J.+Egerton&author=C.+Bountra&author=N.+S.+Williams&author=P+Anand&title=Sensory+fibres+expressing+capsaicin+receptor+TRPV1+in+patients+with+rectal+hypersensitivity+and+faecal+urgency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DC.%2BL.%26atitle%3DSensory%2520fibres%2520expressing%2520capsaicin%2520receptor%2520TRPV1%2520in%2520patients%2520with%2520rectal%2520hypersensitivity%2520and%2520faecal%2520urgency%26jtitle%3DLancet%26date%3D2003%26volume%3D361%26issue%3D9355%26spage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00010"><div class="reference"><div class="NLM_citation" id="jm060065yb00010_1"><span><span class="NLM_string-ref">Tominaga, M.; Caterina, M. J.; Malmberg, A. B.; Rosen, T. A.; Gilbert, H.; Skinner, K.; Raumann, B. E.; Basbaum, A. I. Julius, D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. <i>  Neuron</i><b>1998</b>, <i>21</i>, 531−543.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=543&author=M.+Tominaga&author=M.+J.+Caterina&author=A.+B.+Malmberg&author=T.+A.+Rosen&author=H.+Gilbert&author=K.+Skinner&author=B.+E.+Raumann&author=A.+I.+Basbaum&author=D+Julius&title=The+cloned+capsaicin+receptor+integrates+multiple+pain-producing+stimuli"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTominaga%26aufirst%3DM.%26atitle%3DThe%2520cloned%2520capsaicin%2520receptor%2520integrates%2520multiple%2520pain-producing%2520stimuli%26jtitle%3DNeuron%26date%3D1998%26volume%3D21%26spage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm060065yb00011_1"><span><span class="NLM_string-ref">Smart, D.; Gunthrope, M. J.; Jerman, J. C.; Nasir, S.; Gray, J.; Muir, A. I.; Chambers, J. K.; Randal, A. D.; Davis, J. B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). <i>  Br. J. </i><i>Pharm</i>. <b>2000</b>, <i>129</i>, 227−230.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=230&author=D.+Smart&author=M.+J.+Gunthrope&author=J.+C.+Jerman&author=S.+Nasir&author=J.+Gray&author=A.+I.+Muir&author=J.+K.+Chambers&author=A.+D.+Randal&author=J.+B+Davis&title=The+endogenous+lipid+anandamide+is+a+full+agonist+at+the+human+vanilloid+receptor+%28hVR1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DD.%26atitle%3DThe%2520endogenous%2520lipid%2520anandamide%2520is%2520a%2520full%2520agonist%2520at%2520the%2520human%2520vanilloid%2520receptor%2520%2528hVR1%2529%26jtitle%3DBr.%2520J.%2520Pharm.%26date%3D2000%26volume%3D129%26spage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm060065yb00012_1"><span><span class="NLM_string-ref">Hwang, S. W.; Cho, H.; Kwak, J.; Lee, S.-Y.; Kang, C.-J.; Jung, J.; Cho, S.; Min, K. H.; Suh, Y.-G.; Kim, D.; Oh, U. Direct activation of capsaicin receptors by products of lipoxygenases:  Endogenous capsaicin-like substances. <i>  Proc. Natl. Acad. Sci. U.S.A.</i><b>2000</b>, <i>97</i>, 6155−6160.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=6160&author=S.+W.+Hwang&author=H.+Cho&author=J.+Kwak&author=S.-Y.+Lee&author=C.-J.+Kang&author=J.+Jung&author=S.+Cho&author=K.+H.+Min&author=Y.-G.+Suh&author=D.+Kim&author=U+Oh&title=Direct+activation+of+capsaicin+receptors+by+products+of+lipoxygenases%3A%E2%80%89+Endogenous+capsaicin-like+substances"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.%2BW.%26atitle%3DDirect%2520activation%2520of%2520capsaicin%2520receptors%2520by%2520products%2520of%2520lipoxygenases%253A%25E2%2580%2589%2520Endogenous%2520capsaicin-like%2520substances%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D6160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm060065yb00013_1"><span><span class="NLM_string-ref">Appendino, G.; Szallasi, A. Euphorbium:  Modern research on its active principle, resiniferatoxin, revives an ancient medicine. <i>  Life Sci.</i><b>1997</b>, <i>60</i>, 681−696.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1997&pages=696&author=G.+Appendino&author=A.+Szallasi&author=+Euphorbium&title=Modern+research+on+its+active+principle%2C+resiniferatoxin%2C+revives+an+ancient+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppendino%26aufirst%3DG.%26atitle%3DModern%2520research%2520on%2520its%2520active%2520principle%252C%2520resiniferatoxin%252C%2520revives%2520an%2520ancient%2520medicine%26jtitle%3DLife%2520Sci.%26date%3D1997%26volume%3D60%26spage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm060065yb00014_1"><span><span class="NLM_string-ref">Appendino, G.; Munoz, E.; Fiebich, B. L. TRPV1 (vanilloid receptor, capsaicin receptor) agonists and antagonists. <i>  Expert Opin. Ther. Patents</i><b>2003</b>, <i>13</i>, 1825−1837.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1837&author=G.+Appendino&author=E.+Munoz&author=B.+L.+Fiebich&title=agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppendino%26aufirst%3DG.%26atitle%3Dagonists%2520and%2520antagonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2003%26volume%3D13%26spage%3D1837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm060065yb00015_1"><span><span class="NLM_string-ref">Caterina, M. J.; Leffler, A.; Malmberg, A. B.; Martin, W. J.; Trafton. J.; Petersen-Zeitz, K. R.; Koltzenburg, M.; Basbaum, A. I.; Julius, D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. <i>  Science</i><b>2000</b>, <i>288</i>, 306−313.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2000&pages=313&author=M.+J.+Caterina&author=A.+Leffler&author=A.+B.+Malmberg&author=W.+J.+Martin&author=J.+Trafton&author=K.+R.+Petersen-Zeitz&author=M.+Koltzenburg&author=A.+I.+Basbaum&author=D+Julius&title=Impaired+nociception+and+pain+sensation+in+mice+lacking+the+capsaicin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaterina%26aufirst%3DM.%2BJ.%26atitle%3DImpaired%2520nociception%2520and%2520pain%2520sensation%2520in%2520mice%2520lacking%2520the%2520capsaicin%2520receptor%26jtitle%3DScience%26date%3D2000%26volume%3D288%26spage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm060065yb00016_1"><span><span class="NLM_string-ref">Davis, J. B.; Gray, J.; Gunthrope, M. J.; Hatcher, J. P.; Davey, P. T.; Overend, P.; Harries, M. H.; Latcham, J.; Clapham, C.; Atkinson, K.; Hughes, S. A.; Rance, K.; Grau, E.; Harper, A. J.; Pugh, P. L.; Rogers, D. C.; Bingham, S.; Randall, A.; Sheardown, S. A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. <i>  Nature</i><b>2000</b>, <i>405</i>, 183−187.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=187&author=J.+B.+Davis&author=J.+Gray&author=M.+J.+Gunthrope&author=J.+P.+Hatcher&author=P.+T.+Davey&author=P.+Overend&author=M.+H.+Harries&author=J.+Latcham&author=C.+Clapham&author=K.+Atkinson&author=S.+A.+Hughes&author=K.+Rance&author=E.+Grau&author=A.+J.+Harper&author=P.+L.+Pugh&author=D.+C.+Rogers&author=S.+Bingham&author=A.+Randall&author=S.+A+Sheardown&title=Vanilloid+receptor-1+is+essential+for+inflammatory+thermal+hyperalgesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DJ.%2BB.%26atitle%3DVanilloid%2520receptor-1%2520is%2520essential%2520for%2520inflammatory%2520thermal%2520hyperalgesia%26jtitle%3DNature%26date%3D2000%26volume%3D405%26spage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm060065yb00017_1"><span><span class="NLM_string-ref">Walpole, C. S. J.; Bevan, S.; Bovermann, G.; Boelsterli, J. J.; Breckenridge, R.; Davies, J. W.; Hughes, G. A.; James, I. F.; Oberer, L.; Winter, J.; Wrigglesworth, R. The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. <i>  J. </i><i>Med. Chem</i>. <b>1994</b>, <i>37</i>, 1942−1954.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1954&author=C.+S.+J.+Walpole&author=S.+Bevan&author=G.+Bovermann&author=J.+J.+Boelsterli&author=R.+Breckenridge&author=J.+W.+Davies&author=G.+A.+Hughes&author=I.+F.+James&author=L.+Oberer&author=J.+Winter&author=R+Wrigglesworth&title=The+discovery+of+capsazepine%2C+the+first+competitive+antagonist+of+the+sensory+neuron+excitants+capsaicin+and+resiniferatoxin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalpole%26aufirst%3DC.%2BS.%2BJ.%26atitle%3DThe%2520discovery%2520of%2520capsazepine%252C%2520the%2520first%2520competitive%2520antagonist%2520of%2520the%2520sensory%2520neuron%2520excitants%2520capsaicin%2520and%2520resiniferatoxin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm060065yb00018_1"><span><span class="NLM_string-ref">Kwak, J. Y.; Jung, J. Y.; Hwang, S. W.; Lee, W. T.; Oh. U. A capsaicin-receptor antagonist, capsazepine, reduces inflammation-induced hyperalgesic responses in the rat:  Evidence for an endogenous capsaicin-like substance. <i>  Neuroscience</i><b>1998</b>, <i>86</i>, 619−626.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1998&pages=626&author=J.+Y.+Kwak&author=J.+Y.+Jung&author=S.+W.+Hwang&author=W.+T.+Lee&author=U+Oh&title=A+capsaicin-receptor+antagonist%2C+capsazepine%2C+reduces+inflammation-induced+hyperalgesic+responses+in+the+rat%3A%E2%80%89+Evidence+for+an+endogenous+capsaicin-like+substance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DJ.%2BY.%26atitle%3DA%2520capsaicin-receptor%2520antagonist%252C%2520capsazepine%252C%2520reduces%2520inflammation-induced%2520hyperalgesic%2520responses%2520in%2520the%2520rat%253A%25E2%2580%2589%2520Evidence%2520for%2520an%2520endogenous%2520capsaicin-like%2520substance%26jtitle%3DNeuroscience%26date%3D1998%26volume%3D86%26spage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm060065yb00019_1"><span><span class="NLM_string-ref">Santos, A. R. S.; Calixto, J. B. Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice. <i>  Neurosci. Lett</i>. <b>1997</b>, <i>235</i>, 73−76.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1997&pages=76&author=A.+R.+S.+Santos&author=J.+B+Calixto&title=Ruthenium+red+and+capsazepine+antinociceptive+effect+in+formalin+and+capsaicin+models+of+pain+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DA.%2BR.%2BS.%26atitle%3DRuthenium%2520red%2520and%2520capsazepine%2520antinociceptive%2520effect%2520in%2520formalin%2520and%2520capsaicin%2520models%2520of%2520pain%2520in%2520mice%26jtitle%3DNeurosci.%2520Lett.%26date%3D1997%26volume%3D235%26spage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00020"><div class="reference"><div class="NLM_citation" id="jm060065yb00020_1"><span><span class="NLM_string-ref">Walker, K. M.; Urban, L.; Medhurst, S. J.; Patel, S.; Panesar, M.; Fox, A. J.; McIntyre, P. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and meuropathic pain. <i>  J. </i><i>Pharmacol. Exp. Ther</i>. <b>2003</b>, <i>304</i>, 56−62.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=62&author=K.+M.+Walker&author=L.+Urban&author=S.+J.+Medhurst&author=S.+Patel&author=M.+Panesar&author=A.+J.+Fox&author=P+McIntyre&title=The+VR1+antagonist+capsazepine+reverses+mechanical+hyperalgesia+in+models+of+inflammatory+and+meuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DK.%2BM.%26atitle%3DThe%2520VR1%2520antagonist%2520capsazepine%2520reverses%2520mechanical%2520hyperalgesia%2520in%2520models%2520of%2520inflammatory%2520and%2520meuropathic%2520pain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26spage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm060065yb00021_1"><span><span class="NLM_string-ref">Docherty, R. J.; Yeats, J. C.; Piper, A. S. Capsazepine block of voltage-gated calcium channels in adult rat dorsal root ganglion neurons in culture. <i>  Br. J. </i><i>Pharmacol.</i><b>1997</b>, <i>121</i>, 1461−1467.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1997&pages=1467&author=R.+J.+Docherty&author=J.+C.+Yeats&author=A.+S+Piper&title=Capsazepine+block+of+voltage-gated+calcium+channels+in+adult+rat+dorsal+root+ganglion+neurons+in+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDocherty%26aufirst%3DR.%2BJ.%26atitle%3DCapsazepine%2520block%2520of%2520voltage-gated%2520calcium%2520channels%2520in%2520adult%2520rat%2520dorsal%2520root%2520ganglion%2520neurons%2520in%2520culture%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D121%26spage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm060065yb00022_1"><span><span class="NLM_string-ref">Liu, L.; Simon, S. A. Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia. <i>  Neurosci. Lett</i>. <b>1997</b>, <i>228</i>, 29−32.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=1997&pages=32&author=L.+Liu&author=S.+A+Simon&title=Capsazepine%2C+a+vanilloid+receptor+antagonist%2C+inhibits+nicotinic+acetylcholine+receptors+in+rat+trigeminal+ganglia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DCapsazepine%252C%2520a%2520vanilloid%2520receptor%2520antagonist%252C%2520inhibits%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520rat%2520trigeminal%2520ganglia%26jtitle%3DNeurosci.%2520Lett.%26date%3D1997%26volume%3D228%26spage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm060065yb00023_1"><span><span class="NLM_string-ref">Rami, K. H.; Gunthorpe, M. J. The therapeutic potential of TRPV1 (VR1) antagonists:  Clinical answers await. <i>  Drug </i><i>Discuss.</i><i> Today:  Ther. Strategies</i><b>2004</b>, <i>1</i>, 97−104.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=K.+H.+Rami&author=M.+J.+Gunthorpe&title=The+therapeutic+potential+of+TRPV1+%28VR1%29+antagonists%3A%E2%80%89+Clinical+answers+await.+Drug+Discuss.+Today%3A%E2%80%89+Ther.+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRami%26aufirst%3DK.%2BH.%26btitle%3DThe%2520therapeutic%2520potential%2520of%2520TRPV1%2520%2528VR1%2529%2520antagonists%253A%25E2%2580%2589%2520Clinical%2520answers%2520await.%2520Drug%2520Discuss.%2520Today%253A%25E2%2580%2589%2520Ther.%2520Strategies%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm060065yb00024_1"><span><span class="NLM_string-ref">Szallasi, A.; Appendino, G. Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse? <i>J. Med. </i><i>Chem. </i><b>2004</b>, <i>47</i>, 2717−2723.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2723&author=A.+Szallasi&author=G+Appendino&title=Vanilloid+receptor+TRPV1+antagonists+as+the+next+generation+of+painkillers.+Are+we+putting+the+cart+before+the+horse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26atitle%3DVanilloid%2520receptor%2520TRPV1%2520antagonists%2520as%2520the%2520next%2520generation%2520of%2520painkillers.%2520Are%2520we%2520putting%2520the%2520cart%2520before%2520the%2520horse%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00025"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00025'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="jm060065yb00025_1"><span><span class="NLM_string-ref">Planellls-Cases R.; Garcia-Martinez, C.; Royo, M.; Perez-Paya, E.; Carreno, C.; Albericio, F.; Messeguer, A.; Ferrer-Montiel, A. Small molecules targeting the vanilloid receptor complex as drugs for inflammatory pain. <i>  Drugs Future </i><b>2003</b>, <i>28</i>, 787−795.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=795&author=R.+Planellls-Cases&author=C.+Garcia-Martinez&author=M.+Royo&author=E.+Perez-Paya&author=C.+Carreno&author=F.+Albericio&author=A.+Messeguer&author=A+Ferrer-Montiel&title=Small+molecules+targeting+the+vanilloid+receptor+complex+as+drugs+for+inflammatory+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlanellls-Cases%26aufirst%3DR.%26atitle%3DSmall%2520molecules%2520targeting%2520the%2520vanilloid%2520receptor%2520complex%2520as%2520drugs%2520for%2520inflammatory%2520pain%26jtitle%3DDrugs%2520Future%26date%3D2003%26volume%3D28%26spage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00026"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00026'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="jm060065yb00026_1"><span><span class="NLM_string-ref">Lopez-Rodriguez, M.; Viso, A.; Ortega-Gutierrez, S. VR1 receptor modulators as potential drugs for neuropatic pain. <i>  Mini Rev. Med. Chem. </i><b>2003</b>, <i>3</i>, 729−748.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=748&author=M.+Lopez-Rodriguez&author=A.+Viso&author=S.+Ortega-Gutierrez&title=receptor+modulators+as+potential+drugs+for+neuropatic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%26atitle%3Dreceptor%2520modulators%2520as%2520potential%2520drugs%2520for%2520neuropatic%2520pain%26jtitle%3DMini%2520Rev.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00027"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00027'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="jm060065yb00027_1"><span><span class="NLM_string-ref">McDonnell, M. E.; Zhang. S.-P.; Nasser, N.; Dubin, A. E.; Dax, S. L. 7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1. <i>  Bioorg. Med. Chem. Lett</i>. <b>2004</b>, <i>14</i>, 531−534.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=534&author=M.+E.+McDonnell&author=S.-P.+Zhang&author=N.+Nasser&author=A.+E.+Dubin&author=S.+L.+Dax&author=+Hydroxynaphthalen&title=and+-amide+antagonists+of+human+vanilloid+receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonnell%26aufirst%3DM.%2BE.%26atitle%3Dand%2520-amide%2520antagonists%2520of%2520human%2520vanilloid%2520receptor%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00028"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00028'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="jm060065yb00028_1"><span><span class="NLM_string-ref">Rami, H. R.; Thompson, M.; Wyman, P.; Jerman, J. C.; Egerton, J.; Brough, S.; Stevens, A. J.; Randall, A. D.; Smart, D.; Gunthorpe, M. J.; Davis, J. B. Discovery of small molecule antagonists of TRPV1.<i> Bioorg. Med. Chem. </i><i>Lett</i>. <b>2004</b>, <i>14</i>, 3631−3634.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3634&author=H.+R.+Rami&author=M.+Thompson&author=P.+Wyman&author=J.+C.+Jerman&author=J.+Egerton&author=S.+Brough&author=A.+J.+Stevens&author=A.+D.+Randall&author=D.+Smart&author=M.+J.+Gunthorpe&author=J.+B+Davis&title=Discovery+of+small+molecule+antagonists+of+TRPV1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRami%26aufirst%3DH.%2BR.%26atitle%3DDiscovery%2520of%2520small%2520molecule%2520antagonists%2520of%2520TRPV1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00029"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00029'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="jm060065yb00029_1"><span><span class="NLM_string-ref">Lee, J.; Kang, S. U.; Lim, J.-O.; Choi, H.-K.; Jin, M.-K.; Toth, A.; Pearce, L. V.; Tran, R.; Wang, Y.; Szabo, T.; Blumberg, P. M. <i>  N</i>-[4-(Methylsulfonylamino)benzyl]thiourea analogs as vanilloid receptor antagonists:  Analysis of structure−activity relationships for the “C-region”. <i>Bioorg</i>. <i>Med. Chem</i>. <b>2004</b>, <i>12</i>, 371−385.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Lee%2C+J.%3B+Kang%2C+S.+U.%3B+Lim%2C+J.-O.%3B+Choi%2C+H.-K.%3B+Jin%2C+M.-K.%3B+Toth%2C+A.%3B+Pearce%2C+L.+V.%3B+Tran%2C+R.%3B+Wang%2C+Y.%3B+Szabo%2C+T.%3B+Blumberg%2C+P.+M.+N-%5B4-%28Methylsulfonylamino%29benzyl%5Dthiourea+analogs+as+vanilloid+receptor+antagonists%3A%E2%80%89+Analysis+of+structure%E2%88%92activity+relationships+for+the+%E2%80%9CC-region%E2%80%9D.+Bioorg.+Med.+Chem.+2004%2C+12%2C+371%E2%88%92385.+Lee%2C+J.%3B+Kang%2C+S.+U.%3B+Lim%2C+J.-O.%3B+Choi%2C+H.-K.%3B+Jin%2C+M.-K.%3B+Toth%2C+A.%3B+Pearce%2C+L.+V.%3B+Tran%2C+R.%3B+Wang%2C+Y.%3B+Szabo%2C+T.%3B+Blumberg%2C+P.+M.+N-%5B4-%28Methylsulfonylamino%29benzyl%5Dthiourea+analogs+as+vanilloid+receptor+antagonists%3A%E2%80%89+Analysis+of+structure%E2%88%92activity+relationships+for+the+%E2%80%9CC-region%E2%80%9D.+Bioorg.+Med.+Chem.+2004%2C+12%2C+371%E2%88%92385."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00030"><div class="reference"><div class="NLM_citation" id="jm060065yb00030_1"><span><span class="NLM_string-ref">Sun, Q.; Tafesse, L.; Islam, K.; Zhou, X.; Victory, S. F.; Zhang, C.; Hachicha, M.; Schmid, L. A.; Patel, A.; Rotshteyn, Y.; Valenzano, K. J.; Kyle, D. J. 4-(2-Pyridyl)piperazine-1-carboxamides:  Potent vanilloid receptor 1 antagonists. <i>  Bioorg. Med. Chem. Lett.</i><b> 2003</b>, <i>13</i>, 3611−3616.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3616&author=Q.+Sun&author=L.+Tafesse&author=K.+Islam&author=X.+Zhou&author=S.+F.+Victory&author=C.+Zhang&author=M.+Hachicha&author=L.+A.+Schmid&author=A.+Patel&author=Y.+Rotshteyn&author=K.+J.+Valenzano&author=D.+J.+Kyle&author=+Pyridyl&title=Potent+vanilloid+receptor+1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DQ.%26atitle%3DPotent%2520vanilloid%2520receptor%25201%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00031"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00031'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="jm060065yb00031_1"><span><span class="NLM_string-ref">Bakthavatchalam, R. Capsaicin receptor ligands. WO 0208221-A1, 2002.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=R.+Bakthavatchalam&title=Capsaicin+receptor+ligands.+WO+0208221-A1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBakthavatchalam%26aufirst%3DR.%26btitle%3DCapsaicin%2520receptor%2520ligands.%2520WO%25200208221-A1%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00032"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00032'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="jm060065yb00032_1"><span><span class="NLM_string-ref">Dax, S.; Dublin, A.; Jetter, M.; Nasser, N.; Shah, C.; Swanson, D.; Carruthers, N. I. Vanilloid receptor antagonists:  Structure−activity relationships via parallel and targeted synthesis. <i>  Drugs Future</i><b>2002</b>, <i>27</i> (Suppl. A), 93.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27+%28Suppl.+A&publication_year=2002&pages=93&author=S.+Dax&author=A.+Dublin&author=M.+Jetter&author=N.+Nasser&author=C.+Shah&author=D.+Swanson&author=N.+I+Carruthers&title=Vanilloid+receptor+antagonists%3A%E2%80%89+Structure%E2%88%92activity+relationships+via+parallel+and+targeted+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDax%26aufirst%3DS.%26atitle%3DVanilloid%2520receptor%2520antagonists%253A%25E2%2580%2589%2520Structure%25E2%2588%2592activity%2520relationships%2520via%2520parallel%2520and%2520targeted%2520synthesis%26jtitle%3DDrugs%2520Future%26date%3D2002%26volume%3D27%2520%2528Suppl.%2520A%26spage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00033"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00033'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="jm060065yb00033_1"><span><span class="NLM_string-ref">Yura, T.; Mogi, M.; Ikegami, Y.; Masuda, T.; Kokubo, T.; Urbahns, K.; Yoshida, N.; Marumo, M.; Shiroo, M.; Tajimi, M.; Takeshita, K.; Moriwaki, T.; Tsukumi, Y. Piperazinecarboxamide derivative. JP 2003192673-A2, 2003.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=192673-1926A2&author=T.+Yura&author=M.+Mogi&author=Y.+Ikegami&author=T.+Masuda&author=T.+Kokubo&author=K.+Urbahns&author=N.+Yoshida&author=M.+Marumo&author=M.+Shiroo&author=M.+Tajimi&author=K.+Takeshita&author=T.+Moriwaki&author=Y+Tsukumi&title=Piperazinecarboxamide+derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYura%26aufirst%3DT.%26atitle%3DPiperazinecarboxamide%2520derivative%26jtitle%3DJP%26date%3D2003%26spage%3D192673%26epage%3D1926A2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00034"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00034'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="jm060065yb00034_1"><span><span class="NLM_string-ref">Rami, H. K.; Thompson, M.; Macdonald, G. J. Westaway, S. M.; Mitchell, D. J. Vanilloid receptor modulators. WO 03068749-A1, 2003.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=H.+K.+Rami&author=M.+Thompson&author=G.+J.+Macdonald&author=S.+M.+Westaway&author=D.+J.+Mitchell&title=Vanilloid+receptor+modulators.+WO+03068749-A1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRami%26aufirst%3DH.%2BK.%26btitle%3DVanilloid%2520receptor%2520modulators.%2520WO%252003068749-A1%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00035"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00035'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="jm060065yb00035_1"><span><span class="NLM_string-ref">Lee, C.-H.; Bayburt, E. K.; Didomenico, S., Jr.; Drizin, I.; Gomtsyan, A. R.; Koenig, J. R.; Perner, R, J.; Schmidt, R, G.; Turner, S. C.; White, T. K.; Zheng, G. Z. Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor. WO 03070247, 2003.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=C.-H.+Lee&author=E.+K.+Bayburt&author=S.+Didomenico&author=+Jr&author=A.+R.+Gomtsyan&author=J.+R.+Koenig&author=R%2C+J+Perner&author=R%2C+G+Schmidt&author=S.+C.+Turner&author=T.+K.+White&author=G.+Z.+Zheng&title=Fused+azabicyclic+compounds+that+inhibit+vanilloid+receptor+subtype+1+%28VR1%29+receptor.+WO+03070247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.-H.%26btitle%3DFused%2520azabicyclic%2520compounds%2520that%2520inhibit%2520vanilloid%2520receptor%2520subtype%25201%2520%2528VR1%2529%2520receptor.%2520WO%252003070247%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00036"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00036'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="jm060065yb00036_1"><span><span class="NLM_string-ref">Tafesse, L.; Sun, Q.; Schmid, L.; Valenzano, K. J.; Rotshteyn, Y.; Su, Xi, Su.; Kyle, D. Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonists. <i>  Bioorg. Med. Chem. Lett</i>. <b>2004</b>, <i>14</i>, 5513−5519.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5519&author=L.+Tafesse&author=Q.+Sun&author=L.+Schmid&author=K.+J.+Valenzano&author=Y.+Rotshteyn&author=+Su&author=+Su&title=Synthesis+and+evaluation+of+pyridazinylpiperazines+as+vanilloid+receptor+1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTafesse%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520pyridazinylpiperazines%2520as%2520vanilloid%2520receptor%25201%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00037"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00037'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="jm060065yb00037_1"><span><span class="NLM_string-ref">Chen, J. J.; Zhang, Y.; Hammond, S.; Dewdney, N.; Ho, T.; Lin, X.; Browner, M. F.; Castelhano, A. L. Design, synthesis, activity, and structure of a novel class of matrix metalloproteinase inhibitors containing a heterocyclic P2‘-P3‘ amide bond isostere. <i>  Bioorg. Med. Chem. Lett</i>. <b>1996</b>, <i>6</i>, 1601−1606.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=1606&author=J.+J.+Chen&author=Y.+Zhang&author=S.+Hammond&author=N.+Dewdney&author=T.+Ho&author=X.+Lin&author=M.+F.+Browner&author=A.+L.+Castelhano&author=+Design&title=and+structure+of+a+novel+class+of+matrix+metalloproteinase+inhibitors+containing+a+heterocyclic+P2%E2%80%98-P3%E2%80%98+amide+bond+isostere"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26atitle%3Dand%2520structure%2520of%2520a%2520novel%2520class%2520of%2520matrix%2520metalloproteinase%2520inhibitors%2520containing%2520a%2520heterocyclic%2520P2%25E2%2580%2598-P3%25E2%2580%2598%2520amide%2520bond%2520isostere%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D1606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00038"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00038'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="jm060065yb00038_1"><span><span class="NLM_string-ref">Balan, C.; Bo, Y.; Dominguez, C.; Fotsch, C.; Gore, V. K.; Ma, V. V.; Norman, M. H.; Ognyanov, V. I.; Qian, Y.; Wang, X.; Xi, N.; Xu, S. Benzimidazole derivatives and their use as vanilloid receptor ligands. WO 04035549-A1, 2004.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=C.+Balan&author=Y.+Bo&author=C.+Dominguez&author=C.+Fotsch&author=V.+K.+Gore&author=V.+V.+Ma&author=M.+H.+Norman&author=V.+I.+Ognyanov&author=Y.+Qian&author=X.+Wang&author=N.+Xi&author=S.+Xu&title=Benzimidazole+derivatives+and+their+use+as+vanilloid+receptor+ligands.+WO+04035549-A1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBalan%26aufirst%3DC.%26btitle%3DBenzimidazole%2520derivatives%2520and%2520their%2520use%2520as%2520vanilloid%2520receptor%2520ligands.%2520WO%252004035549-A1%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00039"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00039'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="jm060065yb00039_1"><span><span class="NLM_string-ref">After our disclosure, Purdue Pharma published a patent application [(a) Sun, Q.; Tafesse, L.; Victory, S. Benzoazolylpiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity. WO 04058754-A1, 2004.] and a short communication [(b) Shao, B.; Huang, J.; Sun, Q.; Valenzano, K. J.; Schmid, L.; Scott Nolan, S. 4-(2-Pyridyl)piperazine-1-benzimidazoles as potent TRPV1 antagonists. <i>  Bioorg. Med. Chem</i>. <i>Lett.</i><b>2005</b>, <i>15</i>, 719−723.] describing the same type of benzimidazole template.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=+After&title=Q."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAfter%26atitle%3DPurdue%2520Pharma%2520published%2520a%2520patent%2520application%2520%255B%2528a%2529%2520Sun%26btitle%3DQ.%26date%3D2004%26pub%3DLett" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00040"><div class="reference"><div class="NLM_citation" id="jm060065yb00040_1"><span><span class="NLM_string-ref">Koch, V.; Schnatterer, S. Chemistry of 3-hydroxypyridine part 2:  Synthesis of 5,6-dihalo-3-hydroxypyridines. <i>  Synthesis</i><b>1990</b>, 499−501.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=499&publication_year=1990&pages=501&author=V.+Koch&author=S+Schnatterer&title=Chemistry+of+3-hydroxypyridine+part+2%3A%E2%80%89+Synthesis+of+5%2C6-dihalo-3-hydroxypyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00040_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DV.%26atitle%3DChemistry%2520of%25203-hydroxypyridine%2520part%25202%253A%25E2%2580%2589%2520Synthesis%2520of%25205%252C6-dihalo-3-hydroxypyridines%26jtitle%3DSynthesis%26date%3D1990%26volume%3D499%26spage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00041"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00041'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="jm060065yb00041_1"><span><span class="NLM_string-ref">VanRheenen, V.; Kelly, R. C.; Cha, D. Y. An improved catalytic oxidation of olefins to <i>cis</i>-1,2-glycols using tertiary amine oxides as the oxidant. <i>  Tetrahedron Lett</i>. <b>1976</b>, <i>23</i>, 1973−1976.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1976&pages=1976&author=V.+VanRheenen&author=R.+C.+Kelly&author=D.+Y+Cha&title=An+improved+catalytic+oxidation+of+olefins+to+cis-1%2C2-glycols+using+tertiary+amine+oxides+as+the+oxidant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00041_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVanRheenen%26aufirst%3DV.%26atitle%3DAn%2520improved%2520catalytic%2520oxidation%2520of%2520olefins%2520to%2520cis-1%252C2-glycols%2520using%2520tertiary%2520amine%2520oxides%2520as%2520the%2520oxidant%26jtitle%3DTetrahedron%2520Lett.%26date%3D1976%26volume%3D23%26spage%3D1976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00042"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00042'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="jm060065yb00042_1"><span><span class="NLM_string-ref">Chesterfield, J.; McOmie, J. F. W.; Sayer, E. R. Pyrimidines. Part VIII. Halogeno- and hydrazino-pyrimidines. <i>  J. Chem. Soc. </i>(Resumed) <b>1955</b>, 3478−3481.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3478&publication_year=1955&pages=3481&author=J.+Chesterfield&author=J.+F.+W.+McOmie&author=E.+R.+Sayer&author=VIII+Pyrimidines&title=Halogeno-+and+hydrazino-pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00042_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChesterfield%26aufirst%3DJ.%26atitle%3DHalogeno-%2520and%2520hydrazino-pyrimidines%26jtitle%3DJ.%2520Chem.%2520Soc.%2520%2528Resumed%2529%26date%3D1955%26volume%3D3478%26spage%3D3481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00043"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00043'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="jm060065yb00043_1"><span><span class="NLM_string-ref">Jaisinghani, H. G.; Khadilkar, B. M. Rapid and efficient synthesis of 1-arylpiperazines under microwave irradiation. <i>  Tetrahedron Lett.</i><b>1997</b>, <i>38</i>, 6875−6876.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=6876&author=H.+G.+Jaisinghani&author=B.+M+Khadilkar&title=Rapid+and+efficient+synthesis+of+1-arylpiperazines+under+microwave+irradiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00043_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaisinghani%26aufirst%3DH.%2BG.%26atitle%3DRapid%2520and%2520efficient%2520synthesis%2520of%25201-arylpiperazines%2520under%2520microwave%2520irradiation%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26spage%3D6876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00044"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00044'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="jm060065yb00044_1"><span><span class="NLM_string-ref">All compounds were tested in a separate assay for agonist activity.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+All+compounds+were+tested+in+a+separate+assay+for+agonist+activity.+All+compounds+were+tested+in+a+separate+assay+for+agonist+activity."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00044_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm060065yb00045"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm060065yb00045'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="jm060065yb00045_1"><span><span class="NLM_string-ref">This result showing that the trifluoromethyl group is the most preferable substituent at position 3‘ of the pyridine ring is consistent with that reported in ref 39b by Purdue Pharma researchers.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+This+result+showing+that+the+trifluoromethyl+group+is+the+most+preferable+substituent+at+position+3%E2%80%98+of+the+pyridine+ring+is+consistent+with+that+reported+in+ref+39b+by+Purdue+Pharma+researchers.+This+result+showing+that+the+trifluoromethyl+group+is+the+most+preferable+substituent+at+position+3%E2%80%98+of+the+pyridine+ring+is+consistent+with+that+reported+in+ref+39b+by+Purdue+Pharma+researchers."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00045_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm060065yb00001':['jm060065yb00001_1'],'jm060065yb00002':['jm060065yb00002_1'],'jm060065yb00003':['jm060065yb00003_1'],'jm060065yb00004':['jm060065yb00004_1'],'jm060065yb00005':['jm060065yb00005_1'],'jm060065yb00006':['jm060065yb00006_1'],'jm060065yb00007':['jm060065yb00007_1'],'jm060065yb00008':['jm060065yb00008_1'],'jm060065yb00009':['jm060065yb00009_1'],'jm060065yb00010':['jm060065yb00010_1'],'jm060065yb00011':['jm060065yb00011_1'],'jm060065yb00012':['jm060065yb00012_1'],'jm060065yb00013':['jm060065yb00013_1'],'jm060065yb00014':['jm060065yb00014_1'],'jm060065yb00015':['jm060065yb00015_1'],'jm060065yb00016':['jm060065yb00016_1'],'jm060065yb00017':['jm060065yb00017_1'],'jm060065yb00018':['jm060065yb00018_1'],'jm060065yb00019':['jm060065yb00019_1'],'jm060065yb00020':['jm060065yb00020_1'],'jm060065yb00021':['jm060065yb00021_1'],'jm060065yb00022':['jm060065yb00022_1'],'jm060065yb00023':['jm060065yb00023_1'],'jm060065yb00024':['jm060065yb00024_1'],'jm060065yb00025':['jm060065yb00025_1'],'jm060065yb00026':['jm060065yb00026_1'],'jm060065yb00027':['jm060065yb00027_1'],'jm060065yb00028':['jm060065yb00028_1'],'jm060065yb00029':['jm060065yb00029_1'],'jm060065yb00030':['jm060065yb00030_1'],'jm060065yb00031':['jm060065yb00031_1'],'jm060065yb00032':['jm060065yb00032_1'],'jm060065yb00033':['jm060065yb00033_1'],'jm060065yb00034':['jm060065yb00034_1'],'jm060065yb00035':['jm060065yb00035_1'],'jm060065yb00036':['jm060065yb00036_1'],'jm060065yb00037':['jm060065yb00037_1'],'jm060065yb00038':['jm060065yb00038_1'],'jm060065yb00039':['jm060065yb00039_1'],'jm060065yb00040':['jm060065yb00040_1'],'jm060065yb00041':['jm060065yb00041_1'],'jm060065yb00042':['jm060065yb00042_1'],'jm060065yb00043':['jm060065yb00043_1'],'jm060065yb00044':['jm060065yb00044_1'],'jm060065yb00045':['jm060065yb00045_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 63 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chao Qian, <span class="NLM_string-name hlFld-ContribAuthor">Wenjun Tang</span>. </span><span class="cited-content_cbyCitation_article-title">A Versatile Synthesis of Vinyl-Substituted Heterocycles via Regio- and Enantioselective Pd-Catalyzed Tandem Allylic Substitution. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (11)
                                     , 4483-4488. <a href="https://doi.org/10.1021/acs.orglett.0c01490" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01490%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BVersatile%252BSynthesis%252Bof%252BVinyl-Substituted%252BHeterocycles%252Bvia%252BRegio-%252Band%252BEnantioselective%252BPd-Catalyzed%252BTandem%252BAllylic%252BSubstitution%26aulast%3DQian%26aufirst%3DChao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29042020%26date%3D26052020%26volume%3D22%26issue%3D11%26spage%3D4483%26epage%3D4488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Uday Kiran Velagapudi, Marie-France Langelier, Cristina Delgado-Martin, Morgan E. Diolaiti, Sietske Bakker, Alan Ashworth, Bhargav A. Patel, Xuwei Shao, John M. Pascal, <span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Poly(ADP-ribose) Polymerase Inhibitors: Impact of Adenosine Pocket-Binding Motif Appendage to the 3-Oxo-2,3-dihydrobenzofuran-7-carboxamide on Potency and Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (11)
                                     , 5330-5357. <a href="https://doi.org/10.1021/acs.jmedchem.8b01709" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01709%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BPoly%252528ADP-ribose%252529%252BPolymerase%252BInhibitors%25253A%252BImpact%252Bof%252BAdenosine%252BPocket-Binding%252BMotif%252BAppendage%252Bto%252Bthe%252B3-Oxo-2%25252C3-dihydrobenzofuran-7-carboxamide%252Bon%252BPotency%252Band%252BSelectivity%26aulast%3DVelagapudi%26aufirst%3DUday%2BKiran%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D01112018%26date%3D24052019%26date%3D01052019%26volume%3D62%26issue%3D11%26spage%3D5330%26epage%3D5357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert J. Moreau, Colin K. Skepper, Brent A. Appleton, Anke Blechschmidt, Carl J. Balibar, Bret M. Benton, Joseph E. Drumm, III, Brian Y. Feng, Mei Geng, Cindy Li, Mika K. Lindvall, Andreas Lingel, Yipin Lu, Mulugeta Mamo, Wosenu Mergo, Valery Polyakov, Thomas M. Smith, Kenneth Takeoka, Kyoko Uehara, Lisha Wang, Jun-Rong Wei, Andrew H. Weiss, Lili Xie, Wenjian Xu, Qiong Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Javier de Vicente</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3309-3324. <a href="https://doi.org/10.1021/acs.jmedchem.7b01691" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01691</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01691%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BDrug%252BDiscovery%252Bof%252BInhibitors%252Bof%252BPhosphopantetheine%252BAdenylyltransferase%252Bfrom%252BGram-Negative%252BBacteria%26aulast%3DMoreau%26aufirst%3DRobert%2BJ.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D15122017%26date%3D09042018%26date%3D02032018%26volume%3D61%26issue%3D8%26spage%3D3309%26epage%3D3324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James D.  Firth</span>, <span class="hlFld-ContribAuthor ">Peter  O’Brien</span>, and <span class="hlFld-ContribAuthor ">Leigh  Ferris</span>  . </span><span class="cited-content_cbyCitation_article-title">General Procedures for the Lithiation/Trapping of N-Boc Piperazines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (13)
                                     , 7023-7031. <a href="https://doi.org/10.1021/acs.joc.7b00913" title="DOI URL">https://doi.org/10.1021/acs.joc.7b00913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b00913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b00913%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DGeneral%252BProcedures%252Bfor%252Bthe%252BLithiation%25252FTrapping%252Bof%252BN-Boc%252BPiperazines%26aulast%3DFirth%26aufirst%3DJames%2BD.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D16042017%26date%3D20062017%26date%3D07072017%26date%3D02062017%26volume%3D82%26issue%3D13%26spage%3D7023%26epage%3D7031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James D.  Firth</span>, <span class="hlFld-ContribAuthor ">Peter  O’Brien</span>, and <span class="hlFld-ContribAuthor ">Leigh  Ferris</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Enantiopure Piperazines via Asymmetric Lithiation–Trapping of N-Boc Piperazines: Unexpected Role of the Electrophile and Distal N-Substituent. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2016,</strong> <em>138 </em>
                                    (2)
                                     , 651-659. <a href="https://doi.org/10.1021/jacs.5b11288" title="DOI URL">https://doi.org/10.1021/jacs.5b11288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.5b11288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.5b11288%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSynthesis%252Bof%252BEnantiopure%252BPiperazines%252Bvia%252BAsymmetric%252BLithiation%2525E2%252580%252593Trapping%252Bof%252BN-Boc%252BPiperazines%25253A%252BUnexpected%252BRole%252Bof%252Bthe%252BElectrophile%252Band%252BDistal%252BN-Substituent%26aulast%3DFirth%26aufirst%3DJames%2BD.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D28102015%26date%3D31122015%26date%3D20012016%26date%3D18122015%26volume%3D138%26issue%3D2%26spage%3D651%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Chi</span>, <span class="hlFld-ContribAuthor ">Wen-Xiong  Zhang</span>, and <span class="hlFld-ContribAuthor ">Zhenfeng  Xi</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxidant-Switchable Selective Synthesis of 2-Aminobenzimidazoles via C–H Amination/Acetoxylation of Guanidines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (24)
                                     , 6274-6277. <a href="https://doi.org/10.1021/ol502815p" title="DOI URL">https://doi.org/10.1021/ol502815p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol502815p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol502815p%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DOxidant-Switchable%252BSelective%252BSynthesis%252Bof%252B2-Aminobenzimidazoles%252Bvia%252BC%2525E2%252580%252593H%252BAmination%25252FAcetoxylation%252Bof%252BGuanidines%26aulast%3DChi%26aufirst%3DYue%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D23092014%26date%3D04122014%26date%3D19122014%26volume%3D16%26issue%3D24%26spage%3D6274%26epage%3D6277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laykea  Tafesse</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Kanemasa</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Kurose</span>, <span class="hlFld-ContribAuthor ">Jianming  Yu</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Asaki</span>, <span class="hlFld-ContribAuthor ">Gang  Wu</span>, <span class="hlFld-ContribAuthor ">Yuka  Iwamoto</span>, <span class="hlFld-ContribAuthor ">Yoshitaka  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Chiyou  Ni</span>, <span class="hlFld-ContribAuthor ">John  Engel</span>, <span class="hlFld-ContribAuthor ">Naoki  Tsuno</span>, <span class="hlFld-ContribAuthor ">Aniket  Patel</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Zhou</span>, <span class="hlFld-ContribAuthor ">Takuya  Shintani</span>, <span class="hlFld-ContribAuthor ">Kevin  Brown</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Manjunath  Shet</span>, <span class="hlFld-ContribAuthor ">Yasuyoshi  Iso</span>, <span class="hlFld-ContribAuthor ">Akira  Kato</span>, and <span class="hlFld-ContribAuthor ">Donald J.  Kyle</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship Studies and Discovery of a Potent Transient Receptor Potential Vanilloid (TRPV1) Antagonist 4-[3-Chloro-5-[(1S)-1,2-dihydroxyethyl]-2-pyridyl]-N-[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2H-pyridine-1-carboxamide (V116517) as a Clinical Candidate for Pain Management. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (15)
                                     , 6781-6794. <a href="https://doi.org/10.1021/jm500818a" title="DOI URL">https://doi.org/10.1021/jm500818a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500818a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500818a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%252Band%252BDiscovery%252Bof%252Ba%252BPotent%252BTransient%252BReceptor%252BPotential%252BVanilloid%252B%252528TRPV1%252529%252BAntagonist%252B4-%25255B3-Chloro-5-%25255B%2525281S%252529-1%25252C2-dihydroxyethyl%25255D-2-pyridyl%25255D-N-%25255B5-%252528trifluoromethyl%252529-2-pyridyl%25255D-3%25252C6-dihydro-2H-pyridine-1-carboxamide%252B%252528V116517%252529%252Bas%252Ba%252BClinical%252BCandidate%252Bfor%252BPain%252BManagement%26aulast%3DTafesse%26aufirst%3DLaykea%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D28052014%26date%3D01082014%26date%3D14082014%26date%3D24072014%26volume%3D57%26issue%3D15%26spage%3D6781%26epage%3D6794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Indrajeet J.  Barve</span>, <span class="hlFld-ContribAuthor ">Chih-Hau  Chen</span>, <span class="hlFld-ContribAuthor ">Chih-Hsien  Kao</span>, and <span class="hlFld-ContribAuthor ">Chung-Ming  Sun</span>  . </span><span class="cited-content_cbyCitation_article-title">Regioselective Piperidine-Catalyzed Tandem Imination–Isocyanate Annulation to Fused Tricyclic Triazines. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2014,</strong> <em>16 </em>
                                    (5)
                                     , 244-249. <a href="https://doi.org/10.1021/co400159z" title="DOI URL">https://doi.org/10.1021/co400159z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/co400159z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fco400159z%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DRegioselective%252BPiperidine-Catalyzed%252BTandem%252BImination%2525E2%252580%252593Isocyanate%252BAnnulation%252Bto%252BFused%252BTricyclic%252BTriazines%26aulast%3DBarve%26aufirst%3DIndrajeet%2BJ.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D2014%26date%3D10122013%26date%3D09032014%26date%3D28032014%26date%3D12052014%26date%3D19032014%26volume%3D16%26issue%3D5%26spage%3D244%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiguo  Feng</span>, <span class="hlFld-ContribAuthor ">Lulu  Tao</span>, and <span class="hlFld-ContribAuthor ">Zhanzhu  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of Microtubule-Stabilizing Agent Ceratamine A. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (24)
                                     , 12814-12818. <a href="https://doi.org/10.1021/jo402165n" title="DOI URL">https://doi.org/10.1021/jo402165n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo402165n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo402165n%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTotal%252BSynthesis%252Bof%252BMicrotubule-Stabilizing%252BAgent%252BCeratamine%252BA%26aulast%3DFeng%26aufirst%3DQiguo%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D08102013%26date%3D10122013%26date%3D20122013%26date%3D04122013%26volume%3D78%26issue%3D24%26spage%3D12814%26epage%3D12818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zebin  Xia</span>, <span class="hlFld-ContribAuthor ">Lulu  Farhana</span>, <span class="hlFld-ContribAuthor ">Ricardo G.  Correa</span>, <span class="hlFld-ContribAuthor ">Jayanta K.  Das</span>, <span class="hlFld-ContribAuthor ">David J.  Castro</span>, <span class="hlFld-ContribAuthor ">Jinghua  Yu</span>, <span class="hlFld-ContribAuthor ">Robert G.  Oshima</span>, <span class="hlFld-ContribAuthor ">John C.  Reed</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Fontana</span>, and <span class="hlFld-ContribAuthor ">Marcia I.  Dawson</span>  . </span><span class="cited-content_cbyCitation_article-title">Heteroatom-Substituted Analogues of Orphan Nuclear Receptor Small Heterodimer Partner Ligand and Apoptosis Inducer (E)-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic Acid. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (11)
                                     , 3793-3816. <a href="https://doi.org/10.1021/jm200051z" title="DOI URL">https://doi.org/10.1021/jm200051z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200051z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200051z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHeteroatom-Substituted%252BAnalogues%252Bof%252BOrphan%252BNuclear%252BReceptor%252BSmall%252BHeterodimer%252BPartner%252BLigand%252Band%252BApoptosis%252BInducer%252B%252528E%252529-4-%25255B3-%2525281-Adamantyl%252529-4-hydroxyphenyl%25255D-3-chlorocinnamic%252BAcid%26aulast%3DXia%26aufirst%3DZebin%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D18012011%26date%3D06052011%26date%3D09062011%26volume%3D54%26issue%3D11%26spage%3D3793%26epage%3D3816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prasenjit  Saha</span>, <span class="hlFld-ContribAuthor ">Tamminana  Ramana</span>, <span class="hlFld-ContribAuthor ">Nibadita  Purkait</span>, <span class="hlFld-ContribAuthor ">Md Ashif  Ali</span>, <span class="hlFld-ContribAuthor ">Rajesh  Paul</span> and <span class="hlFld-ContribAuthor ">Tharmalingam  Punniyamurthy</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-Free Copper-Catalyzed Synthesis of Substituted Benzimidazoles, 2-Aminobenzimidazoles, 2-Aminobenzothiazoles, and Benzoxazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2009,</strong> <em>74 </em>
                                    (22)
                                     , 8719-8725. <a href="https://doi.org/10.1021/jo901813g" title="DOI URL">https://doi.org/10.1021/jo901813g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo901813g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo901813g%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DLigand-Free%252BCopper-Catalyzed%252BSynthesis%252Bof%252BSubstituted%252BBenzimidazoles%25252C%252B2-Aminobenzimidazoles%25252C%252B2-Aminobenzothiazoles%25252C%252Band%252BBenzoxazoles%26aulast%3DSaha%26aufirst%3DPrasenjit%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D25082009%26date%3D20102009%26date%3D20112009%26volume%3D74%26issue%3D22%26spage%3D8719%26epage%3D8725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana  Almaşi</span>, <span class="hlFld-ContribAuthor ">Diego A.  Alonso</span>, <span class="hlFld-ContribAuthor ">Enrique  Gómez-Bengoa</span> and <span class="hlFld-ContribAuthor ">Carmen  Nájera</span>  . </span><span class="cited-content_cbyCitation_article-title">Chiral 2-Aminobenzimidazoles as Recoverable Organocatalysts for the Addition of 1,3-Dicarbonyl Compounds to Nitroalkenes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2009,</strong> <em>74 </em>
                                    (16)
                                     , 6163-6168. <a href="https://doi.org/10.1021/jo9010552" title="DOI URL">https://doi.org/10.1021/jo9010552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo9010552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo9010552%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DChiral%252B2-Aminobenzimidazoles%252Bas%252BRecoverable%252BOrganocatalysts%252Bfor%252Bthe%252BAddition%252Bof%252B1%25252C3-Dicarbonyl%252BCompounds%252Bto%252BNitroalkenes%26aulast%3DAlma%25C5%259Fi%26aufirst%3DDiana%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D20052009%26date%3D23072009%26date%3D21082009%26volume%3D74%26issue%3D16%26spage%3D6163%26epage%3D6168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaohu  Deng</span>, <span class="hlFld-ContribAuthor ">Heather  McAllister</span> and <span class="hlFld-ContribAuthor ">Neelakandha S.  Mani</span>. </span><span class="cited-content_cbyCitation_article-title">CuI-Catalyzed Amination of Arylhalides with Guanidines or Amidines: A Facile Synthesis of 1-H-2-Substituted Benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2009,</strong> <em>74 </em>
                                    (15)
                                     , 5742-5745. <a href="https://doi.org/10.1021/jo900912h" title="DOI URL">https://doi.org/10.1021/jo900912h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo900912h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo900912h%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCuI-Catalyzed%252BAmination%252Bof%252BArylhalides%252Bwith%252BGuanidines%252Bor%252BAmidines%25253A%252BA%252BFacile%252BSynthesis%252Bof%252B1-H-2-Substituted%252BBenzimidazoles%26aulast%3DDeng%26aufirst%3DXiaohu%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D01052009%26date%3D15062009%26date%3D07082009%26volume%3D74%26issue%3D15%26spage%3D5742%26epage%3D5745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ulrik S.  Sørensen</span>, <span class="hlFld-ContribAuthor ">Dorte  Strøbæk</span>, <span class="hlFld-ContribAuthor ">Palle  Christophersen</span>, <span class="hlFld-ContribAuthor ">Charlotte  Hougaard</span>, <span class="hlFld-ContribAuthor ">Marianne L.  Jensen</span>, <span class="hlFld-ContribAuthor ">Elsebet Ø.  Nielsen</span>, <span class="hlFld-ContribAuthor ">Dan  Peters</span> and <span class="hlFld-ContribAuthor ">Lene  Teuber</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure−Activity Relationship Studies of 2-(N-Substituted)-aminobenzimidazoles as Potent Negative Gating Modulators of Small Conductance Ca2+-Activated K+ Channels. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (23)
                                     , 7625-7634. <a href="https://doi.org/10.1021/jm800809f" title="DOI URL">https://doi.org/10.1021/jm800809f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm800809f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm800809f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252588%252592Activity%252BRelationship%252BStudies%252Bof%252B2-%252528N-Substituted%252529-aminobenzimidazoles%252Bas%252BPotent%252BNegative%252BGating%252BModulators%252Bof%252BSmall%252BConductance%252BCa2%25252B-Activated%252BK%25252B%252BChannels%26aulast%3DS%25C3%25B8rensen%26aufirst%3DUlrik%2BS.%26date%3D2008%26date%3D2008%26date%3D2008%26date%3D11%252012%25202008%26date%3D11%252011%25202008%26date%3D4%252007%25202008%26volume%3D51%26issue%3D23%26spage%3D7625%26epage%3D7634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ravichandran  Veerasamy</span>, <span class="hlFld-ContribAuthor ">Anitha  Roy</span>, <span class="hlFld-ContribAuthor ">Rohini  Karunakaran</span>, <span class="hlFld-ContribAuthor ">Harish  Rajak</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship Analysis of Benzimidazoles as Emerging Anti-Inflammatory Agents: An Overview. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (7)
                                     , 663. <a href="https://doi.org/10.3390/ph14070663" title="DOI URL">https://doi.org/10.3390/ph14070663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14070663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14070663%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252BAnalysis%252Bof%252BBenzimidazoles%252Bas%252BEmerging%252BAnti-Inflammatory%252BAgents%25253A%252BAn%252BOverview%26aulast%3DVeerasamy%26aufirst%3DRavichandran%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D7%26spage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Hu</span>, <span class="hlFld-ContribAuthor ">Mengkang  Gao</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yusui  Wang</span>, <span class="hlFld-ContribAuthor ">Zhenrui  Qiao</span>, <span class="hlFld-ContribAuthor ">Weiya  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Yan</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Novel piperazine urea derivatives as highly potent transient receptor potential vanilloid 1 (TRPV1) antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>82 </em>, 105229. <a href="https://doi.org/10.1016/j.bioorg.2021.105229" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105229%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Bpiperazine%252Burea%252Bderivatives%252Bas%252Bhighly%252Bpotent%252Btransient%252Breceptor%252Bpotential%252Bvanilloid%252B1%252B%252528TRPV1%252529%252Bantagonists%26aulast%3DHu%26aufirst%3DJing%26date%3D2021%26volume%3D82%26spage%3D105229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cunbin  Nie</span>, <span class="hlFld-ContribAuthor ">Qifei  Li</span>, <span class="hlFld-ContribAuthor ">Yue  Qiao</span>, <span class="hlFld-ContribAuthor ">Jing  Hu</span>, <span class="hlFld-ContribAuthor ">Mengkang  Gao</span>, <span class="hlFld-ContribAuthor ">Yusui  Wang</span>, <span class="hlFld-ContribAuthor ">Zhenrui  Qiao</span>, <span class="hlFld-ContribAuthor ">Qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Yan</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Study on chemical modification and analgesic activity of N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl) piperazine-1-carboxamide. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>194 </em>, 112236. <a href="https://doi.org/10.1016/j.ejmech.2020.112236" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112236%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStudy%252Bon%252Bchemical%252Bmodification%252Band%252Banalgesic%252Bactivity%252Bof%252BN-%2525284-tert-butylphenyl%252529-4-%2525283-chloropyridin-2-yl%252529%252Bpiperazine-1-carboxamide%26aulast%3DNie%26aufirst%3DCunbin%26date%3D2020%26volume%3D194%26spage%3D112236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Cruz</span>, <span class="hlFld-ContribAuthor ">Itzia I. Padilla  Martínez</span>, <span class="hlFld-ContribAuthor ">Angel A.  Ramos-Organillo</span>. </span><span class="cited-content_cbyCitation_article-title">Methods to Access 2-aminobenzimidazoles of Medicinal Importance. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2020,</strong> <em>23 </em>
                                    (23)
                                     , 2573-2597. <a href="https://doi.org/10.2174/1385272823666191023150201" title="DOI URL">https://doi.org/10.2174/1385272823666191023150201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272823666191023150201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272823666191023150201%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DMethods%252Bto%252BAccess%252B2-aminobenzimidazoles%252Bof%252BMedicinal%252BImportance%26aulast%3DCruz%26aufirst%3DAlejandro%26date%3D2020%26volume%3D23%26issue%3D23%26spage%3D2573%26epage%3D2597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter R.  Clark</span>, <span class="hlFld-ContribAuthor ">Glynn D.  Williams</span>, <span class="hlFld-ContribAuthor ">Nicholas C. O.  Tomkinson</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalysed C–H functionalisation gives access to 2-aminobenzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (34)
                                     , 7943-7955. <a href="https://doi.org/10.1039/C9OB01651A" title="DOI URL">https://doi.org/10.1039/C9OB01651A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01651A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01651A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DCopper-catalysed%252BC%2525E2%252580%252593H%252Bfunctionalisation%252Bgives%252Baccess%252Bto%252B2-aminobenzimidazoles%26aulast%3DClark%26aufirst%3DPeter%2BR.%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D34%26spage%3D7943%26epage%3D7955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasa rao  Pinapati</span>, <span class="hlFld-ContribAuthor ">Usha rani  Mandapati</span>, <span class="hlFld-ContribAuthor ">Ramana  Tamminana</span>, <span class="hlFld-ContribAuthor ">Ramesh raju  Rudraraju</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Route to Substituted 2-(
              N
              -Arylamino)benzothiazoles via Iron-Promoted
              C-S
              Bond Formation. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (1)
                                     , 254-258. <a href="https://doi.org/10.1002/slct.201803441" title="DOI URL">https://doi.org/10.1002/slct.201803441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201803441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201803441%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DA%252BNovel%252BRoute%252Bto%252BSubstituted%252B2-%252528%252BN%252B-Arylamino%252529benzothiazoles%252Bvia%252BIron-Promoted%252BC-S%252BBond%252BFormation%26aulast%3DPinapati%26aufirst%3DSrinivasa%2Brao%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D1%26spage%3D254%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lakshmi  Kondraganti</span>, <span class="hlFld-ContribAuthor ">Surendra babu  Manabolu</span>, <span class="hlFld-ContribAuthor ">Ramachandran  Dittakavi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Benzimidazoles
              via
              Domino Intra and Intermolecular
              C‐N
              Cross‐Coupling Reaction. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (42)
                                     , 11744-11748. <a href="https://doi.org/10.1002/slct.201802754" title="DOI URL">https://doi.org/10.1002/slct.201802754</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201802754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201802754%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Bof%252BBenzimidazoles%252Bvia%252BDomino%252BIntra%252Band%252BIntermolecular%252BC%2525E2%252580%252590N%252BCross%2525E2%252580%252590Coupling%252BReaction%26aulast%3DKondraganti%26aufirst%3DLakshmi%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D42%26spage%3D11744%26epage%3D11748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. N. Murthy  Boddapati</span>, <span class="hlFld-ContribAuthor ">Chandra Mohan  Kurmarayuni</span>, <span class="hlFld-ContribAuthor ">Baby Ramana  Mutchu</span>, <span class="hlFld-ContribAuthor ">Ramana  Tamminana</span>, <span class="hlFld-ContribAuthor ">Hari Babu  Bollikolla</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed synthesis of 2-aminophenyl benzothiazoles: a novel approach. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (37)
                                     , 8267-8272. <a href="https://doi.org/10.1039/C8OB02018C" title="DOI URL">https://doi.org/10.1039/C8OB02018C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB02018C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB02018C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DCopper-catalyzed%252Bsynthesis%252Bof%252B2-aminophenyl%252Bbenzothiazoles%25253A%252Ba%252Bnovel%252Bapproach%26aulast%3DBoddapati%26aufirst%3DS.%2BN.%2BMurthy%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D37%26spage%3D8267%26epage%3D8272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Joji  Yui</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Yusuke  Kurihara</span>, <span class="hlFld-ContribAuthor ">Masanao  Ogawa</span>, <span class="hlFld-ContribAuthor ">Wakana  Mori</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">[ 11 C]BCTC: Radiosynthesis and in vivo binding to transient receptor potential vanilloid subfamily member 1 (TRPV1) receptor in the mouse trigeminal nerve. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (19)
                                     , 4521-4524. <a href="https://doi.org/10.1016/j.bmcl.2017.08.061" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.08.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.08.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.08.061%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D%25255B%252B11%252BC%25255DBCTC%25253A%252BRadiosynthesis%252Band%252Bin%252Bvivo%252Bbinding%252Bto%252Btransient%252Breceptor%252Bpotential%252Bvanilloid%252Bsubfamily%252Bmember%252B1%252B%252528TRPV1%252529%252Breceptor%252Bin%252Bthe%252Bmouse%252Btrigeminal%252Bnerve%26aulast%3DKumata%26aufirst%3DKatsushi%26date%3D2017%26volume%3D27%26issue%3D19%26spage%3D4521%26epage%3D4524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhookya  Shankar</span>, <span class="hlFld-ContribAuthor ">Pochampally  Jalapathi</span>, <span class="hlFld-ContribAuthor ">Anil  Valeru</span>, <span class="hlFld-ContribAuthor ">Angajala  Kishor Kumar</span>, <span class="hlFld-ContribAuthor ">Balabadra  Saikrishna</span>, <span class="hlFld-ContribAuthor ">Karunakar rao  Kudle</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of new 2-(6-alkyl-pyrazin-2-yl)-1H-benz[d]imidazoles as potent anti-inflammatory and antioxidant agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2017,</strong> <em>26 </em>
                                    (9)
                                     , 1835-1846. <a href="https://doi.org/10.1007/s00044-017-1897-7" title="DOI URL">https://doi.org/10.1007/s00044-017-1897-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-017-1897-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-017-1897-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252B2-%2525286-alkyl-pyrazin-2-yl%252529-1H-benz%25255Bd%25255Dimidazoles%252Bas%252Bpotent%252Banti-inflammatory%252Band%252Bantioxidant%252Bagents%26aulast%3DShankar%26aufirst%3DBhookya%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D9%26spage%3D1835%26epage%3D1846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajendra  Kristam</span>, <span class="hlFld-ContribAuthor ">Shashidhar N.  Rao</span>, <span class="hlFld-ContribAuthor ">Anne Sudha  D’Cruz</span>, <span class="hlFld-ContribAuthor ">Vijayalakshmi  Mahadevan</span>, <span class="hlFld-ContribAuthor ">Vellarkad N.  Viswanadhan</span>. </span><span class="cited-content_cbyCitation_article-title">TRPV1 antagonism by piperazinyl-aryl compounds: A Topomer-CoMFA study and its use in virtual screening for identification of novel antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2017,</strong> <em>72 </em>, 112-128. <a href="https://doi.org/10.1016/j.jmgm.2017.01.010" title="DOI URL">https://doi.org/10.1016/j.jmgm.2017.01.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2017.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2017.01.010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DTRPV1%252Bantagonism%252Bby%252Bpiperazinyl-aryl%252Bcompounds%25253A%252BA%252BTopomer-CoMFA%252Bstudy%252Band%252Bits%252Buse%252Bin%252Bvirtual%252Bscreening%252Bfor%252Bidentification%252Bof%252Bnovel%252Bantagonists%26aulast%3DKristam%26aufirst%3DRajendra%26date%3D2017%26volume%3D72%26spage%3D112%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehdi  Ghandi</span>, <span class="hlFld-ContribAuthor ">Meysam  Khodadadi</span>, <span class="hlFld-ContribAuthor ">Alireza  Abbasi</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective synthesis of novel N-substituted pyrrolidine-2-one containing piperazine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2016,</strong> <em>13 </em>
                                    (9)
                                     , 1691-1698. <a href="https://doi.org/10.1007/s13738-016-0886-y" title="DOI URL">https://doi.org/10.1007/s13738-016-0886-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-016-0886-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-016-0886-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DDiastereoselective%252Bsynthesis%252Bof%252Bnovel%252BN-substituted%252Bpyrrolidine-2-one%252Bcontaining%252Bpiperazine%252Bderivatives%26aulast%3DGhandi%26aufirst%3DMehdi%26date%3D2016%26date%3D2016%26volume%3D13%26issue%3D9%26spage%3D1691%26epage%3D1698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Yan</span>, <span class="hlFld-ContribAuthor ">Jingjie  Wang</span>, <span class="hlFld-ContribAuthor ">Miaobo  Pan</span>, <span class="hlFld-ContribAuthor ">Qianqian  Qiu</span>, <span class="hlFld-ContribAuthor ">Wenlong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Analogues of BCTC Incorporating a Pyrrolidinyl Linker and Biological Evaluation as Transient Receptor Potential Vanilloid 1 Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2016,</strong> <em>87 </em>
                                    (2)
                                     , 306-311. <a href="https://doi.org/10.1111/cbdd.12661" title="DOI URL">https://doi.org/10.1111/cbdd.12661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12661%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Bof%252BAnalogues%252Bof%252BBCTC%252BIncorporating%252Ba%252BPyrrolidinyl%252BLinker%252Band%252BBiological%252BEvaluation%252Bas%252BTransient%252BReceptor%252BPotential%252BVanilloid%252B1%252BAntagonists%26aulast%3DYan%26aufirst%3DLin%26date%3D2016%26date%3D2015%26volume%3D87%26issue%3D2%26spage%3D306%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dimitrios  Gritzalis</span>, <span class="hlFld-ContribAuthor ">Jaeok  Park</span>, <span class="hlFld-ContribAuthor ">Wei  Chiu</span>, <span class="hlFld-ContribAuthor ">Hyungjun  Cho</span>, <span class="hlFld-ContribAuthor ">Yih-Shyan  Lin</span>, <span class="hlFld-ContribAuthor ">Joris W.  De Schutter</span>, <span class="hlFld-ContribAuthor ">Cyrus M.  Lacbay</span>, <span class="hlFld-ContribAuthor ">Michal  Zielinski</span>, <span class="hlFld-ContribAuthor ">Albert M.  Berghuis</span>, <span class="hlFld-ContribAuthor ">Youla S.  Tsantrizos</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (5)
                                     , 1117-1123. <a href="https://doi.org/10.1016/j.bmcl.2014.12.089" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.089%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DProbing%252Bthe%252Bmolecular%252Band%252Bstructural%252Belements%252Bof%252Bligands%252Bbinding%252Bto%252Bthe%252Bactive%252Bsite%252Bversus%252Ban%252Ballosteric%252Bpocket%252Bof%252Bthe%252Bhuman%252Bfarnesyl%252Bpyrophosphate%252Bsynthase%26aulast%3DGritzalis%26aufirst%3DDimitrios%26date%3D2015%26volume%3D25%26issue%3D5%26spage%3D1117%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafael  Brito</span>, <span class="hlFld-ContribAuthor ">Sandeep  Sheth</span>, <span class="hlFld-ContribAuthor ">Debashree  Mukherjea</span>, <span class="hlFld-ContribAuthor ">Leonard  Rybak</span>, <span class="hlFld-ContribAuthor ">Vickram  Ramkumar</span>. </span><span class="cited-content_cbyCitation_article-title">TRPV1: A Potential Drug Target for Treating Various Diseases. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2014,</strong> <em>3 </em>
                                    (2)
                                     , 517-545. <a href="https://doi.org/10.3390/cells3020517" title="DOI URL">https://doi.org/10.3390/cells3020517</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells3020517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells3020517%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DTRPV1%25253A%252BA%252BPotential%252BDrug%252BTarget%252Bfor%252BTreating%252BVarious%252BDiseases%26aulast%3DBrito%26aufirst%3DRafael%26date%3D2014%26date%3D2014%26volume%3D3%26issue%3D2%26spage%3D517%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Gaba</span>, <span class="hlFld-ContribAuthor ">Sarbjot  Singh</span>, <span class="hlFld-ContribAuthor ">Chander  Mohan</span>. </span><span class="cited-content_cbyCitation_article-title">Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>76 </em>, 494-505. <a href="https://doi.org/10.1016/j.ejmech.2014.01.030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.01.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.01.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzimidazole%25253A%252BAn%252Bemerging%252Bscaffold%252Bfor%252Banalgesic%252Band%2525C2%2525A0anti-inflammatory%252Bagents%26aulast%3DGaba%26aufirst%3DMonika%26date%3D2014%26volume%3D76%26spage%3D494%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. F.  Salikov</span>, <span class="hlFld-ContribAuthor ">D. N.  Platonov</span>, <span class="hlFld-ContribAuthor ">D. L.  Lipilin</span>, <span class="hlFld-ContribAuthor ">A. E.  Frumkin</span>, <span class="hlFld-ContribAuthor ">Yu. V.  Tomilov</span>. </span><span class="cited-content_cbyCitation_article-title">The cyclopropyliminium rearrangement of 2-cyclopropyl-4-nitrobenzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2014,</strong> <em>63 </em>
                                    (3)
                                     , 765-769. <a href="https://doi.org/10.1007/s11172-014-0505-y" title="DOI URL">https://doi.org/10.1007/s11172-014-0505-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-014-0505-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-014-0505-y%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DThe%252Bcyclopropyliminium%252Brearrangement%252Bof%252B2-cyclopropyl-4-nitrobenzimidazoles%26aulast%3DSalikov%26aufirst%3DR.%2BF.%26date%3D2014%26date%3D2014%26volume%3D63%26issue%3D3%26spage%3D765%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajendra  Kristam</span>, <span class="hlFld-ContribAuthor ">Vinod  Parmar</span>, <span class="hlFld-ContribAuthor ">Vellarkad N.  Viswanadhan</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR analysis of TRPV1 inhibitors reveals a pharmacophore applicable to diverse scaffolds and clinical candidates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2013,</strong> <em>45 </em>, 157-172. <a href="https://doi.org/10.1016/j.jmgm.2013.08.014" title="DOI URL">https://doi.org/10.1016/j.jmgm.2013.08.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2013.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2013.08.014%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3D3D-QSAR%252Banalysis%252Bof%252BTRPV1%252Binhibitors%252Breveals%252Ba%252Bpharmacophore%252Bapplicable%252Bto%252Bdiverse%252Bscaffolds%252Band%252Bclinical%252Bcandidates%26aulast%3DKristam%26aufirst%3DRajendra%26date%3D2013%26volume%3D45%26spage%3D157%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam J.  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Theresa M.  Williams</span>, <span class="hlFld-ContribAuthor ">Abraham J.  Jordan</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Clark</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-amino-imidazo[4,5-b]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2013,</strong> <em>11 </em>
                                    (18)
                                     , 3064. <a href="https://doi.org/10.1039/c3ob40413g" title="DOI URL">https://doi.org/10.1039/c3ob40413g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ob40413g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ob40413g%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-amino-imidazo%25255B4%25252C5-b%25255Dpyridines%26aulast%3DRosenberg%26aufirst%3DAdam%2BJ.%26date%3D2013%26volume%3D11%26issue%3D18%26spage%3D3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zihao  Hua</span>, <span class="hlFld-ContribAuthor ">Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Howard  Bregman</span>, <span class="hlFld-ContribAuthor ">Nagasree  Chakka</span>, <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Doherty</span>, <span class="hlFld-ContribAuthor ">Jon  Goldstein</span>, <span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>, <span class="hlFld-ContribAuthor ">Hongbing  Huang</span>, <span class="hlFld-ContribAuthor ">Stephanie  Mercede</span>, <span class="hlFld-ContribAuthor ">John  Newcomb</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, <span class="hlFld-ContribAuthor ">Susan M.  Turci</span>, <span class="hlFld-ContribAuthor ">Jie  Yan</span>, <span class="hlFld-ContribAuthor ">Cindy  Wilson</span>, <span class="hlFld-ContribAuthor ">Matthew W.  Martin</span>. </span><span class="cited-content_cbyCitation_article-title">2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (17)
                                     , 5392-5395. <a href="https://doi.org/10.1016/j.bmcl.2012.07.046" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.07.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.07.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.07.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D2-Phenylamino-6-cyano-1H-benzimidazole-based%252Bisoform%252Bselective%252Bcasein%252Bkinase%252B1%252Bgamma%252B%252528CK1%2525CE%2525B3%252529%252Binhibitors%26aulast%3DHua%26aufirst%3DZihao%26date%3D2012%26volume%3D22%26issue%3D17%26spage%3D5392%26epage%3D5395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehdi  Ghandi</span>, <span class="hlFld-ContribAuthor ">Nahid  Zarezadeh</span>, <span class="hlFld-ContribAuthor ">Abuzar  Taheri</span>. </span><span class="cited-content_cbyCitation_article-title">A three-component, intramolecular Ugi reaction toward unique indoloketopiperazines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2012,</strong> <em>53 </em>
                                    (26)
                                     , 3353-3356. <a href="https://doi.org/10.1016/j.tetlet.2012.04.090" title="DOI URL">https://doi.org/10.1016/j.tetlet.2012.04.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2012.04.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2012.04.090%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bthree-component%25252C%252Bintramolecular%252BUgi%252Breaction%252Btoward%252Bunique%252Bindoloketopiperazines%26aulast%3DGhandi%26aufirst%3DMehdi%26date%3D2012%26volume%3D53%26issue%3D26%26spage%3D3353%26epage%3D3356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Christophe  Andrez</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-amino-imidazoles, purines, and benzoxazolamines through DIB oxidation. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2012,</strong> <em>2 </em>
                                    (8)
                                     , 3261. <a href="https://doi.org/10.1039/c2ra20101a" title="DOI URL">https://doi.org/10.1039/c2ra20101a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2ra20101a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2ra20101a%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Bof%252B2-amino-imidazoles%25252C%252Bpurines%25252C%252Band%252Bbenzoxazolamines%252Bthrough%252BDIB%252Boxidation%26aulast%3DAndrez%26aufirst%3DJean-Christophe%26date%3D2012%26volume%3D2%26issue%3D8%26spage%3D3261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abhijit Datta  Khoje</span>, <span class="hlFld-ContribAuthor ">Colin  Charnock</span>, <span class="hlFld-ContribAuthor ">Baojie  Wan</span>, <span class="hlFld-ContribAuthor ">Scott  Franzblau</span>, <span class="hlFld-ContribAuthor ">Lise-Lotte  Gundersen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines: Imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2011,</strong> <em>19 </em>
                                    (11)
                                     , 3483-3491. <a href="https://doi.org/10.1016/j.bmc.2011.04.023" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.04.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.04.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantimycobacterial%252Bactivities%252Bof%252Bnon-purine%252Banalogs%252Bof%252B6-aryl-9-benzylpurines%25253A%252BImidazopyridines%25252C%252Bpyrrolopyridines%25252C%252Bbenzimidazoles%25252C%252Band%252Bindoles%26aulast%3DKhoje%26aufirst%3DAbhijit%2BDatta%26date%3D2011%26volume%3D19%26issue%3D11%26spage%3D3483%26epage%3D3491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyung H.  Gahm</span>, <span class="hlFld-ContribAuthor ">Ke  Huang</span>, <span class="hlFld-ContribAuthor ">Wesley W.  Barnhart</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Goetzinger</span>. </span><span class="cited-content_cbyCitation_article-title">Development of supercritical fluid extraction and supercritical fluid chromatography purification methods using rapid solubility screening with multiple solubility chambers. </span><span class="cited-content_cbyCitation_journal-name">Chirality</span><span> <strong>2011,</strong> <em>23 </em>
                                    (1E)
                                     , E65-E73. <a href="https://doi.org/10.1002/chir.20967" title="DOI URL">https://doi.org/10.1002/chir.20967</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chir.20967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchir.20967%26sid%3Dliteratum%253Aachs%26jtitle%3DChirality%26atitle%3DDevelopment%252Bof%252Bsupercritical%252Bfluid%252Bextraction%252Band%252Bsupercritical%252Bfluid%252Bchromatography%252Bpurification%252Bmethods%252Busing%252Brapid%252Bsolubility%252Bscreening%252Bwith%252Bmultiple%252Bsolubility%252Bchambers%26aulast%3DGahm%26aufirst%3DKyung%2BH.%26date%3D2011%26date%3D2011%26volume%3D23%26issue%3D1E%26spage%3DE65%26epage%3DE73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rong  Xia</span>, <span class="hlFld-ContribAuthor ">Kim  Dekermendjian</span>, <span class="hlFld-ContribAuthor ">Elke  Lullau</span>, <span class="hlFld-ContribAuthor ">Niek  Dekker</span>. </span><span class="cited-content_cbyCitation_article-title">TRPV1: A Therapy Target That Attracts the Pharmaceutical Interests. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 637-665. <a href="https://doi.org/10.1007/978-94-007-0265-3_34" title="DOI URL">https://doi.org/10.1007/978-94-007-0265-3_34</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-94-007-0265-3_34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-94-007-0265-3_34%26sid%3Dliteratum%253Aachs%26atitle%3DTRPV1%25253A%252BA%252BTherapy%252BTarget%252BThat%252BAttracts%252Bthe%252BPharmaceutical%252BInterests%26aulast%3DXia%26aufirst%3DRong%26date%3D2011%26date%3D2010%26spage%3D637%26epage%3D665%26pub%3DSpringer%2520Netherlands%26atitle%3DTransient%252BReceptor%252BPotential%252BChannels%26aulast%3DIslam%26aufirst%3DMd.%2BShahidul%26date%3D2011%26volume%3D704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagahisa  Yamaoka</span>, <span class="hlFld-ContribAuthor ">Hidehiko  Kodama</span>, <span class="hlFld-ContribAuthor ">Yuko  Izuhara</span>, <span class="hlFld-ContribAuthor ">Toshio  Miyata</span>, <span class="hlFld-ContribAuthor ">Kanji  Meguro</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Relationships of New N-Acylanthranilic Acid Derivatives as Plasminogen Activator Inhibitor-1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2011,</strong> <em>59 </em>
                                    (2)
                                     , 215-224. <a href="https://doi.org/10.1248/cpb.59.215" title="DOI URL">https://doi.org/10.1248/cpb.59.215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.59.215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.59.215%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DStructure-Activity%252BRelationships%252Bof%252BNew%252BN-Acylanthranilic%252BAcid%252BDerivatives%252Bas%252BPlasminogen%252BActivator%252BInhibitor-1%252BInhibitors%26aulast%3DYamaoka%26aufirst%3DNagahisa%26date%3D2011%26volume%3D59%26issue%3D2%26spage%3D215%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehdi  Ghandi</span>, <span class="hlFld-ContribAuthor ">Nahid  Zarezadeh</span>, <span class="hlFld-ContribAuthor ">Abuzar  Taheri</span>. </span><span class="cited-content_cbyCitation_article-title">Unique substituted 3-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]benzimidazole-1-carboxamides generated by Ugi 3CC using bifunctional starting material. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2010,</strong> <em>66 </em>
                                    (42)
                                     , 8231-8237. <a href="https://doi.org/10.1016/j.tet.2010.08.057" title="DOI URL">https://doi.org/10.1016/j.tet.2010.08.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2010.08.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2010.08.057%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DUnique%252Bsubstituted%252B3-oxo-1%25252C2%25252C3%25252C4-tetrahydropyrazino%25255B1%25252C2-a%25255Dbenzimidazole-1-carboxamides%252Bgenerated%252Bby%252BUgi%252B3CC%252Busing%252Bbifunctional%252Bstarting%252Bmaterial%26aulast%3DGhandi%26aufirst%3DMehdi%26date%3D2010%26volume%3D66%26issue%3D42%26spage%3D8231%26epage%3D8237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeong Geun  Kim</span>, <span class="hlFld-ContribAuthor ">Eun Hae  Yang</span>, <span class="hlFld-ContribAuthor ">Woo Sup  Youn</span>, <span class="hlFld-ContribAuthor ">Ji Won  Choi</span>, <span class="hlFld-ContribAuthor ">Deok-Chan  Ha</span>, <span class="hlFld-ContribAuthor ">Jae Du  Ha</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted amination of 3-bromo-2-chloropyridine with various substituted aminoethanols. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2010,</strong> <em>51 </em>
                                    (30)
                                     , 3886-3889. <a href="https://doi.org/10.1016/j.tetlet.2010.05.021" title="DOI URL">https://doi.org/10.1016/j.tetlet.2010.05.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2010.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2010.05.021%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DMicrowave-assisted%252Bamination%252Bof%252B3-bromo-2-chloropyridine%252Bwith%252Bvarious%252Bsubstituted%252Baminoethanols%26aulast%3DKim%26aufirst%3DJeong%2BGeun%26date%3D2010%26volume%3D51%26issue%3D30%26spage%3D3886%26epage%3D3889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">References. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 917-970. <a href="https://doi.org/10.1016/B978-0-08-095843-9.00018-5" title="DOI URL">https://doi.org/10.1016/B978-0-08-095843-9.00018-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-095843-9.00018-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-095843-9.00018-5%26sid%3Dliteratum%253Aachs%26atitle%3DReferences%26date%3D2010%26spage%3D917%26epage%3D970%26pub%3DElsevier%26atitle%3DHandbook%252Bof%252BHeterocyclic%252BChemistry%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katja  Sterz</span>, <span class="hlFld-ContribAuthor ">Lars  Möllmann</span>, <span class="hlFld-ContribAuthor ">Anna  Jacobs</span>, <span class="hlFld-ContribAuthor ">Dieter  Baumert</span>, <span class="hlFld-ContribAuthor ">Michael  Wiese</span>. </span><span class="cited-content_cbyCitation_article-title">Activators of P-glycoprotein: Structure-Activity Relationships and Investigation of their Mode of Action. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2009,</strong> <em>4 </em>
                                    (11)
                                     , 1897-1911. <a href="https://doi.org/10.1002/cmdc.200900283" title="DOI URL">https://doi.org/10.1002/cmdc.200900283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.200900283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.200900283%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DActivators%252Bof%252BP-glycoprotein%25253A%252BStructure-Activity%252BRelationships%252Band%252BInvestigation%252Bof%252Btheir%252BMode%252Bof%252BAction%26aulast%3DSterz%26aufirst%3DKatja%26date%3D2009%26volume%3D4%26issue%3D11%26spage%3D1897%26epage%3D1911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gilbert Y.  Wong</span>, <span class="hlFld-ContribAuthor ">Narender R.  Gavva</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Reviews</span><span> <strong>2009,</strong> <em>60 </em>
                                    (1)
                                     , 267-277. <a href="https://doi.org/10.1016/j.brainresrev.2008.12.006" title="DOI URL">https://doi.org/10.1016/j.brainresrev.2008.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresrev.2008.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresrev.2008.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Reviews%26atitle%3DTherapeutic%252Bpotential%252Bof%252Bvanilloid%252Breceptor%252BTRPV1%252Bagonists%252Band%252Bantagonists%252Bas%252Banalgesics%25253A%252BRecent%252Badvances%252Band%252Bsetbacks%26aulast%3DWong%26aufirst%3DGilbert%2BY.%26date%3D2009%26volume%3D60%26issue%3D1%26spage%3D267%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Xiao</span>, <span class="hlFld-ContribAuthor ">Anandan  Palani</span>, <span class="hlFld-ContribAuthor ">Robert  Aslanian</span>, <span class="hlFld-ContribAuthor ">Brian A.  McKittrick</span>, <span class="hlFld-ContribAuthor ">Andrew T.  McPhail</span>, <span class="hlFld-ContribAuthor ">Craig C.  Correll</span>, <span class="hlFld-ContribAuthor ">P. Tara  Phelps</span>, <span class="hlFld-ContribAuthor ">John C.  Anthes</span>, <span class="hlFld-ContribAuthor ">Diane  Rindgen</span>. </span><span class="cited-content_cbyCitation_article-title">Spiro-piperidine azetidinones as potent TRPV1 antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (3)
                                     , 783-787. <a href="https://doi.org/10.1016/j.bmcl.2008.12.024" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.12.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.12.024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSpiro-piperidine%252Bazetidinones%252Bas%252Bpotent%252BTRPV1%252Bantagonists%26aulast%3DXiao%26aufirst%3DDong%26date%3D2009%26volume%3D19%26issue%3D3%26spage%3D783%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">József  Lázár</span>, <span class="hlFld-ContribAuthor ">Laxmikant  Gharat</span>, <span class="hlFld-ContribAuthor ">Neelima  Khairathkar-Joshi</span>, <span class="hlFld-ContribAuthor ">Peter M  Blumberg</span>, <span class="hlFld-ContribAuthor ">Arpad  Szallasi</span>. </span><span class="cited-content_cbyCitation_article-title">Screening TRPV1 antagonists for the treatment of pain: lessons learned over a decade. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2009,</strong> <em>4 </em>
                                    (2)
                                     , 159-180. <a href="https://doi.org/10.1517/17460440802681300" title="DOI URL">https://doi.org/10.1517/17460440802681300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460440802681300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460440802681300%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DScreening%252BTRPV1%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bpain%25253A%252Blessons%252Blearned%252Bover%252Ba%252Bdecade%26aulast%3DL%25C3%25A1z%25C3%25A1r%26aufirst%3DJ%25C3%25B3zsef%26date%3D2009%26date%3D2009%26volume%3D4%26issue%3D2%26spage%3D159%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Narender R.  Gavva</span>. </span><span class="cited-content_cbyCitation_article-title">Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2008,</strong> <em>29 </em>
                                    (11)
                                     , 550-557. <a href="https://doi.org/10.1016/j.tips.2008.08.003" title="DOI URL">https://doi.org/10.1016/j.tips.2008.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2008.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2008.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DBody-temperature%252Bmaintenance%252Bas%252Bthe%252Bpredominant%252Bfunction%252Bof%252Bthe%252Bvanilloid%252Breceptor%252BTRPV1%26aulast%3DGavva%26aufirst%3DNarender%2BR.%26date%3D2008%26volume%3D29%26issue%3D11%26spage%3D550%26epage%3D557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles A.  Blum</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Harry  Brielmann</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Hodgetts</span>, <span class="hlFld-ContribAuthor ">Rajagopal  Bakthavatchalam</span>, <span class="hlFld-ContribAuthor ">Jayaraman  Chandrasekhar</span>, <span class="hlFld-ContribAuthor ">James E.  Krause</span>, <span class="hlFld-ContribAuthor ">Daniel  Cortright</span>, <span class="hlFld-ContribAuthor ">David  Matson</span>, <span class="hlFld-ContribAuthor ">Marci  Crandall</span>, <span class="hlFld-ContribAuthor ">Chu K.  Ngo</span>, <span class="hlFld-ContribAuthor ">Lawrence  Fung</span>, <span class="hlFld-ContribAuthor ">Marta  Day</span>, <span class="hlFld-ContribAuthor ">Mark  Kershaw</span>, <span class="hlFld-ContribAuthor ">Stéphane  De Lombaert</span>, <span class="hlFld-ContribAuthor ">Bertrand L.  Chenard</span>. </span><span class="cited-content_cbyCitation_article-title">Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (16)
                                     , 4573-4577. <a href="https://doi.org/10.1016/j.bmcl.2008.07.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.07.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.07.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAminoquinazolines%252Bas%252BTRPV1%252Bantagonists%25253A%252BModulation%252Bof%252Bdrug-like%252Bproperties%252Bthrough%252Bthe%252Bexploration%252Bof%252B2-position%252Bsubstitution%26aulast%3DBlum%26aufirst%3DCharles%2BA.%26date%3D2008%26volume%3D18%26issue%3D16%26spage%3D4573%26epage%3D4577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joey L.  Methot</span>, <span class="hlFld-ContribAuthor ">Theresa A.  Dunstan</span>, <span class="hlFld-ContribAuthor ">Dawn M.  Mampreian</span>, <span class="hlFld-ContribAuthor ">Bruce  Adams</span>, <span class="hlFld-ContribAuthor ">Michael D.  Altman</span>. </span><span class="cited-content_cbyCitation_article-title">An unexpected aminocyclopropane reductive rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2008,</strong> <em>49 </em>
                                    (7)
                                     , 1155-1159. <a href="https://doi.org/10.1016/j.tetlet.2007.12.054" title="DOI URL">https://doi.org/10.1016/j.tetlet.2007.12.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2007.12.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2007.12.054%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Bunexpected%252Baminocyclopropane%252Breductive%252Brearrangement%26aulast%3DMethot%26aufirst%3DJoey%2BL.%26date%3D2008%26volume%3D49%26issue%3D7%26spage%3D1155%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laxmikant A  Gharat</span>, <span class="hlFld-ContribAuthor ">Arpad  Szallasi</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2008,</strong> <em>18 </em>
                                    (2)
                                     , 159-209. <a href="https://doi.org/10.1517/13543776.18.2.159" title="DOI URL">https://doi.org/10.1517/13543776.18.2.159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.18.2.159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.18.2.159%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DAdvances%252Bin%252Bthe%252Bdesign%252Band%252Btherapeutic%252Buse%252Bof%252Bcapsaicin%252Breceptor%252BTRPV1%252Bagonists%252Band%252Bantagonists%26aulast%3DGharat%26aufirst%3DLaxmikant%2BA%26date%3D2008%26date%3D2008%26volume%3D18%26issue%3D2%26spage%3D159%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.  Xi</span>, <span class="hlFld-ContribAuthor ">Q.  Huang</span>, <span class="hlFld-ContribAuthor ">L.  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 143-364. <a href="https://doi.org/10.1016/B978-008044992-0.00402-8" title="DOI URL">https://doi.org/10.1016/B978-008044992-0.00402-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-008044992-0.00402-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-008044992-0.00402-8%26sid%3Dliteratum%253Aachs%26atitle%3DImidazoles%26aulast%3DXi%26aufirst%3DN.%26date%3D2008%26spage%3D143%26epage%3D364%26pub%3DElsevier%26atitle%3DComprehensive%252BHeterocyclic%252BChemistry%252BIII%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heidi L.  Fraser</span>, <span class="hlFld-ContribAuthor ">Darrin W.  Hopper</span>, <span class="hlFld-ContribAuthor ">Kristina M.K.  Kutterer</span>, <span class="hlFld-ContribAuthor ">Aimee L.  Crombie</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 6.1 Six-membered ring systems: pyridine and benzo derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 314-352. <a href="https://doi.org/10.1016/S0959-6380(08)80014-1" title="DOI URL">https://doi.org/10.1016/S0959-6380(08)80014-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0959-6380(08)80014-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0959-6380%2808%2980014-1%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B6.1%252BSix-membered%252Bring%252Bsystems%25253A%252Bpyridine%252Band%252Bbenzo%252Bderivatives%26aulast%3DFraser%26aufirst%3DHeidi%2BL.%26date%3D2008%26spage%3D314%26epage%3D352%26pub%3DElsevier%26atitle%3DA%252Bcritical%252Breview%252Bof%252Bthe%252B2006%252Bliterature%252Bpreceded%252Bby%252Btwo%252Bchapters%252Bon%252Bcurrent%252Bheterocyclic%252Btopics%26date%3D2008%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stuart J.  Conway</span>. </span><span class="cited-content_cbyCitation_article-title">TRPing the switch on pain: an introduction to the chemistry and biology of capsaicin and TRPV1. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2008,</strong> <em>37 </em>
                                    (8)
                                     , 1530. <a href="https://doi.org/10.1039/b610226n" title="DOI URL">https://doi.org/10.1039/b610226n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b610226n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb610226n%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DTRPing%252Bthe%252Bswitch%252Bon%252Bpain%25253A%252Ban%252Bintroduction%252Bto%252Bthe%252Bchemistry%252Band%252Bbiology%252Bof%252Bcapsaicin%252Band%252BTRPV1%26aulast%3DConway%26aufirst%3DStuart%2BJ.%26date%3D2008%26volume%3D37%26issue%3D8%26spage%3D1530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laxmikant  Gharat</span>, <span class="hlFld-ContribAuthor ">Arpad  Szallasi</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry of the vanilloid (Capsaicin) TRPV1 receptor: current knowledge and future perspectives. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2007,</strong> <em>68 </em>
                                    (8)
                                     , 477-497. <a href="https://doi.org/10.1002/ddr.20218" title="DOI URL">https://doi.org/10.1002/ddr.20218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.20218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.20218%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DMedicinal%252Bchemistry%252Bof%252Bthe%252Bvanilloid%252B%252528Capsaicin%252529%252BTRPV1%252Breceptor%25253A%252Bcurrent%252Bknowledge%252Band%252Bfuture%252Bperspectives%26aulast%3DGharat%26aufirst%3DLaxmikant%26date%3D2007%26date%3D2008%26volume%3D68%26issue%3D8%26spage%3D477%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vijay K.  Gore</span>, <span class="hlFld-ContribAuthor ">Vu V.  Ma</span>, <span class="hlFld-ContribAuthor ">Rami  Tamir</span>, <span class="hlFld-ContribAuthor ">Narender R.  Gavva</span>, <span class="hlFld-ContribAuthor ">James J.S.  Treanor</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2007,</strong> <em>17 </em>
                                    (21)
                                     , 5825-5830. <a href="https://doi.org/10.1016/j.bmcl.2007.08.044" title="DOI URL">https://doi.org/10.1016/j.bmcl.2007.08.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2007.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2007.08.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationship%252B%252528SAR%252529%252Binvestigations%252Bof%252Bsubstituted%252Bimidazole%252Banalogs%252Bas%252BTRPV1%252Bantagonists%26aulast%3DGore%26aufirst%3DVijay%2BK.%26date%3D2007%26volume%3D17%26issue%3D21%26spage%3D5825%26epage%3D5830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Narender R.  Gavva</span>, <span class="hlFld-ContribAuthor ">Anthony W.  Bannon</span>, <span class="hlFld-ContribAuthor ">David N.  Hovland</span>, <span class="hlFld-ContribAuthor ">Sonya G.  Lehto</span>, <span class="hlFld-ContribAuthor ">Lana  Klionsky</span>, <span class="hlFld-ContribAuthor ">Sekhar  Surapaneni</span>, <span class="hlFld-ContribAuthor ">David C.  Immke</span>, <span class="hlFld-ContribAuthor ">Charles  Henley</span>, <span class="hlFld-ContribAuthor ">Leyla  Arik</span>, <span class="hlFld-ContribAuthor ">Annette  Bak</span>, <span class="hlFld-ContribAuthor ">James  Davis</span>, <span class="hlFld-ContribAuthor ">Nadia  Ernst</span>, <span class="hlFld-ContribAuthor ">Gal  Hever</span>, <span class="hlFld-ContribAuthor ">Rongzhen  Kuang</span>, <span class="hlFld-ContribAuthor ">Licheng  Shi</span>, <span class="hlFld-ContribAuthor ">Rami  Tamir</span>, <span class="hlFld-ContribAuthor ">Jue  Wang</span>, <span class="hlFld-ContribAuthor ">Weiya  Wang</span>, <span class="hlFld-ContribAuthor ">Gary  Zajic</span>, <span class="hlFld-ContribAuthor ">Dawn  Zhu</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">Jean-Claude  Louis</span>, <span class="hlFld-ContribAuthor ">Ella  Magal</span>, <span class="hlFld-ContribAuthor ">James J. S.  Treanor</span>. </span><span class="cited-content_cbyCitation_article-title">Repeated Administration of Vanilloid Receptor TRPV1 Antagonists Attenuates Hyperthermia Elicited by TRPV1 Blockade. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2007,</strong> <em>323 </em>
                                    (1)
                                     , 128-137. <a href="https://doi.org/10.1124/jpet.107.125674" title="DOI URL">https://doi.org/10.1124/jpet.107.125674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.107.125674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.107.125674%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DRepeated%252BAdministration%252Bof%252BVanilloid%252BReceptor%252BTRPV1%252BAntagonists%252BAttenuates%252BHyperthermia%252BElicited%252Bby%252BTRPV1%252BBlockade%26aulast%3DGavva%26aufirst%3DNarender%2BR.%26date%3D2007%26date%3D2007%26volume%3D323%26issue%3D1%26spage%3D128%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alma  Viso</span>, <span class="hlFld-ContribAuthor ">Roberto  Fernández de la Pradilla</span>, <span class="hlFld-ContribAuthor ">Aída  Flores</span>, <span class="hlFld-ContribAuthor ">Ana  García</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of enantiopure vicinal diaminoesters and ketopiperazines from N-sulfinylimidazolidines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2007,</strong> <em>63 </em>
                                    (33)
                                     , 8017-8026. <a href="https://doi.org/10.1016/j.tet.2007.05.062" title="DOI URL">https://doi.org/10.1016/j.tet.2007.05.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2007.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2007.05.062%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Benantiopure%252Bvicinal%252Bdiaminoesters%252Band%252Bketopiperazines%252Bfrom%252BN-sulfinylimidazolidines%26aulast%3DViso%26aufirst%3DAlma%26date%3D2007%26volume%3D63%26issue%3D33%26spage%3D8017%26epage%3D8026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">Jiawang  Zhu</span>, <span class="hlFld-ContribAuthor ">Christopher  Fotsch</span>, <span class="hlFld-ContribAuthor ">Yunxin  Bo</span>, <span class="hlFld-ContribAuthor ">Ning  Chen</span>, <span class="hlFld-ContribAuthor ">Partha  Chakrabarti</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Doherty</span>, <span class="hlFld-ContribAuthor ">Narender R.  Gavva</span>, <span class="hlFld-ContribAuthor ">Nobuko  Nishimura</span>, <span class="hlFld-ContribAuthor ">Thomas  Nixey</span>, <span class="hlFld-ContribAuthor ">Vassil I.  Ognyanov</span>, <span class="hlFld-ContribAuthor ">Robert M.  Rzasa</span>, <span class="hlFld-ContribAuthor ">Markian  Stec</span>, <span class="hlFld-ContribAuthor ">Sekhar  Surapaneni</span>, <span class="hlFld-ContribAuthor ">Rami  Tamir</span>, <span class="hlFld-ContribAuthor ">Vellarkad N.  Viswanadhan</span>, <span class="hlFld-ContribAuthor ">James J. S.  Treanor</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Vanilloid Receptor-1 Antagonists:  1. Conformationally Restricted Analogues of
              trans
              -Cinnamides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2007,</strong> <em>50 </em>
                                    (15)
                                     , 3497-3514. <a href="https://doi.org/10.1021/jm070189q" title="DOI URL">https://doi.org/10.1021/jm070189q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm070189q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm070189q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BVanilloid%252BReceptor-1%252BAntagonists%25253A%2525E2%252580%252589%252B1.%252BConformationally%252BRestricted%252BAnalogues%252Bof%252Btrans%252B-Cinnamides%26aulast%3DNorman%26aufirst%3DMark%2BH.%26date%3D2007%26date%3D2007%26volume%3D50%26issue%3D15%26spage%3D3497%26epage%3D3514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Jodie  Katon</span>, <span class="hlFld-ContribAuthor ">Chenera  Balan</span>, <span class="hlFld-ContribAuthor ">Anthony W.  Bannon</span>, <span class="hlFld-ContribAuthor ">Charles  Bernard</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Doherty</span>, <span class="hlFld-ContribAuthor ">Celia  Dominguez</span>, <span class="hlFld-ContribAuthor ">Narender R.  Gavva</span>, <span class="hlFld-ContribAuthor ">Vijay  Gore</span>, <span class="hlFld-ContribAuthor ">Vu  Ma</span>, <span class="hlFld-ContribAuthor ">Nobuko  Nishimura</span>, <span class="hlFld-ContribAuthor ">Sekhar  Surapaneni</span>, <span class="hlFld-ContribAuthor ">Phi  Tang</span>, <span class="hlFld-ContribAuthor ">Rami  Tamir</span>, <span class="hlFld-ContribAuthor ">Oliver  Thiel</span>, <span class="hlFld-ContribAuthor ">James J. S.  Treanor</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Vanilloid Receptor-1 Antagonists:  3. The Identification of a Second-Generation Clinical Candidate with Improved Physicochemical and Pharmacokinetic Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2007,</strong> <em>50 </em>
                                    (15)
                                     , 3528-3539. <a href="https://doi.org/10.1021/jm070191h" title="DOI URL">https://doi.org/10.1021/jm070191h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm070191h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm070191h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BVanilloid%252BReceptor-1%252BAntagonists%25253A%2525E2%252580%252589%252B3.%252BThe%252BIdentification%252Bof%252Ba%252BSecond-Generation%252BClinical%252BCandidate%252Bwith%252BImproved%252BPhysicochemical%252Band%252BPharmacokinetic%252BProperties%26aulast%3DWang%26aufirst%3DHui-Ling%26date%3D2007%26date%3D2007%26volume%3D50%26issue%3D15%26spage%3D3528%26epage%3D3539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Han</span>, <span class="hlFld-ContribAuthor ">Heath A.  McDonald</span>, <span class="hlFld-ContribAuthor ">Bruce R.  Bianchi</span>, <span class="hlFld-ContribAuthor ">Rachid El  Kouhen</span>, <span class="hlFld-ContribAuthor ">Melissa H.  Vos</span>, <span class="hlFld-ContribAuthor ">Michael F.  Jarvis</span>, <span class="hlFld-ContribAuthor ">Connie R.  Faltynek</span>, <span class="hlFld-ContribAuthor ">Robert B.  Moreland</span>. </span><span class="cited-content_cbyCitation_article-title">Capsaicin causes protein synthesis inhibition and microtubule disassembly through TRPV1 activities both on the plasma membrane and intracellular membranes. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2007,</strong> <em>73 </em>
                                    (10)
                                     , 1635-1645. <a href="https://doi.org/10.1016/j.bcp.2006.12.035" title="DOI URL">https://doi.org/10.1016/j.bcp.2006.12.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2006.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2006.12.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DCapsaicin%252Bcauses%252Bprotein%252Bsynthesis%252Binhibition%252Band%252Bmicrotubule%252Bdisassembly%252Bthrough%252BTRPV1%252Bactivities%252Bboth%252Bon%252Bthe%252Bplasma%252Bmembrane%252Band%252Bintracellular%252Bmembranes%26aulast%3DHan%26aufirst%3DPing%26date%3D2007%26volume%3D73%26issue%3D10%26spage%3D1635%26epage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arpad  Szallasi</span>, <span class="hlFld-ContribAuthor ">Daniel N.  Cortright</span>, <span class="hlFld-ContribAuthor ">Charles A.  Blum</span>, <span class="hlFld-ContribAuthor ">Samer R.  Eid</span>. </span><span class="cited-content_cbyCitation_article-title">The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2007,</strong> <em>6 </em>
                                    (5)
                                     , 357-372. <a href="https://doi.org/10.1038/nrd2280" title="DOI URL">https://doi.org/10.1038/nrd2280</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd2280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd2280%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DThe%252Bvanilloid%252Breceptor%252BTRPV1%25253A%252B10%252Byears%252Bfrom%252Bchannel%252Bcloning%252Bto%252Bantagonist%252Bproof-of-concept%26aulast%3DSzallasi%26aufirst%3DArpad%26date%3D2007%26volume%3D6%26issue%3D5%26spage%3D357%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anil  Vasudevan</span>, <span class="hlFld-ContribAuthor ">Michael E.  Kort</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 6 Advances in Transient Receptor Potential Modulators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2007,</strong>,, 81-91. <a href="https://doi.org/10.1016/S0065-7743(07)42006-1" title="DOI URL">https://doi.org/10.1016/S0065-7743(07)42006-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0065-7743(07)42006-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0065-7743%2807%2942006-1%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B6%252BAdvances%252Bin%252BTransient%252BReceptor%252BPotential%252BModulators%26aulast%3DVasudevan%26aufirst%3DAnil%26date%3D2007%26spage%3D81%26epage%3D91%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B42%26date%3D2007%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yf00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yf00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00001.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 The TRPV1 agonists capsaicin and resiniferatoxin and selected examples of TRPV1 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yf00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yh00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00001.jpeg" id="rightTab-_i8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> R<sub>1</sub> = H; X, Y, P, and Q = C or N. <i><sup>b</sup></i><sup></sup>Conditions:  (a) <i>N</i>,<i>N</i>-diisopropylethylamine, CH<sub>3</sub>CN, 180 °C, microwave; (b) <i>N</i>,<i>N</i>-diisopropylethylamine, DMSO, 80 °C; (c) Et<sub>3</sub>N, CuI, 3-methyl-1-butanol, 220 °C, microwave; (d) <i>N</i>,<i>N</i>-diisopropylethylamine, dioxane, 190 °C, microwave; (e) NaHCO<sub>3</sub>, 3-methyl-1-butanol, 150 °C, microwave; (f) <i>N</i>,<i>N</i>-diisopropylethylamine, 250 °C, microwave; (g) K<sub>2</sub>CO<sub>3</sub>, Cu powder, DMF, 120 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yh00002" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00002.jpeg" id="rightTab-_i10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) for <b>8a</b>,<b> 8g</b>,<b> 8h</b>,<b> 8i</b>,<b> 8o</b>, <b>8s</b><b>−</b><b>u</b>, and<b> 8ag</b>, Cu-powder, K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C; for <b>8c</b>, <b>8d</b>, <b>8f</b>, <b>8q</b>, <b>8r, 8ad,</b> and <b>8ae</b>, <i>N</i>,<i>N</i>-diisopropylethylamine, NMP, 240 °C, microwave; for <b>8ab</b> and <b>8ac</b>, NaHCO<sub>3</sub>, 3-methylbutan-1-ol, 170 °C, microwave; (b) MnO<sub>2</sub>, 1:1 CH<sub>2</sub>Cl<sub>2</sub>/hexane, 20 °C; (c) 3 M MeMgBr in Et<sub>2</sub>O, THF, 20 °C; (d) <i>p</i>-TsOH, MeOH, reflux; (e) (1) (COCl)<sub>2</sub>, DMF, 20 °C; (2) 28% NH<sub>4</sub>OH, 20 °C; (f) (1) (COCl)<sub>2</sub>, DMF, 20 °C; (2) CH<sub>3</sub>ONHCH<sub>3</sub>·HCl, 10% K<sub>2</sub>CO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (g) sat. solution of HCl in EtOAc, 20 °C; (h) 2,3,4,5,6-pentafluorophenol, 1,3-dicyclohexylcarbodiimide, EtOAc, 20 °C; (i) 2 M MeNH<sub>2</sub> in THF, 20 °C; (j) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (k) O(COO-<i>t</i>-Bu)<sub>2</sub>, 1 N NaOH, THF, 20 °C; (l) Br<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (m) CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHCO<sub>2</sub>Me, Pd(OAc)<sub>2</sub>, benzyltriethylammonium chloride, DMF, 40 °C; (n) (1) 4% OsO<sub>4</sub> in H<sub>2</sub>O, <i>N</i>-methylmorpholine <i>N</i>-oxide, acetone, 20 °C; (2) Pb(OAc)<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (o) NaBH<sub>4</sub>, MeOH, 0 °C;</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yh00003" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00003.jpeg" id="rightTab-_i12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) <i>N</i>,<i>N</i>-diisopropylethylamine, NMP, 240 °C, microwave; (b) Cu-powder, K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (d) sat. solution of HCl in EtOAc, 20 °C; (e) (1) 200 °C, microwave; (2) 1 N NaOH. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yh00004" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00004.jpeg" id="rightTab-_i14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) MeO<sub>2</sub>CCH<sub>2</sub>NH<sub>2</sub>·HCl, 1-hydroxy-7-azabenzotriazole, <i>N,N</i>-diisopropylethylamine, PS-carbodiimide, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (b) piperidine, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (c) LiAlH<sub>4</sub>, THF, reflux.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yh00005" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00005.jpeg" id="rightTab-_i16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a,b</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> X and Y = C or N. <i><sup>b</sup></i><sup></sup>Conditions:  (a) for <b>19a</b><b>−</b><b>d</b>, <b>19f</b><b>−</b><b>h, 19j</b><b>−</b><b>o</b>, 1,1‘-carbonyldiimidazole, THF, 20 °C; for <b>19e</b>, <i>N</i>,<i>N</i>-disuccinimidyl carbonate, MeCN, 75 °C; (b) 3,4,5-trifluorophenylboronic acid, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, MeO(CH<sub>2</sub>)<sub>2</sub>OMe, H<sub>2</sub>O, EtOH, 120 °C, microwave; (c) POCl<sub>3</sub>, 95 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yh00006" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00006.jpeg" id="rightTab-_i18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) Ac<sub>2</sub>O, 20 °C; (b) concd HNO<sub>3</sub>, concd H<sub>2</sub>SO<sub>4</sub>, 0−20 °C; (c) 3 N NaOH, MeOH, 90 °C; (d) SnCl<sub>2</sub>·H<sub>2</sub>O, EtOAc, EtOH, 70 °C; (e) H<sub>2</sub>, 10% Pd/C, EtOH, 20 °C; (f) 4-methoxybenzylamine, NaHCO<sub>3</sub>, 3-methyl-1-butanol, 220 °C, microwave; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yh00007" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00007.jpeg" id="rightTab-_i20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 7 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) for <b>30a</b>, DMSO, 80 °C; for <b>30b</b>, <i>N</i>,<i>N</i>-diisopropylethylamine, MeCN, 180 °C, microwave.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yh00008" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00008.jpeg" id="rightTab-_i22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 8 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) H<sub>2</sub>, 10% Pd/C, EtOH, 20 °C; (b) 3,4,5-trifluorobenzaldehyde, NaBH(OAc)<sub>3</sub>, CHCl<sub>3</sub>, 20 °C; (c) O(COO-<i>t</i>-Bu)<sub>2</sub>, 1 N NaOH, THF, 20 °C; (d) cyclohexanecarboxylic acid, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide·HCl, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (e) PhCH<sub>2</sub>CHO, NaBH(OAc)<sub>3</sub>, CHCl<sub>3</sub>, 20 °C; (f) SnCl<sub>2</sub>·H<sub>2</sub>O, DMF, 80 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00008"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yh00009" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00009.jpeg" id="rightTab-_i24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 9 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup>  Conditions:  (a) MnO<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (b) for <b>38a</b>, (1) 1 N NaOH, THF, 50 °C; (2) 1 N HCl, 20 °C; for <b>38b</b>, NaBH<sub>4</sub>, MeOH, 0 °C; for <b>38c</b>, CH<sub>3</sub>MgBr, THF, 0 °C; for <b>38d</b>, C<sub>6</sub>H<sub>5</sub>MgBr, THF, 0 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00009"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yh00010" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00010.jpeg" id="rightTab-_i26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 10 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) (1) 50% NaH in mineral oil, DMF, 0−20 °C; (2) C<sub>6</sub>H<sub>5</sub>CH<sub>2</sub>Br, 0 to 20 °C; (3) separation by column chromatography. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00010"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yh00011" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yh00011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00011.jpeg" id="rightTab-_i28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 11 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Conditions:  (a) for <b>46a</b>, <b>42</b>, 3,4-difluorophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, LiCl, MeO(CH<sub>2</sub>)<sub>2</sub>OMe, H<sub>2</sub>O, EtOH, 80 °C; for <b>46b</b>, <b>43a</b>, 4-trifluoromethylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, dioxane, 170 °C, microwave; for <b>46c</b>, <b>43b</b>, 4-CF<sub>3</sub>C<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>NH<sub>2</sub>, tris(dibenzylideneacetone)dipalladium(0), 2-(di-<i>tert</i>-butylphosphino)biphenyl, <i>t</i>-BuONa, toluene, 150 °C, microwave; for <b>46e</b>, <b>34</b>, 4-fluorophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for <b>46g</b>, <b>44b</b>, piperidine, tris(dibenzylideneacetone)dipalladium(0), 2-(di-<i>tert</i>-butylphosphino)biphenyl, <i>t</i>-BuONa, toluene, 150 °C, microwave; for <b>46i</b>, <b>44b</b>, morpholine, tris(dibenzylideneacetone)dipalladium(0), 2-(di-<i>tert</i>-butylphosphino)biphenyl, <i>t</i>-BuONa, toluene, 150 °C, microwave; for <b>46k </b>and<b> 46l</b>, <b>44c</b>, (1) 3,4,5-trifluorophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 0.4 M Na<sub>2</sub>CO<sub>3</sub>, MeCN, 90 °C, (2) separation of diastereoisomers by prep. HPLC; for <b>46m</b>, <b>44a</b>, 3,4,5-trifluorophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, dioxane, 170 °C, microwave; for <b>46n</b>, <b>44a</b>, 2-tributylstannylthiazole, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 140 °C, microwave; for <b>46o</b>, <b>44a</b>, 0.5 M 3,4-difluorobenzylzinc bromide, Pd(PPh<sub>3</sub>)<sub>4</sub>, THF, reflux; for<b> 46p</b>, <b>44a</b>, (1) 4,4,5,5-tetramethyl-2-(4-trifluoromethylcyclohex-1-enyl)[1,3,2]dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, MeO(CH<sub>2</sub>)<sub>2</sub>OMe, 200 °C, microwave; (2) H<sub>2</sub>, 10% Pd/C, EtOH, 20 °C; for<b> 46q</b>, <b>44a</b>, 4-trifluoromethylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, LiCl, MeO(CH<sub>2</sub>)<sub>2</sub>OMe, H<sub>2</sub>O, EtOH, 80 °C; for 46r, <b>44a</b>, phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, LiCl, MeO(CH<sub>2</sub>)<sub>2</sub>OMe, H<sub>2</sub>O, EtOH, 80 °C; for<b> 46s</b>, <b>44a</b>, 3-trifluoromethoxyphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46t</b>, <b>44a</b>, 4-<i>tert</i>-butylphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46u</b>, <b>44a</b>, thiophen-2-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46v</b>, <b>44a</b>, pyridin-4-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46w</b>, <b>44a</b>, 2-tributylstannylpyrazine, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 140 °C, microwave; for <b>46x</b>, <b>44a</b>, 3-(6-methoxypyridyl)boronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46y</b>, <b>44a</b>, benzo[<i>b</i>]thiophen-2-ylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46z</b>, <b>44a</b>, 4-aminophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46aa</b>, <b>44a</b>, 4-dimethylaminophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for<b> 46ab</b>, <b>44a</b>, <i>trans</i>-2-phenylvinylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, H<sub>2</sub>O, EtOH, 82 °C; for <b>46ac</b>, <b>45</b>, CH<sub>2</sub><img src="/entityImage/legacy/dbd.gif" alt="" class="privateChar" /></img>CHSnBu<sub>3</sub>, Pd(Ph<sub>3</sub>P)<sub>4</sub>, 3,5-di-<i>tert</i>-butylphenol, LiCl, dioxane, 95 °C; (b) 2-(trimethylsilyl)ethoxymethyl chloride, <i>N</i>,<i>N</i>-diisopropylethylamine, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (d) (1) CH<sub>3</sub>CO<sub>2</sub>CH<sub>2</sub>CO<sub>2</sub>H, benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate, <i>N</i>,<i>N</i>-diisopropylethylamine, CH<sub>2</sub>Cl<sub>2</sub>, 20 °C; (2) K<sub>2</sub>CO<sub>3</sub>, MeOH, 20 °C; (e) 4-methylmorpholine <i>N</i>-oxide, OsO<sub>4</sub>, acetone, 20 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yh00011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yh00011"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yf00002" data-index="13" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yf00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00002.jpeg" id="rightTab-_i40" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Effect of compound <b>46ad</b> on capsaicin-induced flinching in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yf00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yf00003" data-index="14" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yf00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00003.jpeg" id="rightTab-_i42" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Effect of compound <b>46ad</b> on CFA-induced thermal hyperalgesia in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yf00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm060065yf00004" data-index="15" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/medium/jm060065yf00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00004.jpeg" id="rightTab-_i45" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Summary of SAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-12/jm060065y/production/images/large/jm060065yf00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm060065y&amp;id=jm060065yf00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><a name="jm004901203742" id="jm004901203742"></a></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm060065yb00001"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00001_1"><span><span class="NLM_string-ref">Vanilloid receptor-1 is referred to as TRPV1 in this report according to the recently adopted nomenclature:  Montell, C.; Birnbaumer, L.; Flockerzi, V.; Bindels, R. J.; Bruford, E. A.; Caterina, M. J.; Clapham, D. E.; Harteneck, C.; Heler, S.; Julius, D.; Kojima, I.; Mori, Y.; Penner, R.; Prawitt, D.; Scharenberg, A. M.; Schultz, G.; Shimizu, N.; Zhu, M. X. A unified nomenclature for the superfamily of TRP cation channels. <i>  Mol. Cell</i><b>2002</b>, <i>9</i>, 229−231.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=+Vanilloid&author=L.+Birnbaumer&author=V.+Flockerzi&author=R.+J.+Bindels&author=E.+A.+Bruford&author=M.+J.+Caterina&author=D.+E.+Clapham&author=C.+Harteneck&author=S.+Heler&author=D.+Julius&author=I.+Kojima&author=Y.+Mori&author=R.+Penner&author=D.+Prawitt&author=A.+M.+Scharenberg&author=G.+Schultz&author=N.+Shimizu&author=M.+X.+Zhu&title=A+unified+nomenclature+for+the+superfamily+of+TRP+cation+channels.+Mol.+Cell"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVanilloid%26btitle%3DA%2520unified%2520nomenclature%2520for%2520the%2520superfamily%2520of%2520TRP%2520cation%2520channels.%2520Mol.%2520Cell%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00002"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00002_1"><span><span class="NLM_string-ref">Szallasi, A.; Blumberg, P. M. Vanilloid (capsaicin) receptors and mechanisms. <i>  Pharmacol. Rev</i>. <b>1999</b>, <i>51</i>, 159−212.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=212&author=A.+Szallasi&author=P.+M.+Blumberg&author=+Vanilloid&title=receptors+and+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26atitle%3Dreceptors%2520and%2520mechanisms%26jtitle%3DPharmacol.%2520Rev.%26date%3D1999%26volume%3D51%26spage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00003"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00003_1"><span><span class="NLM_string-ref">Caterina, M. J.; Julius, D. The vanilloid receptor:  A molecular gateway to the pain pathway. <i>  Annu. Rev. Neurosci</i>. <b>2001</b>, <i>24</i>, 487−517.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=517&author=M.+J.+Caterina&author=D+Julius&title=The+vanilloid+receptor%3A%E2%80%89+A+molecular+gateway+to+the+pain+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaterina%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520vanilloid%2520receptor%253A%25E2%2580%2589%2520A%2520molecular%2520gateway%2520to%2520the%2520pain%2520pathway%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D24%26spage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00004"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00004_1"><span><span class="NLM_string-ref">Szallasi, A. Vanilloid (capsaicin) receptors in health and disease. <i>  Am. J. Clin. </i><i>Pathol</i>. <b>2002</b>, <i>118</i>, 110−121.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2002&pages=121&author=A.+Szallasi&author=+Vanilloid&title=receptors+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26atitle%3Dreceptors%2520in%2520health%2520and%2520disease%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D2002%26volume%3D118%26spage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00005"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00005_1"><span><span class="NLM_string-ref">Tominaga, M.; Caterina, M. J.; Malmberg, A. B.; Rosen, T. A.; Gilbert, H.; Skinner, K.; Raumann, B. E.; Basbaum, A. I.; Julius, D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. <i>  Neuron </i><b>1998</b>, <i>21</i>, 531−543.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=543&author=M.+Tominaga&author=M.+J.+Caterina&author=A.+B.+Malmberg&author=T.+A.+Rosen&author=H.+Gilbert&author=K.+Skinner&author=B.+E.+Raumann&author=A.+I.+Basbaum&author=D+Julius&title=The+cloned+capsaicin+receptor+integrates+multiple+pain-producing+stimuli"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTominaga%26aufirst%3DM.%26atitle%3DThe%2520cloned%2520capsaicin%2520receptor%2520integrates%2520multiple%2520pain-producing%2520stimuli%26jtitle%3DNeuron%26date%3D1998%26volume%3D21%26spage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00006"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00006_1"><span><span class="NLM_string-ref">Ji, R. R.; Samad, T. A.; Jin, S. X.; Schmoll, R.; Woolf, C. J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. <i>  Neuron</i><b>2002</b>, <i>36</i>, 57−68.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=68&author=R.+R.+Ji&author=T.+A.+Samad&author=S.+X.+Jin&author=R.+Schmoll&author=C.+J.+Woolf&title=MAPK+activation+by+NGF+in+primary+sensory+neurons+after+inflammation+increases+TRPV1+levels+and+maintains+heat+hyperalgesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DR.%2BR.%26atitle%3DMAPK%2520activation%2520by%2520NGF%2520in%2520primary%2520sensory%2520neurons%2520after%2520inflammation%2520increases%2520TRPV1%2520levels%2520and%2520maintains%2520heat%2520hyperalgesia%26jtitle%3DNeuron%26date%3D2002%26volume%3D36%26spage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00007"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00007_1"><span><span class="NLM_string-ref">Hudson, L. J.; Bevan, S.; Witherspoon, G.; Gentry, C.; Fox, A.; Winter, J. VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. <i>  Eur. J. Neurosci</i>. <b>2001</b>, <i>13</i>, 2105−2114.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=2114&author=L.+J.+Hudson&author=S.+Bevan&author=G.+Witherspoon&author=C.+Gentry&author=A.+Fox&author=J.+Winter&title=protein+expression+increases+in+undamaged+DRG+neurons+after+partial+nerve+injury"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DL.%2BJ.%26atitle%3Dprotein%2520expression%2520increases%2520in%2520undamaged%2520DRG%2520neurons%2520after%2520partial%2520nerve%2520injury%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2001%26volume%3D13%26spage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00008"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00008_1"><span><span class="NLM_string-ref">Tympanidis, P.; Casula, M. A.; Yiangou, Y.; Terenghi, G.; Dowd, P.; Anand, P. Increased vanilloid receptor VR1 in nervation in vulvodynia. <i>  Eur. J. Pain</i><b>2004</b>, <i>8</i>, 129−133.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2004&pages=133&author=P.+Tympanidis&author=M.+A.+Casula&author=Y.+Yiangou&author=G.+Terenghi&author=P.+Dowd&author=P+Anand&title=Increased+vanilloid+receptor+VR1+in+nervation+in+vulvodynia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTympanidis%26aufirst%3DP.%26atitle%3DIncreased%2520vanilloid%2520receptor%2520VR1%2520in%2520nervation%2520in%2520vulvodynia%26jtitle%3DEur.%2520J.%2520Pain%26date%3D2004%26volume%3D8%26spage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00009"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00009_1"><span><span class="NLM_string-ref">Chan, C. L.; Facer, P.; Davis, J. B.; Smith, G. D.; Egerton, J.; Bountra, C.; Williams, N. S.; Anand, P. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. <i>  Lancet</i><b>2003</b>, <i>361 </i>(9355), 385−391.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2003&pages=391&issue=9355&author=C.+L.+Chan&author=P.+Facer&author=J.+B.+Davis&author=G.+D.+Smith&author=J.+Egerton&author=C.+Bountra&author=N.+S.+Williams&author=P+Anand&title=Sensory+fibres+expressing+capsaicin+receptor+TRPV1+in+patients+with+rectal+hypersensitivity+and+faecal+urgency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DC.%2BL.%26atitle%3DSensory%2520fibres%2520expressing%2520capsaicin%2520receptor%2520TRPV1%2520in%2520patients%2520with%2520rectal%2520hypersensitivity%2520and%2520faecal%2520urgency%26jtitle%3DLancet%26date%3D2003%26volume%3D361%26issue%3D9355%26spage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm060065yb00010_1"><span><span class="NLM_string-ref">Tominaga, M.; Caterina, M. J.; Malmberg, A. B.; Rosen, T. A.; Gilbert, H.; Skinner, K.; Raumann, B. E.; Basbaum, A. I. Julius, D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. <i>  Neuron</i><b>1998</b>, <i>21</i>, 531−543.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=543&author=M.+Tominaga&author=M.+J.+Caterina&author=A.+B.+Malmberg&author=T.+A.+Rosen&author=H.+Gilbert&author=K.+Skinner&author=B.+E.+Raumann&author=A.+I.+Basbaum&author=D+Julius&title=The+cloned+capsaicin+receptor+integrates+multiple+pain-producing+stimuli"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTominaga%26aufirst%3DM.%26atitle%3DThe%2520cloned%2520capsaicin%2520receptor%2520integrates%2520multiple%2520pain-producing%2520stimuli%26jtitle%3DNeuron%26date%3D1998%26volume%3D21%26spage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00011"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00011_1"><span><span class="NLM_string-ref">Smart, D.; Gunthrope, M. J.; Jerman, J. C.; Nasir, S.; Gray, J.; Muir, A. I.; Chambers, J. K.; Randal, A. D.; Davis, J. B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). <i>  Br. J. </i><i>Pharm</i>. <b>2000</b>, <i>129</i>, 227−230.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=230&author=D.+Smart&author=M.+J.+Gunthrope&author=J.+C.+Jerman&author=S.+Nasir&author=J.+Gray&author=A.+I.+Muir&author=J.+K.+Chambers&author=A.+D.+Randal&author=J.+B+Davis&title=The+endogenous+lipid+anandamide+is+a+full+agonist+at+the+human+vanilloid+receptor+%28hVR1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmart%26aufirst%3DD.%26atitle%3DThe%2520endogenous%2520lipid%2520anandamide%2520is%2520a%2520full%2520agonist%2520at%2520the%2520human%2520vanilloid%2520receptor%2520%2528hVR1%2529%26jtitle%3DBr.%2520J.%2520Pharm.%26date%3D2000%26volume%3D129%26spage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00012"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00012_1"><span><span class="NLM_string-ref">Hwang, S. W.; Cho, H.; Kwak, J.; Lee, S.-Y.; Kang, C.-J.; Jung, J.; Cho, S.; Min, K. H.; Suh, Y.-G.; Kim, D.; Oh, U. Direct activation of capsaicin receptors by products of lipoxygenases:  Endogenous capsaicin-like substances. <i>  Proc. Natl. Acad. Sci. U.S.A.</i><b>2000</b>, <i>97</i>, 6155−6160.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=6160&author=S.+W.+Hwang&author=H.+Cho&author=J.+Kwak&author=S.-Y.+Lee&author=C.-J.+Kang&author=J.+Jung&author=S.+Cho&author=K.+H.+Min&author=Y.-G.+Suh&author=D.+Kim&author=U+Oh&title=Direct+activation+of+capsaicin+receptors+by+products+of+lipoxygenases%3A%E2%80%89+Endogenous+capsaicin-like+substances"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.%2BW.%26atitle%3DDirect%2520activation%2520of%2520capsaicin%2520receptors%2520by%2520products%2520of%2520lipoxygenases%253A%25E2%2580%2589%2520Endogenous%2520capsaicin-like%2520substances%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D6160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00013"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00013_1"><span><span class="NLM_string-ref">Appendino, G.; Szallasi, A. Euphorbium:  Modern research on its active principle, resiniferatoxin, revives an ancient medicine. <i>  Life Sci.</i><b>1997</b>, <i>60</i>, 681−696.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1997&pages=696&author=G.+Appendino&author=A.+Szallasi&author=+Euphorbium&title=Modern+research+on+its+active+principle%2C+resiniferatoxin%2C+revives+an+ancient+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppendino%26aufirst%3DG.%26atitle%3DModern%2520research%2520on%2520its%2520active%2520principle%252C%2520resiniferatoxin%252C%2520revives%2520an%2520ancient%2520medicine%26jtitle%3DLife%2520Sci.%26date%3D1997%26volume%3D60%26spage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00014"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00014_1"><span><span class="NLM_string-ref">Appendino, G.; Munoz, E.; Fiebich, B. L. TRPV1 (vanilloid receptor, capsaicin receptor) agonists and antagonists. <i>  Expert Opin. Ther. Patents</i><b>2003</b>, <i>13</i>, 1825−1837.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1837&author=G.+Appendino&author=E.+Munoz&author=B.+L.+Fiebich&title=agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppendino%26aufirst%3DG.%26atitle%3Dagonists%2520and%2520antagonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2003%26volume%3D13%26spage%3D1837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00015"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00015_1"><span><span class="NLM_string-ref">Caterina, M. J.; Leffler, A.; Malmberg, A. B.; Martin, W. J.; Trafton. J.; Petersen-Zeitz, K. R.; Koltzenburg, M.; Basbaum, A. I.; Julius, D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. <i>  Science</i><b>2000</b>, <i>288</i>, 306−313.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2000&pages=313&author=M.+J.+Caterina&author=A.+Leffler&author=A.+B.+Malmberg&author=W.+J.+Martin&author=J.+Trafton&author=K.+R.+Petersen-Zeitz&author=M.+Koltzenburg&author=A.+I.+Basbaum&author=D+Julius&title=Impaired+nociception+and+pain+sensation+in+mice+lacking+the+capsaicin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaterina%26aufirst%3DM.%2BJ.%26atitle%3DImpaired%2520nociception%2520and%2520pain%2520sensation%2520in%2520mice%2520lacking%2520the%2520capsaicin%2520receptor%26jtitle%3DScience%26date%3D2000%26volume%3D288%26spage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00016"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00016_1"><span><span class="NLM_string-ref">Davis, J. B.; Gray, J.; Gunthrope, M. J.; Hatcher, J. P.; Davey, P. T.; Overend, P.; Harries, M. H.; Latcham, J.; Clapham, C.; Atkinson, K.; Hughes, S. A.; Rance, K.; Grau, E.; Harper, A. J.; Pugh, P. L.; Rogers, D. C.; Bingham, S.; Randall, A.; Sheardown, S. A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. <i>  Nature</i><b>2000</b>, <i>405</i>, 183−187.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=187&author=J.+B.+Davis&author=J.+Gray&author=M.+J.+Gunthrope&author=J.+P.+Hatcher&author=P.+T.+Davey&author=P.+Overend&author=M.+H.+Harries&author=J.+Latcham&author=C.+Clapham&author=K.+Atkinson&author=S.+A.+Hughes&author=K.+Rance&author=E.+Grau&author=A.+J.+Harper&author=P.+L.+Pugh&author=D.+C.+Rogers&author=S.+Bingham&author=A.+Randall&author=S.+A+Sheardown&title=Vanilloid+receptor-1+is+essential+for+inflammatory+thermal+hyperalgesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DJ.%2BB.%26atitle%3DVanilloid%2520receptor-1%2520is%2520essential%2520for%2520inflammatory%2520thermal%2520hyperalgesia%26jtitle%3DNature%26date%3D2000%26volume%3D405%26spage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00017"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00017_1"><span><span class="NLM_string-ref">Walpole, C. S. J.; Bevan, S.; Bovermann, G.; Boelsterli, J. J.; Breckenridge, R.; Davies, J. W.; Hughes, G. A.; James, I. F.; Oberer, L.; Winter, J.; Wrigglesworth, R. The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. <i>  J. </i><i>Med. Chem</i>. <b>1994</b>, <i>37</i>, 1942−1954.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1954&author=C.+S.+J.+Walpole&author=S.+Bevan&author=G.+Bovermann&author=J.+J.+Boelsterli&author=R.+Breckenridge&author=J.+W.+Davies&author=G.+A.+Hughes&author=I.+F.+James&author=L.+Oberer&author=J.+Winter&author=R+Wrigglesworth&title=The+discovery+of+capsazepine%2C+the+first+competitive+antagonist+of+the+sensory+neuron+excitants+capsaicin+and+resiniferatoxin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalpole%26aufirst%3DC.%2BS.%2BJ.%26atitle%3DThe%2520discovery%2520of%2520capsazepine%252C%2520the%2520first%2520competitive%2520antagonist%2520of%2520the%2520sensory%2520neuron%2520excitants%2520capsaicin%2520and%2520resiniferatoxin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00018"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00018_1"><span><span class="NLM_string-ref">Kwak, J. Y.; Jung, J. Y.; Hwang, S. W.; Lee, W. T.; Oh. U. A capsaicin-receptor antagonist, capsazepine, reduces inflammation-induced hyperalgesic responses in the rat:  Evidence for an endogenous capsaicin-like substance. <i>  Neuroscience</i><b>1998</b>, <i>86</i>, 619−626.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1998&pages=626&author=J.+Y.+Kwak&author=J.+Y.+Jung&author=S.+W.+Hwang&author=W.+T.+Lee&author=U+Oh&title=A+capsaicin-receptor+antagonist%2C+capsazepine%2C+reduces+inflammation-induced+hyperalgesic+responses+in+the+rat%3A%E2%80%89+Evidence+for+an+endogenous+capsaicin-like+substance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DJ.%2BY.%26atitle%3DA%2520capsaicin-receptor%2520antagonist%252C%2520capsazepine%252C%2520reduces%2520inflammation-induced%2520hyperalgesic%2520responses%2520in%2520the%2520rat%253A%25E2%2580%2589%2520Evidence%2520for%2520an%2520endogenous%2520capsaicin-like%2520substance%26jtitle%3DNeuroscience%26date%3D1998%26volume%3D86%26spage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00019"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00019_1"><span><span class="NLM_string-ref">Santos, A. R. S.; Calixto, J. B. Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice. <i>  Neurosci. Lett</i>. <b>1997</b>, <i>235</i>, 73−76.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=1997&pages=76&author=A.+R.+S.+Santos&author=J.+B+Calixto&title=Ruthenium+red+and+capsazepine+antinociceptive+effect+in+formalin+and+capsaicin+models+of+pain+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DA.%2BR.%2BS.%26atitle%3DRuthenium%2520red%2520and%2520capsazepine%2520antinociceptive%2520effect%2520in%2520formalin%2520and%2520capsaicin%2520models%2520of%2520pain%2520in%2520mice%26jtitle%3DNeurosci.%2520Lett.%26date%3D1997%26volume%3D235%26spage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm060065yb00020_1"><span><span class="NLM_string-ref">Walker, K. M.; Urban, L.; Medhurst, S. J.; Patel, S.; Panesar, M.; Fox, A. J.; McIntyre, P. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and meuropathic pain. <i>  J. </i><i>Pharmacol. Exp. Ther</i>. <b>2003</b>, <i>304</i>, 56−62.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=62&author=K.+M.+Walker&author=L.+Urban&author=S.+J.+Medhurst&author=S.+Patel&author=M.+Panesar&author=A.+J.+Fox&author=P+McIntyre&title=The+VR1+antagonist+capsazepine+reverses+mechanical+hyperalgesia+in+models+of+inflammatory+and+meuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DK.%2BM.%26atitle%3DThe%2520VR1%2520antagonist%2520capsazepine%2520reverses%2520mechanical%2520hyperalgesia%2520in%2520models%2520of%2520inflammatory%2520and%2520meuropathic%2520pain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26spage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00021"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00021_1"><span><span class="NLM_string-ref">Docherty, R. J.; Yeats, J. C.; Piper, A. S. Capsazepine block of voltage-gated calcium channels in adult rat dorsal root ganglion neurons in culture. <i>  Br. J. </i><i>Pharmacol.</i><b>1997</b>, <i>121</i>, 1461−1467.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1997&pages=1467&author=R.+J.+Docherty&author=J.+C.+Yeats&author=A.+S+Piper&title=Capsazepine+block+of+voltage-gated+calcium+channels+in+adult+rat+dorsal+root+ganglion+neurons+in+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDocherty%26aufirst%3DR.%2BJ.%26atitle%3DCapsazepine%2520block%2520of%2520voltage-gated%2520calcium%2520channels%2520in%2520adult%2520rat%2520dorsal%2520root%2520ganglion%2520neurons%2520in%2520culture%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D121%26spage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00022"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00022_1"><span><span class="NLM_string-ref">Liu, L.; Simon, S. A. Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia. <i>  Neurosci. Lett</i>. <b>1997</b>, <i>228</i>, 29−32.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=1997&pages=32&author=L.+Liu&author=S.+A+Simon&title=Capsazepine%2C+a+vanilloid+receptor+antagonist%2C+inhibits+nicotinic+acetylcholine+receptors+in+rat+trigeminal+ganglia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DCapsazepine%252C%2520a%2520vanilloid%2520receptor%2520antagonist%252C%2520inhibits%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520rat%2520trigeminal%2520ganglia%26jtitle%3DNeurosci.%2520Lett.%26date%3D1997%26volume%3D228%26spage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00023"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00023_1"><span><span class="NLM_string-ref">Rami, K. H.; Gunthorpe, M. J. The therapeutic potential of TRPV1 (VR1) antagonists:  Clinical answers await. <i>  Drug </i><i>Discuss.</i><i> Today:  Ther. Strategies</i><b>2004</b>, <i>1</i>, 97−104.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=K.+H.+Rami&author=M.+J.+Gunthorpe&title=The+therapeutic+potential+of+TRPV1+%28VR1%29+antagonists%3A%E2%80%89+Clinical+answers+await.+Drug+Discuss.+Today%3A%E2%80%89+Ther.+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRami%26aufirst%3DK.%2BH.%26btitle%3DThe%2520therapeutic%2520potential%2520of%2520TRPV1%2520%2528VR1%2529%2520antagonists%253A%25E2%2580%2589%2520Clinical%2520answers%2520await.%2520Drug%2520Discuss.%2520Today%253A%25E2%2580%2589%2520Ther.%2520Strategies%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00024"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00024_1"><span><span class="NLM_string-ref">Szallasi, A.; Appendino, G. Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse? <i>J. Med. </i><i>Chem. </i><b>2004</b>, <i>47</i>, 2717−2723.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2723&author=A.+Szallasi&author=G+Appendino&title=Vanilloid+receptor+TRPV1+antagonists+as+the+next+generation+of+painkillers.+Are+we+putting+the+cart+before+the+horse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzallasi%26aufirst%3DA.%26atitle%3DVanilloid%2520receptor%2520TRPV1%2520antagonists%2520as%2520the%2520next%2520generation%2520of%2520painkillers.%2520Are%2520we%2520putting%2520the%2520cart%2520before%2520the%2520horse%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00025"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00025" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00025_1"><span><span class="NLM_string-ref">Planellls-Cases R.; Garcia-Martinez, C.; Royo, M.; Perez-Paya, E.; Carreno, C.; Albericio, F.; Messeguer, A.; Ferrer-Montiel, A. Small molecules targeting the vanilloid receptor complex as drugs for inflammatory pain. <i>  Drugs Future </i><b>2003</b>, <i>28</i>, 787−795.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=795&author=R.+Planellls-Cases&author=C.+Garcia-Martinez&author=M.+Royo&author=E.+Perez-Paya&author=C.+Carreno&author=F.+Albericio&author=A.+Messeguer&author=A+Ferrer-Montiel&title=Small+molecules+targeting+the+vanilloid+receptor+complex+as+drugs+for+inflammatory+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlanellls-Cases%26aufirst%3DR.%26atitle%3DSmall%2520molecules%2520targeting%2520the%2520vanilloid%2520receptor%2520complex%2520as%2520drugs%2520for%2520inflammatory%2520pain%26jtitle%3DDrugs%2520Future%26date%3D2003%26volume%3D28%26spage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00026"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00026" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00026_1"><span><span class="NLM_string-ref">Lopez-Rodriguez, M.; Viso, A.; Ortega-Gutierrez, S. VR1 receptor modulators as potential drugs for neuropatic pain. <i>  Mini Rev. Med. Chem. </i><b>2003</b>, <i>3</i>, 729−748.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=748&author=M.+Lopez-Rodriguez&author=A.+Viso&author=S.+Ortega-Gutierrez&title=receptor+modulators+as+potential+drugs+for+neuropatic+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Rodriguez%26aufirst%3DM.%26atitle%3Dreceptor%2520modulators%2520as%2520potential%2520drugs%2520for%2520neuropatic%2520pain%26jtitle%3DMini%2520Rev.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00027"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00027" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00027_1"><span><span class="NLM_string-ref">McDonnell, M. E.; Zhang. S.-P.; Nasser, N.; Dubin, A. E.; Dax, S. L. 7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1. <i>  Bioorg. Med. Chem. Lett</i>. <b>2004</b>, <i>14</i>, 531−534.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=534&author=M.+E.+McDonnell&author=S.-P.+Zhang&author=N.+Nasser&author=A.+E.+Dubin&author=S.+L.+Dax&author=+Hydroxynaphthalen&title=and+-amide+antagonists+of+human+vanilloid+receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonnell%26aufirst%3DM.%2BE.%26atitle%3Dand%2520-amide%2520antagonists%2520of%2520human%2520vanilloid%2520receptor%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00028"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00028" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00028_1"><span><span class="NLM_string-ref">Rami, H. R.; Thompson, M.; Wyman, P.; Jerman, J. C.; Egerton, J.; Brough, S.; Stevens, A. J.; Randall, A. D.; Smart, D.; Gunthorpe, M. J.; Davis, J. B. Discovery of small molecule antagonists of TRPV1.<i> Bioorg. Med. Chem. </i><i>Lett</i>. <b>2004</b>, <i>14</i>, 3631−3634.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3634&author=H.+R.+Rami&author=M.+Thompson&author=P.+Wyman&author=J.+C.+Jerman&author=J.+Egerton&author=S.+Brough&author=A.+J.+Stevens&author=A.+D.+Randall&author=D.+Smart&author=M.+J.+Gunthorpe&author=J.+B+Davis&title=Discovery+of+small+molecule+antagonists+of+TRPV1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRami%26aufirst%3DH.%2BR.%26atitle%3DDiscovery%2520of%2520small%2520molecule%2520antagonists%2520of%2520TRPV1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00029"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00029" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00029_1"><span><span class="NLM_string-ref">Lee, J.; Kang, S. U.; Lim, J.-O.; Choi, H.-K.; Jin, M.-K.; Toth, A.; Pearce, L. V.; Tran, R.; Wang, Y.; Szabo, T.; Blumberg, P. M. <i>  N</i>-[4-(Methylsulfonylamino)benzyl]thiourea analogs as vanilloid receptor antagonists:  Analysis of structure−activity relationships for the “C-region”. <i>Bioorg</i>. <i>Med. Chem</i>. <b>2004</b>, <i>12</i>, 371−385.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Lee%2C+J.%3B+Kang%2C+S.+U.%3B+Lim%2C+J.-O.%3B+Choi%2C+H.-K.%3B+Jin%2C+M.-K.%3B+Toth%2C+A.%3B+Pearce%2C+L.+V.%3B+Tran%2C+R.%3B+Wang%2C+Y.%3B+Szabo%2C+T.%3B+Blumberg%2C+P.+M.+N-%5B4-%28Methylsulfonylamino%29benzyl%5Dthiourea+analogs+as+vanilloid+receptor+antagonists%3A%E2%80%89+Analysis+of+structure%E2%88%92activity+relationships+for+the+%E2%80%9CC-region%E2%80%9D.+Bioorg.+Med.+Chem.+2004%2C+12%2C+371%E2%88%92385.+Lee%2C+J.%3B+Kang%2C+S.+U.%3B+Lim%2C+J.-O.%3B+Choi%2C+H.-K.%3B+Jin%2C+M.-K.%3B+Toth%2C+A.%3B+Pearce%2C+L.+V.%3B+Tran%2C+R.%3B+Wang%2C+Y.%3B+Szabo%2C+T.%3B+Blumberg%2C+P.+M.+N-%5B4-%28Methylsulfonylamino%29benzyl%5Dthiourea+analogs+as+vanilloid+receptor+antagonists%3A%E2%80%89+Analysis+of+structure%E2%88%92activity+relationships+for+the+%E2%80%9CC-region%E2%80%9D.+Bioorg.+Med.+Chem.+2004%2C+12%2C+371%E2%88%92385."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00030"><div class="reference"><div class="NLM_citation" id="rightTab-jm060065yb00030_1"><span><span class="NLM_string-ref">Sun, Q.; Tafesse, L.; Islam, K.; Zhou, X.; Victory, S. F.; Zhang, C.; Hachicha, M.; Schmid, L. A.; Patel, A.; Rotshteyn, Y.; Valenzano, K. J.; Kyle, D. J. 4-(2-Pyridyl)piperazine-1-carboxamides:  Potent vanilloid receptor 1 antagonists. <i>  Bioorg. Med. Chem. Lett.</i><b> 2003</b>, <i>13</i>, 3611−3616.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3616&author=Q.+Sun&author=L.+Tafesse&author=K.+Islam&author=X.+Zhou&author=S.+F.+Victory&author=C.+Zhang&author=M.+Hachicha&author=L.+A.+Schmid&author=A.+Patel&author=Y.+Rotshteyn&author=K.+J.+Valenzano&author=D.+J.+Kyle&author=+Pyridyl&title=Potent+vanilloid+receptor+1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DQ.%26atitle%3DPotent%2520vanilloid%2520receptor%25201%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00031"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00031" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00031_1"><span><span class="NLM_string-ref">Bakthavatchalam, R. Capsaicin receptor ligands. WO 0208221-A1, 2002.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=R.+Bakthavatchalam&title=Capsaicin+receptor+ligands.+WO+0208221-A1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBakthavatchalam%26aufirst%3DR.%26btitle%3DCapsaicin%2520receptor%2520ligands.%2520WO%25200208221-A1%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00032"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00032" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00032_1"><span><span class="NLM_string-ref">Dax, S.; Dublin, A.; Jetter, M.; Nasser, N.; Shah, C.; Swanson, D.; Carruthers, N. I. Vanilloid receptor antagonists:  Structure−activity relationships via parallel and targeted synthesis. <i>  Drugs Future</i><b>2002</b>, <i>27</i> (Suppl. A), 93.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27+%28Suppl.+A&publication_year=2002&pages=93&author=S.+Dax&author=A.+Dublin&author=M.+Jetter&author=N.+Nasser&author=C.+Shah&author=D.+Swanson&author=N.+I+Carruthers&title=Vanilloid+receptor+antagonists%3A%E2%80%89+Structure%E2%88%92activity+relationships+via+parallel+and+targeted+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDax%26aufirst%3DS.%26atitle%3DVanilloid%2520receptor%2520antagonists%253A%25E2%2580%2589%2520Structure%25E2%2588%2592activity%2520relationships%2520via%2520parallel%2520and%2520targeted%2520synthesis%26jtitle%3DDrugs%2520Future%26date%3D2002%26volume%3D27%2520%2528Suppl.%2520A%26spage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00033"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00033" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00033_1"><span><span class="NLM_string-ref">Yura, T.; Mogi, M.; Ikegami, Y.; Masuda, T.; Kokubo, T.; Urbahns, K.; Yoshida, N.; Marumo, M.; Shiroo, M.; Tajimi, M.; Takeshita, K.; Moriwaki, T.; Tsukumi, Y. Piperazinecarboxamide derivative. JP 2003192673-A2, 2003.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=192673-1926A2&author=T.+Yura&author=M.+Mogi&author=Y.+Ikegami&author=T.+Masuda&author=T.+Kokubo&author=K.+Urbahns&author=N.+Yoshida&author=M.+Marumo&author=M.+Shiroo&author=M.+Tajimi&author=K.+Takeshita&author=T.+Moriwaki&author=Y+Tsukumi&title=Piperazinecarboxamide+derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYura%26aufirst%3DT.%26atitle%3DPiperazinecarboxamide%2520derivative%26jtitle%3DJP%26date%3D2003%26spage%3D192673%26epage%3D1926A2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00034"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00034" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00034_1"><span><span class="NLM_string-ref">Rami, H. K.; Thompson, M.; Macdonald, G. J. Westaway, S. M.; Mitchell, D. J. Vanilloid receptor modulators. WO 03068749-A1, 2003.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=H.+K.+Rami&author=M.+Thompson&author=G.+J.+Macdonald&author=S.+M.+Westaway&author=D.+J.+Mitchell&title=Vanilloid+receptor+modulators.+WO+03068749-A1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRami%26aufirst%3DH.%2BK.%26btitle%3DVanilloid%2520receptor%2520modulators.%2520WO%252003068749-A1%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00035"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00035" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00035_1"><span><span class="NLM_string-ref">Lee, C.-H.; Bayburt, E. K.; Didomenico, S., Jr.; Drizin, I.; Gomtsyan, A. R.; Koenig, J. R.; Perner, R, J.; Schmidt, R, G.; Turner, S. C.; White, T. K.; Zheng, G. Z. Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor. WO 03070247, 2003.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=C.-H.+Lee&author=E.+K.+Bayburt&author=S.+Didomenico&author=+Jr&author=A.+R.+Gomtsyan&author=J.+R.+Koenig&author=R%2C+J+Perner&author=R%2C+G+Schmidt&author=S.+C.+Turner&author=T.+K.+White&author=G.+Z.+Zheng&title=Fused+azabicyclic+compounds+that+inhibit+vanilloid+receptor+subtype+1+%28VR1%29+receptor.+WO+03070247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.-H.%26btitle%3DFused%2520azabicyclic%2520compounds%2520that%2520inhibit%2520vanilloid%2520receptor%2520subtype%25201%2520%2528VR1%2529%2520receptor.%2520WO%252003070247%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00036"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00036" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00036_1"><span><span class="NLM_string-ref">Tafesse, L.; Sun, Q.; Schmid, L.; Valenzano, K. J.; Rotshteyn, Y.; Su, Xi, Su.; Kyle, D. Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonists. <i>  Bioorg. Med. Chem. Lett</i>. <b>2004</b>, <i>14</i>, 5513−5519.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5519&author=L.+Tafesse&author=Q.+Sun&author=L.+Schmid&author=K.+J.+Valenzano&author=Y.+Rotshteyn&author=+Su&author=+Su&title=Synthesis+and+evaluation+of+pyridazinylpiperazines+as+vanilloid+receptor+1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTafesse%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520pyridazinylpiperazines%2520as%2520vanilloid%2520receptor%25201%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00037"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00037" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00037_1"><span><span class="NLM_string-ref">Chen, J. J.; Zhang, Y.; Hammond, S.; Dewdney, N.; Ho, T.; Lin, X.; Browner, M. F.; Castelhano, A. L. Design, synthesis, activity, and structure of a novel class of matrix metalloproteinase inhibitors containing a heterocyclic P2‘-P3‘ amide bond isostere. <i>  Bioorg. Med. Chem. Lett</i>. <b>1996</b>, <i>6</i>, 1601−1606.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=1606&author=J.+J.+Chen&author=Y.+Zhang&author=S.+Hammond&author=N.+Dewdney&author=T.+Ho&author=X.+Lin&author=M.+F.+Browner&author=A.+L.+Castelhano&author=+Design&title=and+structure+of+a+novel+class+of+matrix+metalloproteinase+inhibitors+containing+a+heterocyclic+P2%E2%80%98-P3%E2%80%98+amide+bond+isostere"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26atitle%3Dand%2520structure%2520of%2520a%2520novel%2520class%2520of%2520matrix%2520metalloproteinase%2520inhibitors%2520containing%2520a%2520heterocyclic%2520P2%25E2%2580%2598-P3%25E2%2580%2598%2520amide%2520bond%2520isostere%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D1606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00038"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00038" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00038_1"><span><span class="NLM_string-ref">Balan, C.; Bo, Y.; Dominguez, C.; Fotsch, C.; Gore, V. K.; Ma, V. V.; Norman, M. H.; Ognyanov, V. I.; Qian, Y.; Wang, X.; Xi, N.; Xu, S. Benzimidazole derivatives and their use as vanilloid receptor ligands. WO 04035549-A1, 2004.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=C.+Balan&author=Y.+Bo&author=C.+Dominguez&author=C.+Fotsch&author=V.+K.+Gore&author=V.+V.+Ma&author=M.+H.+Norman&author=V.+I.+Ognyanov&author=Y.+Qian&author=X.+Wang&author=N.+Xi&author=S.+Xu&title=Benzimidazole+derivatives+and+their+use+as+vanilloid+receptor+ligands.+WO+04035549-A1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBalan%26aufirst%3DC.%26btitle%3DBenzimidazole%2520derivatives%2520and%2520their%2520use%2520as%2520vanilloid%2520receptor%2520ligands.%2520WO%252004035549-A1%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00039"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00039" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00039_1"><span><span class="NLM_string-ref">After our disclosure, Purdue Pharma published a patent application [(a) Sun, Q.; Tafesse, L.; Victory, S. Benzoazolylpiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity. WO 04058754-A1, 2004.] and a short communication [(b) Shao, B.; Huang, J.; Sun, Q.; Valenzano, K. J.; Schmid, L.; Scott Nolan, S. 4-(2-Pyridyl)piperazine-1-benzimidazoles as potent TRPV1 antagonists. <i>  Bioorg. Med. Chem</i>. <i>Lett.</i><b>2005</b>, <i>15</i>, 719−723.] describing the same type of benzimidazole template.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=+After&title=Q."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DAfter%26atitle%3DPurdue%2520Pharma%2520published%2520a%2520patent%2520application%2520%255B%2528a%2529%2520Sun%26btitle%3DQ.%26date%3D2004%26pub%3DLett" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00040"><div class="reference"><div class="NLM_citation" id="rightTab-jm060065yb00040_1"><span><span class="NLM_string-ref">Koch, V.; Schnatterer, S. Chemistry of 3-hydroxypyridine part 2:  Synthesis of 5,6-dihalo-3-hydroxypyridines. <i>  Synthesis</i><b>1990</b>, 499−501.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=499&publication_year=1990&pages=501&author=V.+Koch&author=S+Schnatterer&title=Chemistry+of+3-hydroxypyridine+part+2%3A%E2%80%89+Synthesis+of+5%2C6-dihalo-3-hydroxypyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00040_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DV.%26atitle%3DChemistry%2520of%25203-hydroxypyridine%2520part%25202%253A%25E2%2580%2589%2520Synthesis%2520of%25205%252C6-dihalo-3-hydroxypyridines%26jtitle%3DSynthesis%26date%3D1990%26volume%3D499%26spage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00041"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00041" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00041_1"><span><span class="NLM_string-ref">VanRheenen, V.; Kelly, R. C.; Cha, D. Y. An improved catalytic oxidation of olefins to <i>cis</i>-1,2-glycols using tertiary amine oxides as the oxidant. <i>  Tetrahedron Lett</i>. <b>1976</b>, <i>23</i>, 1973−1976.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1976&pages=1976&author=V.+VanRheenen&author=R.+C.+Kelly&author=D.+Y+Cha&title=An+improved+catalytic+oxidation+of+olefins+to+cis-1%2C2-glycols+using+tertiary+amine+oxides+as+the+oxidant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00041_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVanRheenen%26aufirst%3DV.%26atitle%3DAn%2520improved%2520catalytic%2520oxidation%2520of%2520olefins%2520to%2520cis-1%252C2-glycols%2520using%2520tertiary%2520amine%2520oxides%2520as%2520the%2520oxidant%26jtitle%3DTetrahedron%2520Lett.%26date%3D1976%26volume%3D23%26spage%3D1976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00042"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00042" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00042_1"><span><span class="NLM_string-ref">Chesterfield, J.; McOmie, J. F. W.; Sayer, E. R. Pyrimidines. Part VIII. Halogeno- and hydrazino-pyrimidines. <i>  J. Chem. Soc. </i>(Resumed) <b>1955</b>, 3478−3481.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3478&publication_year=1955&pages=3481&author=J.+Chesterfield&author=J.+F.+W.+McOmie&author=E.+R.+Sayer&author=VIII+Pyrimidines&title=Halogeno-+and+hydrazino-pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00042_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChesterfield%26aufirst%3DJ.%26atitle%3DHalogeno-%2520and%2520hydrazino-pyrimidines%26jtitle%3DJ.%2520Chem.%2520Soc.%2520%2528Resumed%2529%26date%3D1955%26volume%3D3478%26spage%3D3481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00043"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00043" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00043_1"><span><span class="NLM_string-ref">Jaisinghani, H. G.; Khadilkar, B. M. Rapid and efficient synthesis of 1-arylpiperazines under microwave irradiation. <i>  Tetrahedron Lett.</i><b>1997</b>, <i>38</i>, 6875−6876.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=6876&author=H.+G.+Jaisinghani&author=B.+M+Khadilkar&title=Rapid+and+efficient+synthesis+of+1-arylpiperazines+under+microwave+irradiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00043_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaisinghani%26aufirst%3DH.%2BG.%26atitle%3DRapid%2520and%2520efficient%2520synthesis%2520of%25201-arylpiperazines%2520under%2520microwave%2520irradiation%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26spage%3D6876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00044"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00044" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00044_1"><span><span class="NLM_string-ref">All compounds were tested in a separate assay for agonist activity.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+All+compounds+were+tested+in+a+separate+assay+for+agonist+activity.+All+compounds+were+tested+in+a+separate+assay+for+agonist+activity."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00044_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm060065yb00045"><div class="reference"><strong class="refLabel"><a href="#jm060065yb00045" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-jm060065yb00045_1"><span><span class="NLM_string-ref">This result showing that the trifluoromethyl group is the most preferable substituent at position 3‘ of the pyridine ring is consistent with that reported in ref 39b by Purdue Pharma researchers.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+This+result+showing+that+the+trifluoromethyl+group+is+the+most+preferable+substituent+at+position+3%E2%80%98+of+the+pyridine+ring+is+consistent+with+that+reported+in+ref+39b+by+Purdue+Pharma+researchers.+This+result+showing+that+the+trifluoromethyl+group+is+the+most+preferable+substituent+at+position+3%E2%80%98+of+the+pyridine+ring+is+consistent+with+that+reported+in+ref+39b+by+Purdue+Pharma+researchers."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm060065yb00045_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="NLM_notes" id="rightTab-"><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> </h2><div class="NLM_p last"><b>Note Added after ASAP Publication.</b> This manuscript was released ASAP on May 19, 2006, with an incorrect structure for Table 5. The correct version was posted on May 24, 2006. </div></div></div><div class="NLM_notes" id="rightTab-"><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49"><a href="/doi/suppl/10.1021%2Fjm060065y">Supporting Information Available</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Combustion analysis results for all final compounds and synthetic procedures for intermediates that were not included in the Experimental Section. This material is available free of charge via the Internet at <a class="ext-link" href="http://pubs.acs.org" target="_blank">http://pubs.acs.org</a>. </div></div></div><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm060065y/suppl_file/jm060065ysi20060331_062737.pdf">jm060065ysi20060331_062737.pdf (116.86 kb)</a></li></ul></div></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm060065y&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2006.49.issue-12%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm060065y%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm060065y" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                488KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991012c9fa3d18","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
